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Abstract 
This thesis investigates methods of studying brain energy metabolism with a specific focus 
on the substrates oxygen and glucose.  It details the in vitro development and in vivo 
characterisation of microelectrochemical sensors for the detection of brain tissue oxygen, 
and the in vivo characterisation of oxygen and glucose electrodes in the hippocampus 
utilising the technique of long-term in vivo electrochemistry (LIVE).   
Chapter 1 introduces the brain, energy metabolism and neurochemical analysis focusing on 
oxygen and glucose monitoring in the brain.  Chapter 2 discusses the theory relevant to the 
studies performed in this work, whilst Chapter 3 is a detailed description of sensor 
construction and techniques used for the in vivo and in vitro characterisation of the sensors 
utilised in this thesis. 
The results are divided into five sections. The first of these, Chapter 4, details the in vitro 
characterisation of carbon paste electrodes (CPEs) and a Pt-based electrode modified with a 
membrane, methyl methacrylate (Pt-MMA) and makes comparisons between these two 
types of electrodes for use in vivo.  Following on from the in vitro characterisation chapter, 
Pt-MMA electrodes were fully characterised in vivo and comparisons were made with 
previously published CPE data detailed in Chapter 5. 
The development and standardisation of a metal-free electrode for use in conjunction with 
fMRI studies for the detection of brain tissue oxygen is presented in Chapter 6.  The 
complete in vivo characterisation of the fully characterised fMRI compatible O2 electrode 
developed in the previous chapter is detailed in Chapter 7.  
Chapter 8 demonstrates and characterises the simultaneous recording of oxygen and 
glucose using CPEs and a Pt-based glucose biosensor (Pt/PPD/GOx) in the hippocampus of 
freely-moving animals, and utilises these sensors to monitor brain energy metabolism in 
conjunction with a behavioural task.  Finally, overall conclusions in relation to the work 
presented in this thesis are discussed in Chapter 9. 
1. INTRODUCTION 
Chapter 1: Introduction 
2 
1.1 Introduction 
The complexity of the mammalian brain and its function has been of interest for 
hundreds of years.  The brain and spinal cord make up the central nervous system (CNS) 
and the peripheral nervous system (PNS).  The PNS and CNS work in conjunction to 
regulate homeostasis whilst the PNS is responsible for maintaining it.  The brain has a 
multitude of roles such as sensory input and processing, movement coordination, 
sensation, behaviour (Campbell N, 1990), as well as higher cognitive functions such as 
emotions (anxiety, reward), imaginative thought, memory and language (Reinis & 
Goldman, 1982).  The human brain has been divided into 3 main regions: The forebrain, 
midbrain and hindbrain.  A brief summary of these regions and their functions is listed 
below. 
 Forebrain:  The forebrain is the largest part of the brain, most of which is made 
up of the cerebrum. Other important structures found in the forebrain include the 
thalamus, the hypothalamus and the limbic system. 
o Cerebrum; divided into 2 hemispheres connected by a mass of white 
matter, divided into 4 lobes: 
 Frontal lobe; Cortex (motor cortex). 
 Parietal lobe; Cortex (somatosensory cortex). 
 Temporal lobe; Cortex (auditory cortex). 
 Occipital lobe; Cortex (visual cortex). 
o Cerebral Cortex; grey matter, makes up the surface of each hemisphere 
of the cerebrum. 
o Limbic system; a collection of structures within the forebrain,  is 
important in the formation of memories and in controlling emotions, 
decisions, motivation and learning: 
 Amygdala; memory and emotions. 
 Hippocampus; memory and spatial navigation. 
o Thalamus; relays sensory information to the cerebral cortex. 
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o Hypothalamus; regulates visceral functions, such as temperature, 
reproductive functions, eating, sleeping (circadian rhythm) and the 
display of emotion. 
 Midbrain: The midbrain sits between the forebrain and the hindbrain.  It forms a 
major part of the brainstem; the name given to the part of the brain which 
connects the spinal cord and the forebrain.  
o Dorsal surface (tectrum). 
o Ventral surface; cerebral peduncles, fibre bundles that contain axons that 
travel between the cerebral cortex, brainstem and spinal cord.  These 
divide the brain into two halves and each half is divided by a band of grey 
matter, known as the substantia nigra into anterior and posterior regions.   
These structures are important in sensory processes such as vision and 
movement. 
 Hindbrain:  The hindbrain includes the cerebellum, the pons and the medulla 
oblongata which all function to collectively support vital processes in the body. 
o Cerebellum; co-ordination and error-checking during motor, perceptual 
and cognitive tasks. 
o Medulla oblongata; joined to the spinal cord and controls unconscious, 
essential, bodily functions such as breathing, swallowing, blood 
circulation and muscle tone. 
o The Pons; Located above the medulla, serves as a bridge to connect 
the brainstem and the cerebellum. The pons receives information from 
visual areas to control eye and body movements and also plays a role in 
controlling patterns of sleep and arousal. Information is relayed from the 
pons to the cerebellum to control the co-ordination of muscular 
movements and maintain equilibrium. 
The brainstem is made up of the pons, medulla and midbrain. The medulla connects the 
brain to the spinal cord and its motor and sensory tracts allow communication between 
the brain and the rest of the body.  A schematic of the brain can be seen in Figure 1.1. 
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Figure 1.1: Schematic of the human brain detailing the four lobes of the cerebral cortex, the 
cerebellum and the brain stem.  
 
The two main types of cell found in the brain are neurons and glial cells.  Neurons are 
electrically excitable cells that are the functioning units in the brain which processes and 
transmits information through electrical and chemical signals (Figure 1.2).  Glial cells 
provide support, protection and electrical insulation for neurons.  Activation of neurons 
involves a stimulus which causes an electrical impulse (K
+
, Na
+
, Ca
2+
) known as an 
action potential to pass through the axon to the axon terminal.  The axon terminal 
contains synapses, where neurotransmitter release takes place.  The neurotransmitters 
diffuse across the synaptic cleft and bind to receptors embedded in the postsynaptic 
membrane.  The neurotransmitter molecules are either taken up by another neuron or 
quickly degraded by enzymes, terminating the synaptic response. 
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Figure 1.2:  Schematic of a neuron. 
 
This brief outline of the brain regions and their roles show the high complexity of the 
brain not just on an anatomical level but also on a functional and cellular level.  A large 
amount of research has been conducted exploring the structure of the brain as well as the 
roles of neurochemicals in brain metabolism and signalling.   
1.2 Analytical Techniques 
A number of techniques are used to investigate structures, metabolism and 
neurochemicals in the brain ranging from non-invasive techniques such as blood 
oxygenation dependent (BOLD) functional magnetic imaging (fMRI) (Ogawa et al., 
1990; Ogawa et al., 1992), positron emission tomography (PET) (Weaver et al., 2007), 
two-photon fluorescence imaging of NADH (Kasischke et al., 2004), spectroscopic 
analyses, 
1
H-NMR (Mangia et al., 2003) and 
13
C-NMR (Rothman et al., 1992), to 
invasive techniques such as microdialysis (Ungerstedt & Pycock, 1974; Fray et al., 
1996; McNay & Gold, 1999) and in vivo voltammetry (O'Neill et al., 1998; O'Neill & 
Lowry, 2000). 
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1.3 In Vivo Neurochemical Analysis 
1.3.1.1 In Vivo Voltammetry (IVV)  
IVV allows for the direct monitoring of chemicals in the brain’s extracellular fluid 
(ECF). The first reports of voltammetry in the brain date back as far as 1958 (Clark et 
al., 1958; Clark Jr & Lyons, 1965) where oxygen and ascorbic acid were monitored. 
However, Adams and co-workers (Kissinger et al., 1973; Adams, 1976) are credited 
with pioneering the technique.  Many different methodologies have been developed such 
as constant potential amperometry (CPA), cyclic voltammetry (CV), differential pulse 
amperometry (DPA), fast scan voltammetry (FCV) and chronoamperometry.  The basis 
of voltammetric techniques is that a chemical is either oxidised or reduced at the 
sensor’s surface by applying a potential.  The measured faradaic current is proportional 
to the concentration of the chemical at the active surface of the sensor (Marsden et al., 
1988; Adams, 1990).  IVV is a popular choice for neurochemical monitoring and there 
are a number of electroactive species present in the ECF that have been detected using 
this technique such as ascorbic acid (O'Neill & Fillenz, 1985a; Boutelle et al., 1989; 
O'Neill, 1995), homovanillic acid (HVA) (O'Neill & Fillenz, 1985b), uric acid (UA) 
(O'Neill, 1990), nitric oxide (Brown et al., 2005; Finnerty et al., 2012a; Finnerty et al., 
2012b) and oxygen (Lowry et al., 1996; Bolger & Lowry, 2005; Bolger et al., 2011b).  
However, the detection of non-electroactive species such as enzymatic substrates and 
amino acids are not possible without the use of modified electrodes discussed in Section 
1.4.  Biosensors have been developed to monitor substrates such as glucose (Lowry et 
al., 1994b; Hu & Wilson, 1997a; Fillenz & Lowry, 1998; Lowry et al., 1998a; Lowry et 
al., 1998b; Dixon et al., 2002), glutamate (Kulagina et al., 1999; McMahon et al., 
2006a, b; McMahon et al., 2007; Qin et al., 2008; Tian et al., 2009) and lactate (Hu & 
Wilson, 1997b). 
IVV is superior to microdialysis (Section 1.3.1.2) in terms of temporal resolution with 
real-time data acquisition, minimal ECF depletion, smaller probe size and IVV is now 
possible using wireless technology (Serra et al., 2007; Bazzu et al., 2009; Calia et al., 
2009; Russell et al., 2012).  However, the disadvantages of this technique are issues with 
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selectivity and sensitivity, therefore limiting the amount of analytes it is possible to 
measure. The differences in behaviour of the sensors in a tissue matrix and buffer 
solution (Cheng et al., 1979; Dayton et al., 1983; Nicholson & Syková, 1998) can also 
cause disparities between the sensitivity, stability and selectivity of the sensors.  
1.3.1.2 Microdialysis 
Microdialysis is a popular technique for in vivo neurochemical analysis. It allows for the 
sampling of metabolites and neurochemicals. The technique was developed in 1974 
(Ungerstedt & Pycock, 1974) and uses the principle of dialysis.  A membrane in the 
form of a microdialysis probe (Figure 1.3) is implanted into the brain tissue and is 
perfused with a liquid know as the perfusate (i.e. aCSF).  The perfusate equilibrates with 
the ECF by means of diffusion.  The extent of equilibration is dependent on factors such 
as flow rate, membrane length and molecular size.  The dialysate is collected and 
analysed usually by high performance liquid chromatography (HPLC). 
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Figure 1.3: Schematic of a microdialysis probe. 
 
Microdialysis in combination with a suitable detection technique allows for the 
monitoring of time-dependent changes in local tissue chemistry (neurotransmitter release 
and reuptake, drug delivery and energy metabolism) in particular brain regions.  
Microdialysis also allows for the detection of basal concentrations of particular analytes 
as well as physiologically or pharmacologically stimulated release.  The technique has 
proven to be useful in the clinical environment where it has been used to routinely 
monitor head injury patients (Goodman et al., 1999; Hutchinson et al., 2000; Glenn et 
al., 2003) and allowed for the detection of ischemia and secondary brain injury via the 
identification of markers (Zauner et al., 1997; Sarrafzadeh et al., 2003; Vespa et al., 
2003).  The main disadvantages of microdialysis (classical) is its poor temporal 
resolution (30-60 mins (Feuerstein et al., 2010)), although recently reports of real-time 
(30 s) microdialysis with on-line electrochemical detection have been described (Parkin 
et al., 2003; Hopwood et al., 2005; Parkin et al., 2005), depletion of ECF chemicals and 
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large probe size.  However, it is by far superior to other techniques as it offers unlimited 
selectivity for analytes.  
1.4 Electrochemical Sensors 
The advantages of IVV have previously been discussed in Section 1.3.1.1.  The analyses 
of specific substrates is dependent on whether a method of detection for that particular 
substrate has been developed and if so can it be reliably detected without interference 
from other species present in the ECF.  The specificity and selectivity of 
microelectrochemical sensors will be discussed in the subsequent sections.  A chemical 
sensor is a device that transforms chemical information into an analytically useful signal. 
Chemical sensors contain usually two basic components connected in series: a chemical 
(molecular) recognition system (receptor) and a transducer.  Biosensors are chemical 
sensors in which the recognition system utilises a biochemical mechanism (Cammann, 
1977; Clark et al., 1987). 
1.4.1 Biosensors 
There are three sub-divisions of amperometric biosensors (Thévenot et al., 2001).  They 
are categorised by the means by which the electrons reach the electrode surface and are 
defined by the term generation of amperometric biosensors (Wang, 1993). 
 First-generation:  Monitor the consumption of oxygen (McArthur et al., 1962) 
or the production of hydrogen peroxide (H2O2) (Updike & Hicks, 1967).  For the 
oxidation of H2O2 to occur a large over-potential is required which potentially 
results in interference from other oxidisable species such as ascorbic acid. 
 Second-generation:  Include a mediator species which acts as an electron 
transfer agent.  This eliminates the biosensor’s dependence on oxygen which 
removes the need for the high over-potential (El Atrash & O'Neill, 1995).  
However, leaching of potentially toxic mediators from the immobilisation matrix 
(O'Neill & Lowry, 2000) have been reported. 
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 Third-generation:  Involve direct electron transfer between the redox site of the 
enzyme and the active surface of the electrode.  Examples of these biosensors 
include the organic-conducting-salts, examples being tetrathiafulvalene (TTF) 
and tetracyanoquinodimethane (TCNQ) (Albery et al., 1985).  The presence of 
these salts make the surface highly reversible and stable to enzymes (Bartlett, 
2003).  These biosensors have been shown to involve a mediated mechanism 
implying second-generation behaviour (O'Neill & Lowry, 2000).   
This body of work employs first-generation biosensors.  The immobilisation of the 
biological recognition unit of the electrode is one of the main challenges of biosensor 
construction.  The amount of enzyme present on the surface of the electrode has a direct 
effect on the sensitivity of the electrode.  Enzyme immobilisation can be achieved using 
a number of techniques such as physisorption, cross-linking or entrapment in or behind a 
membrane or a mixture of these methods (Pantano & Kuhr, 1995; Eggins, 2002).   
One of the principal difficulties with IVV is the presence of endogenous electroactive 
species.  For first-generation biosensors the principal interferent is ascorbic acid (AA).  
AA oxidises at similar potentials to that of H2O2.  Polymer membranes have been 
employed for interference rejection.  These polymer layers which have a low 
permeability to interferents but still remain permeable to H2O2 are deposited on the 
surface of the electrode.  1,2-diaminobenzene (o-phenylenediamine) has these 
characteristics when electropolymerised onto the electrode surface (Chiba et al., 1987; 
Almeida et al., 1990; Sasso et al., 1990; Lowry & O'Neill, 1994; Losito et al., 2003).  o-
PD also allows incorporation of enzymes into the structure which allowed for the 
successful development of the glucose biosensor containing the enzyme glucose oxidase 
(Lowry et al., 1998b). 
1.5 Oxygen 
Brain tissue oxygen (O2) is one of the most important energy substrates for brain energy 
metabolism with brain cells critically dependent on a continuous supply.  It is thought 
that at any given time the brain consumes approximately 20% of the total O2 used by the 
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body.  O2 is delivered by the blood and the tissue concentration is determined by the 
balance of supply and utilisation (Magistretti et al., 2000).  Molecular O2 was one of the 
first substances to be detected voltammetrically in vivo in the brain (Clark et al., 1958; 
Clark Jr & Lyons, 1965) and in peripheral tissue (Clark Jr & Clark, 1964).  In different 
brain regions the O2 turnover rate varies and it has been established that the cerebral 
cortex has a higher turnover rate than others (Nair et al., 1987).  The concentration of O2 
in the brain varies as supply is altered in different layers of the brain tissue (Baumgärtl et 
al., 1989) and is dependent on the tissue heterogeneity (Murr et al., 1994; Lubbers & 
Baumgärtl, 1997).  O2 tissue concentrations have been reported to range from 40 µM 
(Murr et al., 1994),  50 µM (Zimmerman & Wightman, 1991), 60 µM (Zauner et al., 
1995) to 80 µM (McCreery et al., 1990). 
Carbon-based electrodes such as glassy carbon (Clark Jr & Clark, 1964), carbon fiber 
electrodes (Zimmerman & Wightman, 1991; Zimmerman et al., 1992; Venton et al., 
2003), carbon epoxy (Bazzu et al., 2009) and carbon paste electrodes (Lowry et al., 
1996; Lowry et al., 1997; Bolger & Lowry, 2005; Bolger et al., 2011b) are commonly 
used  for detecting changes in tissue O2.  Carbon electrodes have their advantages and 
disadvantages over noble metal electrodes.  The main advantage of carbon fibre 
electrodes (CFEs) and carbon paste electrodes (CPEs) for use in vivo are that they are 
less susceptible to surface poisoning than noble metal electrodes, which usually require 
the addition of a protective membrane (Wisniewski et al., 2000; Zhao et al., 2001; 
Gifford et al., 2006).  CFEs (Zimmerman & Wightman, 1991) are advantageous due to 
their small diameter (5-50 µm), however if placed closely to blood vessels or  
metabolically active sites the O2 concentration can vary (Lowry et al., 1997).  CPEs are 
advantageous as in vivo they are stable over long periods (O'Neill, 1993; O'Neill & 
Lowry, 1995; O’Neill, 2005; Bolger et al., 2011b).  CPEs have a diameter of 200 µm 
greater than the scale of the capillary zone (<100 µm) (Silver, 1965) which allows 
detection of average tissue O2 levels.  However due to their size they do cause greater 
tissue damage than noble metal electrodes.   
Platinum(Pt)-based electrodes have been shown to be a potential alternative to CPEs to 
monitor brain tissue O2 (Bolger et al., 2011a).  Pt electrodes are easier to manufacture 
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than CPEs and have a smaller diameter (125 µm) resulting in less tissue damage which 
makes them more desirable for use. However, they are prone to surface poisoning 
characteristic of metal-based electrodes and therefore require protective membranes 
making them only suitable for use in short-term experiments.  
1.6 Brain Energy Metabolism 
Increases in brain energy metabolism requirements are thought to have been met by an 
increase in blood flow that delivers glucose and oxygen to the extracellular 
compartment, according to the classical model of brain energy metabolism (Siesjö, 
1978).  In this model there is close coupling between blood flow and the delivery and 
utilisation of glucose and oxygen.  This theory has been replaced by the 
compartmentalisation model known as the astrocyte-neuron-lactate shuttle (ANLS) 
theory (Pellerin & Magistretti, 1994).  This theory hypothesises that lactate produced by 
the astrocytes is used as an energy source by activated neurons.  A causal sequence of 
events is postulated to lead to the uptake of lactate by the neurons, beginning with the 
release of glutamate from nerve terminals upon stimulation whereupon it enters the 
astrocytes surrounding the synaptic complex.  The uptake of glutamate is Na
+
-dependent 
and stimulates Na/K ATPase leading to the uptake of glucose into the astrocytes.  This 
glucose undergoes glycolysis which results in the production of lactate which is 
exported into the extracellular space whereupon it is subsequently taken up by the 
neurons for its ultimate oxidative phosphorylation.  In summary this model suggests that 
increased energy requirements of activated neurons are met by the utlisation of lactate 
not glucose by these neurons and the lactate is being provided by astrocytic glycolysis, 
stimulated by the uptake of glutamate.  This model has been supported by experiments 
using brain slices (Schurr et al., 1988), cell cultures (Tsacopoulos & Magistretti, 1996) 
and NMR (Sibson et al., 1998), however this theory has had many challenges as 
discussed by Fillenz (2005).  The temporal relationships between these processes cannot 
be examined using these techniques therefore in vivo neurochemical analysis has been 
used to monitor changes in metabolic substrates.  As these techniques can be utilised in 
freely-moving animals it is possible to related changes in neuronal activity to specific 
brain regions. 
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Microdialysis has been employed to examine brain energy metabolism.  Using this 
technique it has been demonstrated that there is a stimulation-dependent increase in 
lactate correlated to glutamate uptake (Fray et al., 1996; Demestre et al., 1997) and it 
has been shown that there is a dissociation between increases in regional cerebral blood 
flow (rCBF) and increases in ECF glucose (Fray et al., 1996).  These results support 
employment of lactate as an energy substrate and they also propose that glucose in the 
EC compartment is not directly resulting from the blood vascular compartment. The 
immediate source of EC glucose has led to debate amongst advocates of the 
compartmental model as it has been found that astrocytes in cell culture export lactate 
and not glucose (Dringen et al., 1993) which has led to Magistretti and Pellerin (1996) 
suggesting that glucose enters the EC space directly from the blood stream. 
As discussed previously IVV allows for investigations of the functions and roles of 
specific neurochemicals in neuronal signalling, drug actions, and well-defined 
behaviours in real-time.  A glucose biosensor for use in vivo has been developed for the 
detection of brain glucose (Lowry et al., 2002).  The Pt/PPD/GOx electrode is an 
amperometric biosensor and was constructed by immobilising the enzyme glucose oxide 
(GOx) onto a platinum microelectrode via the polymererisation of poly (o-
phenylenediamine) (PPD) on the electrode surface.  This biosensor was characterised in 
vitro (Lowry et al., 1994a; Lowry et al., 1994b) and subsequently modified, implanted 
and characterised in vivo in freely-moving rats (Lowry et al., 1998b).  The 
characterisation of the Pt/PPD/GOx electrode established the electrode had a high 
sensitivity, selectivity and was not hindered by endogenous species in the brain resulting 
in fowling.  This sensor has been utilised to study brain energy metabolism (Fillenz & 
Lowry, 1998; Lowry & Fillenz, 2001) and is used in conjunction with and oxygen 
(carbon paste) electrodes to simultaneously monitor glucose and oxygen levels in the 
hippocampus (Chapter 8). 
1.7 Conclusions 
In summary, the use of in vivo voltammetry (IVV) and microelectrochemical sensors 
provides advancements in the exploration of metabolic processes such as neurovascular 
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coupling present in the mammalian brain. IVV can provide real-time monitoring of 
metabolic substrates and neurotransmitters which can translate as a useful tool for a 
better understanding of the metabolic and chemical processes in the healthy brain, 
disease states and aid in the development of therapeutic applications such as drug 
discovery.  It also has the potential to be an invaluable clinical tool for the monitoring of 
brain metabolism. 
This thesis details the in vitro development and in vivo characterisation of 
microelectrochemical sensors for the detection of brain tissue oxygen and the in vivo 
characterisation of oxygen and glucose electrodes in the hippocampus.  This chapter 
(Chapter 1) introduces the brain, brain energy metabolism and neurochemical analysis 
focusing on oxygen and glucose monitoring in the brain.  Chapter 2 discusses the theory 
relevant to the studies performed in this work, whilst Chapter 3 is a detailed description 
of sensor construction and techniques used for the in vivo and in vitro characterisation of 
the sensors utilised in this thesis. The in vitro characterisation of CPEs and a Pt-based 
electrode modified with a membrane (MMA) which is potentially suitable for use in the 
clinical environment, and the comparisons between these two types of electrodes are 
presented in Chapter 4.  Chapter 5 details the in vivo characterisation of the Pt-MMA 
electrode characterised in the previous chapter. The development and standardisation of 
a metal-free electrode for use in conjunction with fMRI studies for the detection of brain 
tissue oxygen is presented in Chapter 6 and the full in vivo characterisation of this 
electrode is described in Chapter 7.  Chapter 8 demonstrates and characterises the 
simultaneous recording of oxygen and glucose in the hippocampus of freely-moving 
animals and the use of these sensors to monitor brain energy metabolism in conjunction 
with a behavioural task.  Overall conclusions in relation to the work presented in this 
thesis are discussed in Chapter 9. 
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2.1 Introduction 
This primary aim of this thesis is the in vitro development and subsequent in vivo 
characterisation of microelectrochemical sensors for the detection of brain tissue oxygen 
and the in vivo characterisation of oxygen and glucose electrodes in the hippocampus.  In 
order to accomplish this, two voltammetric electrochemical techniques were employed 
during the course of this project, these being cyclic voltammetry (CV) and constant 
potential amperometry (CPA).  The theory relating to these two techniques is described in 
Section 2.3 and Section 2.4. 
The various oxygen electrodes were characterised using voltammetry by their sensitivity 
(nA/µM) to O2 and R
2
 value.  The Pt-based glucose oxidase (Pt/PPD/GOx) electrodes were 
calibrated by means of their response to the substrate, using Michaelis-Menten kinetics 
(Vmax and KM) and interferent rejection.   
 
The theory of mass transport is a major parameter in all of these techniques, the motion of 
reactants and products to and from the active surface of the electrode. This theory details 
the processes which take place in the bulk liquid medium; it is described in Section 2.2. 
The second process which is involved in all electrochemical techniques is the electron 
transfer which takes places as a species is oxidised or reduced at the active surface. The 
general reaction for this process is detailed in Equation 2.1. 
The generalised equation for the oxidation and reduction of a species at an electrode surface 
is: 
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 neO R  
Equation 2.1 
Where O is the oxidised species, R is the reduced species and n is the number of electrons 
involved in the reaction. 
Mass transport of the reactant to the active surface of the electrode and electron transfer are 
the two main processes involved in this reaction. 
2.2 Mass Transport 
In order to react, a species at an electrode needs to be transported from bulk solution to the 
electrode surface. 
There are three forms of mass transport that can influence an electrolysis reaction. 
 Diffusion 
 Convection 
 Migration 
Diffusion occurs in all solutions and arises from local uneven concentrations of reagents. 
Entropic forces act to adjust these uneven distributions of concentration and are therefore 
the main driving force for this process. Diffusion is described by Fick’s first law (Equation 
2.2): 
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x
c
DJ



 
Equation 2.2 
Where J is the diffusional flux, D is the diffusion coefficient and 
x
c


 is the concentration 
gradient in direction x. The negative sign signifies that material moves down a 
concentration gradient. 
 
Figure 2.1:  A volume segment dx of solution with a concentration gradient, where a flux J is flowing 
from the area of higher concentration to the area of lower concentration.  
Fick’s second law (Equation 2.3) describes how the concentration of material varies as a 
function of time (t) and this can be predicted from the first law 
2
2
x
c
D
t
c





 
Equation 2.3
 
Where c is the concentration and t is time. The steeper the change in concentration, the 
greater the rate of diffusion.  A steady-state current response is obtained: 0







t
c
(no 
change in c with t) for microelectrodes with diameter of between 5-300 µm (O'Neill et al., 
1998) where currents are small and minimal substrate is consumed.  
For any co-ordinate system  is substituted into Equation 2.2 to give Equation 2.4. 
dx 
J(x,t) J(x+dx,t) 
x+dx x 
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cDJ 2  
Equation 2.4 
For all geometries, a generalised version of Fick’s second law (Equation 2.3) is: 
cD
t
c 2


 
Equation 2.5 
 is the Laplace operator, which has varied forms depending upon the coordination of the 
systems.  Electrodes with different geometries have dissimilar forms of the Laplace 
operator. 
For planar (disk) electrodes the species can uniformly access the electrode from the bulk 
solution.  The change in current with respect to time calculated using Fick’s second law 
results in the Cottrell equation (Equation 2.6): 
t
cDnFA
nFAJI


 
Equation 2.6 
Where I is the current measured at the active surface of an area A at time t.  The bulk 
concentration of the species is denoted by c . D is the diffusion coefficient, J is the flux, n 
the number of electrons and F is Faraday’s constant. 
For an electrode of a cylindrical shape with a diameter greater than 50 µm the Laplacian 
Operator takes the form of (Brett & Brett, 1993): 
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Equation 2.7 
In order to solve Fick’s 2nd Law, and thus find the flux variation in time and the diffusion 
limited current, it is necessary to define conditions for the system to obey. These conditions 
specify concentration and/or spatial characteristics, and are defined in relation to time, i.e. 
at t=0. 
Fick’s 1st Law, a species R at the surface of an electrode it is found that the flux, ),0( tJR , is 
proportional to the current density 
A
i
.  This is because the total number of electrons 
transferred per unit time must be proportional to the quantity of R reaching the surface in 
that time t. 
0
0








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RR
x
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Equation 2.8 
where i  is the current, A  is the surface area of the electrode, F  is the Faraday constant 
and n is the number of electrons transferred per molecule that reacts at the surface.   
2.3 Cyclic Voltammetry 
Cyclic voltammetry (CV) is an electrochemical technique which involves the application of 
a triangular waveform potential to drive a redox reaction (Figure 2.2).  An initial potential 
(Ei) where no oxidation occurs, is applied to the working electrode.  The potential is 
increased at a constant scan rate (v) to the maximum potential (Emax).  The scan is then 
reversed until the initial potential has been reached.  As the potential is decreased back to 
the initial starting potential any species that was oxidised on the forward sweep is reduced.  
There is a delay between scans to prevent the previous scan influencing the next scan and 
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measurements are performed in quiescent solutions so that mass transport is diffusion 
controlled. 
 
Figure 2.2:  A cyclic voltammogram potential waveform. 
Two types of current are generated when performing CV.  Current generated from the 
electrochemical process is known as the Faradaic current, fi . The capacitance current, ci , 
know as the background current never dissipates, resulting in constant changes to the 
double layer charge.  It is necessary to subtract the background current which is obtained 
before addition of an analyte to the buffer solution.  This allows for observation of the 
Faradaic current resulting from electrochemical processes of specific analytes of interest.  
 
Figure 2.3:  A typical current-potential profile for a CV of a reversible redox speices. 
Epa 
ipa 
ipc 
Epc 
Potential 
Current 
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Considering the reversible system detailed in Figure 2.3 at Ei only R is present in the system 
so no electron transfere takes place.  As the potential sweeps to positive potentials, electron 
transfer is induced as R is oxidised to O.  Initially the rate of transfer, or the rate of 
oxidation, is limited by the potential. Once a sufficient potential is reached then all R 
reaching the surface is oxidised to O. Further increases in potential from this moment do 
not result in an increased rate of reaction. The process is now being controlled by diffusion 
resulting in larger currents. This occurs until the reverse potential commences. The 
maximum anodic current, ipa, is a balance between the increasing electrochemical rate 
constant, kox, and decreasing surface concentration of R. Before Epa is reached a rapidly 
increasing kox controls i, and at potentials higher than Epa diffusion controls the rate of 
reaction, illustrated in Figure 2.3. 
2.4 Constant Potential Amperometry 
The voltammetric technique used most frequently throughout this project was constant 
potential amperometry (CPA).  During CPA the current resulting from the oxidation or 
reduction of an analyte is recorded, occurring from the application of a fixed applied 
potential.  Diffusion is the only form of mass transport considered to be occurring within 
the system (Section 2.2).  After the initial application of a fixed potential the capacitance 
currents associated with the charged layers at the active surface of the electrode decay, 
resulting in steady-state diffusion-limited currents associated only with substrate reaction at 
the surface.  The applied potentials used in this project were chosen so that all substrate 
reaching the surface of the electrode was oxidised/reduced which is known as 
overpotential.  Therefore, amperometric current measured at the electrode is directly 
proportional to analyte concentration at all times.  The current measured is the sum of two 
contributing factors (Equation 2.9); the Cottrell current ( coti ) and the steady-state current    (
ssi ).  
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ssiiI cotamp   
Equation 2.9 
The Cottrell component disappears for large values of time, t, and the steady-state current 
predominates. It is these diffusion-limited steady-state currents which are reported in this 
work and for a reversible or irreversible reaction they are given by Equation 2.10 (Forster, 
1994). 
r
nFAcD
iss   
Equation 2.10 
where A  is the surface area of the electrode, F  is the Faraday constant, D is the diffusion 
coefficient, c is the concentration, r is the radius of the electrode and n is the number of 
electrons transferred. 
However, additional factors such as the geometry or the insulation thickness of the 
electrode (Dayton et al., 1980) have an effect on ssi . As a result a geometric factor G is 
incorporated into the equation to consider these influences resulting in Equation 2.11. 
r
nFADc
Giss   
Equation 2.11 
Despite theoretical reports of true steady-state behaviour not being reached by 
microelectrodes, a quasi-steady-state is achieved (Aoki, 1993). This is dependant on, and 
proportional to, the radius of the electrode.  
Chapter 2: Theory 
36 
2.5 Measurement of Dissolved Oxygen 
Electrochemical oxygen electrodes are founded on the electrocatalytic reduction of oxygen 
at the working electrode surface.  A number of mechanisms have been proposed for this 
reaction including a four-electron transfer Equation 2.12) which occurs in a single-step 
without the formation of intermediates (Damjanovic et al., 1967). 
OHeHO 22 244 

 
Equation 2.12 
A two-step process (Equation 2.13 Equation 2.14) has also been reported where hydrogen 
peroxide is formed as a measurable intermediate (Hoare, 1968).   
222 22 OHeHO 

 
Equation 2.13 
 
OHeHOH 222 222 

 
Equation 2.14 
Equation 2.12 involves a
e4 pathway, resulting in the reduction of 2O  to 
OH  or OH2 .  
This reduction may involve a peroxide intermediate adsorbed on the electrode surface but 
does not result in peroxide being present in the solution phase.  The two-step process 
involves the peroxide species, present in the solution phase.  2O  results from the 
decomposition of the peroxide species (Equation 2.15) and is recycled via the reaction 
(Equation 2.13) with the overall reaction being a 
e4 pathway.  
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2222 22 OOHOH   
Equation 2.15 
(Damjanovic et al., 1967) proposed that oxygen reduction is a multi-electron process that 
involves a number of series-parallel pathways.  These pathways are indicated by the rate 
constants 1k , 2k  and 3k  corresponding to the reactions in Equation 2.13, Equation 2.14 
Equation 2.15 respectively. 
 
Figure 2.4:  Proposed mechanism for reduction of oxygen in aqueous electrolytes for Pt electrodes 
(Damjanovic et al., 1967). 
2.6 Enzymes 
Enzymes are biological catalysts which increase the rate of metabolic reactions.  They are 
globular proteins, consisting of long chains of amino acids which are folded into a specific 
shape.  The active site acts as the catalyst where the substrate binds and converts to a 
product. Enzymes are highly substrate specific and this specificity makes them extremely 
desirable in the fabrication of biosensors. Immobilisation of an enzyme on the electrode 
surface allows its corresponding substrates concentration to be monitored indirectly by 
electrochemical means. 
Glucose oxidase, an oxidoreductase enzyme is used in this body of work.  Oxidoreductase 
enzymes catalyse the oxidation and reduction of their respective substrates.  In order for the 
oxidase enzymes to catalyse redox reactions, molecular oxygen (O2) must be present.  
Flavin adenine dinucleotide (FAD) is the reactive redox site of these enzymes and it binds 
the O2 after the enzyme and substrate reaction has taken place in order to convert the 
enzyme back to its original form thus enabling it to react with another substrate molecule.  
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The general scheme of an oxidase enzyme reaction process at the surface of a first 
generation biosensor is illustrated in Figure 2.5.  H2O2 is produced when the FAD is 
oxidised and this reacts at the electrode surface to produce a current. 
 
Figure 2.5:  Generalised reaction mechanism of an oxidase enzyme on a first generation biosensor. The 
blue arrows represent reduction and red arrows indicate oxidation. 
2.6.1 Enzyme Kinetics 
The intricate nature of the active site of an enzyme is what allows it to selectively react 
with only one or a limited number of substrates, which leads to complex reaction 
mechanisms.  The overall kinetic parameters of a specific reaction can be determined by 
examining these reactions in a generalised manner.  A single substrate enzyme-catalysed 
reaction where one substrate-binding site is present results in the following general enzyme 
kinetic equation (Equation 2.16).   
E + S ES E + P
k1
k-1
k2
k-2
 
Equation 2.16 
where E  is the enzyme, S  is the substrate , ES  is the enzyme-substrate complex, P  is the 
resulting product of the reaction and k refers to the rate constants for each specific reaction 
Initially it is found in a reaction that the concentration of the product is low and thus the 
reverse reaction of product to the enzyme-substrate complex, indicated by k-2 is negligible. 
H2O2 
O2 
Enzyme/FAD 
Enzyme/FADH
Substrate 
Product 
Electrode 
Active 
Surface 
Chapter 2: Theory 
39 
When experiments were limited to the initial period of the reaction, it follows that the 
product concentration is negligible and the formation of ES  from product by pathway 2k  
can be dismissed.  As a result Equation 2.16 becomes Equation 2.17: 
E + S ES E + P
k1
k-1
k2  
Equation 2.17
 
Michaelis and Menten (1913) derived the rate equation for enzyme catalysis, in which the 
steady-state approximation can be applied to the formation and destruction of the enzyme-
substrate complex, ES .  The rate of change of the concentration of ][ES  with time is 
shown in the Equation 2.18. 
 
][][]][[ 211 ESkESkSEk
dt
ESd
 
 
Equation 2.18 
where ][E  is the concentration of unbound enzyme and ][ES  the concentration of the 
bound enzyme.  Therefore, the total enzyme concentration 0][E , can be substituted into 
Equation 2.18 by Equation 2.19. 
][][][ 0 ESEE   
Equation 2.19 
Combining these two equations and applying the steady-state approximation, where, 
 
0
dt
ESd
, it is found:  
    021101   ESkESkSESkSEk ]][[][][  
Equation 2.20 
From Equation 2.20 it is possible to isolate the concentration of the enzyme-substrate 
complex, giving: 
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21
0
][
][][
][
k
kk
S
SE
ES




  
Equation 2.21 
Replacing the constants  
1
21
k
kk   with KM, the Michaelis constant, further simplifies the 
equation.  Resulting in:  
MKS
SE
ES


][
][][
][ 0  
Equation 2.22 
But the overall rate of reaction, v, is solely dependent on the concentration of the enzyme-
substrate complex and the rate of formation of products, k2, thus: 
          
Equation 2.23 
][ES  has been isolated in order to allow its substitution into the following relationship 
where overall rate of reaction (the rate of formation of products), 2k   is solely dependent on 
it.   
     ][ESk2    
Equation 2.24 
where   is the overall rate of reaction.  Substituting gives: 
     M
KS
SEk


][
][][ 02
  
Equation 2.25 
When substrate concentration is very high all the enzyme exists only as enzyme-substrate 
complex and the limiting initial velocity (rate), maxV , is reached.  Hence, ][S >>KM and  
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     02max
][EkV 
   
Equation 2.26 
and therefore,  
     MKS
SV


][
][max
  
Equation 2.27  
Further assuming that substrate is present in a much higher concentration than the enzyme, 
then the initial substrate concentration, [S]0, is much greater than the initial enzyme 
concentration, 0][S  is much greater than the initial enzyme concentration 0][E  then 
0][][ SS  and as a result Equation 2.27 becomes the Michaelis-Menten equation: 
     
MKS
SV


0
0
][
][max  
Equation 2.28 
where   is the rate of reaction, maxV  is the maximal rate of reaction, 0][S  is the initial 
substrate concentration and MK is the Michaelis constant. 
A rectangular hyperbola is observed when v  is plotted against 0][S  as displayed in Figure 
2.6.  From this graph both maxV   and MK  can be obtained as shown, with MK being ][S
where 
2
maxV . 
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Figure 2.6:  Graph of the reaction rate, v, against substrate concentration, [S]0, for an enzyme 
concentration, [E]0 for a single substrate enzyme catalysed reaction resulting from the Michaelis-
Menten equation (Equation 2.28). 
The hyperbolic response can be seen in Figure 2.6, when more than one molecule of 
substrate binds to a single molecule of enzyme. If each binding site on the enzyme is 
similar and independent the response observed will still be hyperbolic.  If there is an 
increase in affinity to a binding site where the binding of a substrate to one active site on 
the enzyme increases the affinity of other sites on the enzyme to bind more molecules of 
substrate then sigmoidal kinetics are observed, known as the co-operative effect (Ricard & 
Cornish-Bowden, 1987).  The Michaelis-Menten Hill-type equation (Lowry & O'Neill, 
1992; Lowry et al., 1994) is used to quantify the deviation from hyperbolic, idealised 
kinetics and the constants, Vmax and KM,  in this body of work.  It uses the constant α which 
was introduced following work on the aggregation of hæmoglobin and oxygen (Hill, 1910; 
Stryer, 1988).   









][
1
max
S
K
V
i
M
 
Equation 2.29 
where i  indicates the current observed from the electro-oxidation of H2O2 at the surface of 
the electrode. α is used as a measure of deviation from the ideal Michaelis-Menten 
behaviour, with ideal behaviour α=1.  An α value of 2 is indicative of sigmoidal kinetics.   
 
 
KM 
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2.7 Structures and Reactions 
2.7.1 Hydrogen Peroxide 
First generation biosensors (Section 1.4.1) utilising enzymes produce stoichiometrically 
equivalent amounts of H2O2 as the enzyme-substrate reaction occurs.  Platinum is 
commonly used as the electrode material of choice to detect the production of H2O2 (Hall et 
al., 1998).  The process is well known and characterised as a two-electron process 
(Hickling & Wilson, 1951; Lingane et al., 1963).  It is based on a thin oxide film forming 
on the surface of the platinum, with which the H2O2 interacts, similar to that proposed for 
palladium (Gorton, 1985). The mechanism for the oxidation is outlined below in three 
equations (Hall et al., 1998) 
  eHOOH 22222  
Equation 2.30 
22222 2)( OOHPtOHOHPt   
Equation 2.31 
  eHOHPtOHPt 22)(2 22  
Equation 2.32 
 
The complex formation between the oxide film and hydrogen peroxide is described in 
Equation 2.30 and Equation 2.31 describes the breakdown of this complex releasing water 
and oxygen and leaving behind an unoxidised metal surface. Finally in Equation 2.32 it is 
seen that the water recombines with the platinum surface to release two protons and two 
electrons. It is these electrons which produce the current that is measured and related 
directly to the concentration of substrate in solution. 
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2.7.2 Glucose 
The enzyme glucose oxidase is an oxidoreductase enzyme discussed in Section 2.6.  It 
catalyses the oxidation of β-D-glucose into D-glucono-1,5-lactone, which then hydrolyses 
to gluconic acid (Wilson & Turner, 1992) as can be seen in Figure 2.7.  H2O2 is produced 
when the FAD is oxidised and this reacts at the electrode surface to produce a current.  
 
Figure 2.7:  Reaction mechanism for the oxidation of β-D-glucose into D-glucono-1,5-lactone. 
2.7.3 Electropolymerisation of o-Phenylenediamine 
Poly-o-phenylenediamine (PPD) can be polymerised onto the active surface of the 
electrode by electropolymerisation in a neutral electrolyte to form an insulating polymer 
(Malitesta et al., 1990). This insulating film of PPD prevents further electropolymerisation, 
thereby resulting in a reproducible coating.  This coating blocks out any interferent species 
larger than the o-phenylenediamine monomer (Sasso et al., 1990) and therefore it has been 
used as an interference rejection layer in biosensor design (Lowry et al., 1994; Lowry & 
O'Neill, 1994; Rothwell et al., 2010).  Little is still known about the structure of PPD and 
the mechanism by which polyimerisation occurs, particularly under neutral conditions (Li 
et al., 2002). Two different structures of PPD are proposed which appear to be dependent 
on polymerisation conditions.  Under conditions of low pH (<1) it is believed that the 
structure is a phenazine-like ‘ladder’ structure, see Figure 2.8.  This is the most commonly 
reported structure, supported by work on infrared, Raman and UV-Vis spectroscopy, quartz 
Chapter 2: Theory 
45 
microcrystal balance studies, radiometry and electrochemical techniques (Bilal et al., 
2011).   
 
 
Figure 2.8:  Proposed phenazine “ladder” like structures of PPD where A: the oxidised form (Sayyah et 
al., 2009) and B: non-oxidised form (Bilal et al., 2011). 
 
The more ‘open’ or polyaniline-like 1,4-substituted benzenoid-quinoid structure (Yano, 
1995) can be seen in Figure 2.9.  A mechanism for the polymerisation of o-PD to PPD with 
the ‘open’ structure has been proposed (Sayyah et al., 2009). In this project this ‘open’ 
polymer that self-insulates as it polymerises producing a film of ca.10 nm (Malitesta et al., 
1990) is hypothesised to be produced under neutral pH conditions. 
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Figure 2.9:  Proposed 1,4-substituted benzenoid-quinoid structure of PPD, ‘open’ structure (Losito et 
al., 2001). 
2.7.4 Ascorbic Acid  
Ascorbic acid (AA) is one of the main endogenous interferents in electrochemical analysis 
as it’s an electroactive species present in the ECF (Grunewald et al., 1983)  that is readily 
oxidised at metal electrodes, with an E½ in the range -100 to +400 mV vs. SCE (O'Neill et 
al., 1998).  The oxidation of AA at the surface of a platinum electrode involves a 2H
+
, 2e
-
 
mechanism resulting in the production of L-dehydroascorbic acid which rapidly forms an 
electro-inactive open chain product, L-2-3-diketogulonic acid.  The reaction mechanism is 
shown in Figure 2.10. 
  
Figure 2.10:  Reaction mechanism for the oxidation of AA to the electro-inactive product L-2,3-
diketogulonic acid 
Chapter 2: Theory 
47 
2.8 Data Analysis 
Constant potential amperometry (CPA) experiments were performed and relevant data was 
extracted using LabChart 6 software.  Data was exported and either preliminarily processed 
in Microsoft
®
 Excel
®
 or directly analysed in GraphPad Prism
®
 5. 
2.8.1 Linear and Non-Linear Regression 
Linear regression fit was the most commonly used analysis in this body of work and was 
applied to O2 calibrations performed in vitro.  Non-linear regression fits taking the form of 
the Michaelis-Menten equation and the modified Hill-Type equation (see Section 2.6.1) 
were applied to in vitro glucose, enzymatic calibrations. Regression analyses allowed for 
comparisons and for further statistical analysis to be performed. 
2.8.2 Statistical Analysis 
Parametric t-tests allowed for the comparison of two data sets with a quantitative 
examination of the statistical difference between the results.  Unpaired t-tests were 
performed on the mean of the data for the majority of analysis.  However, paired t-tests 
were performed on individual data sets for particular analysis where appropriate.  GraphPad 
InStat
®
 as well as GraphPad Prism
®
 5 was used for t-tests.  Area under the curve (AUC) 
analysis was performed on normalised in vivo data to determine the mean change from the 
baseline signal.  For multiple comparisons, repeated-measures and mixed-factorial analysis 
of variance tests (ANOVA) with either standard Tukey-Kramer Multiple Comparison or 
Bonferroni post-hoc analysis used, where appropriate. 
The P value is a probability, where 0 ≤ P ≤ 1.  It describes the statistical difference between 
two values and allows one to decide whether or not it is significantly different.  Small P 
values indicate that the sampled populations have different means (i.e. difference is 
unlikely to be due to chance) and that the results are significantly different. The standard 
95% confidence interval was used for these tests, so a P-value less than 0.05 would indicate 
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that there was a significant difference between the two sets of data analysed, whereas a P-
value higher than 0.05 would indicate no significant difference.   
 
For one-way ANOVA, the F value (F-test) is used to assess whether the expected values of 
a quantitative variable within several pre-defined groups differ from each other and df 
denotes the degrees of freedom. 
The R
2
 value is a measure of the goodness of fit of a data set to a regression (linear and 
non-linear), where 0 ≤ R2 ≤ 1.  An R2 value of 1 indicates a perfect fit, where all points lie 
directly on the line or curve which is proposed as the fit. A value of 0 indicates that there is 
no relationship between the X and Y values in the data set and that it is not possible to 
assign the chosen trend, linear or non-linear, to them. 
2.8.3 Current Densities 
For electrodes with varying physical dimensions to be compared it is necessary to convert 
current values into current density values ( J ).  This allows for current per unit area, J  
(µA.cm
-2
), to be calculated. Equation 2.33 gives the formula for calculation of the current 
density: 
A
I
J 
 
Equation 2.33 
where J  is the current density, I  is the current and A  is the area of the active surface of 
the electrode.   
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2.8.4 Dissolved Oxygen – Temperature dependence 
For oxygen calibrations performed at 37°C the dissolved oxygen (Do) was determined to be 
214 µM for air saturated solutions and 1020 µM for O2 saturated solutions.  These values 
were calculated using Do = 6.856 mg/L for an air saturated (21 % O2) solution. 
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3.1 Introduction 
This experimental chapter details the design, fabrication and characterisation, in vitro and 
in vivo, of various sensors for the detection of energy substrates in the brain.  The 
electrodes are based on previous sensor development work by the Lowry research group 
(O'Neill et al., 1998).  Carbon paste based electrodes were founded on work by (Lowry et 
al., 1996), carbon composite electrodes on work by (Bazzu et al., 2009),  a standardised 
sensor for O2 detection in an fMRI scanner based on a carbon fibre electrode (Lowry et al., 
2010) and platinum-based sensors on work by (Lowry et al., 1994).   
Sections 3.2 and 3.3 describe computer-based instrumentation, chemicals, enzymes and 
solutions.  The preparation of various electrodes are detailed in section 3.4 as well as 
electrode modifications in section 3.5. 
Electrochemical experiments in vitro are detailed in section 3.6 and all in vivo procedures 
and experiments in section 3.7. 
3.2 Computer-Based Instrumentation, Equipment & Software 
All electrochemical experiments throughout the course of this work involved the use of: 
 A computer  
 An interface:  A Powerlab® or e-corder 
 A potentiostat:  A Biostat or Quadstat 
3.2.1 Potentiostat, CPU & Data Acquisition 
All in vitro electrochemical experiments (constant potential amperometry, CPA) and cyclic 
voltammetry, CV) were performed using a low noise potentiostat (Biostat IV, ACM 
Instruments, Cumbria, UK). Data acquisition was performed using a PowerLab
®
 interface 
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system (ADInstruments Ltd; Oxford, UK) and a Logiq notebook computer (Clevo, 
Berkshire, UK) or an Apple iMac Computer.  The software packages used were LabChart 
for Windows and iMac (Version 6) and EChem for Windows Version 1.5.2 
(ADInstruments Ltd.). 
In vivo freely-moving CPA experiments were performed using low noise potentiostats 
(Biostat IV, ACM Instruments, Cumbria, UK, and Biostat II, with a head-stage amplifier 
from Electrochemical and Medical Systems (EMS), Newbury,UK.  Data acquisition was 
performed using a PowerLab
®
 interface system (ADInstruments Ltd; Oxford, UK) and an 
Apple iMac Computer.  The software package used was LabChart for Mac (Version 6.1). 
In vivo +-maze based CPA experiments were performed using a QuadStat (Model EA164) 
and data acquisition was performed using an e-corder 410 (Model ED410).  The software 
packages used was Edaq chart (Version 5) for Windows. 
The graphical and statistical analysis of acquired data was performed using Microsoft Excel 
2010, GraphPad InStat
®
 and Prism
® 
(Version 5.01) from GraphPad Software, Inc. 
California, USA. 
3.2.2 Additional Equipment 
Air pump: The air pump used for O2 experiments was a Rena Air 200 from RENA
®
, France 
Anaesthetic unit: A multi-system set-up consisting of a vaporiser for induction (Univentor 
400 Anaesthesia unit), an air pump (Stellar S3), an induction chamber with a 1.4 L 
capacity, a gas routing switch and stereotaxic inhalation mask which were all supplied from 
Agnthos, Sweden. 
Carbon fibre bundle wire: Goodfellow Cambridge Ltd; UK. 
Carbon fibre wire (PVA coated 1mm):  World Precision Instruments, Hertfordshire, UK. 
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Conducting silver epoxy: Circuit Works CW2400, RS Components Ltd; UK. 
Electrode wire: All Teflon
®
 coated platinum, silver and gold wire was obtained from 
Advent Research Materials, Suffolk, UK. 
Electronic Balance: Sartorius LA230D, Sartorius Stedim UK Limited, Dublin. 
Gold clips: In vitro- Fine Science Tools, UK. In vivo - Plastics One, VA, USA. 
Hamilton syringe: Fisher Scientific Ireland, Dublin. 
Heat shrink: RS Components Ltd; UK. 
Incubator: The incubator used for animal recovery a Thermacage MKII supplied by 
Datesand Ltd; UK. 
Insulated Copper wire: 1mm PVA insulated Copper wire, RS Components Ltd; UK. 
Magnetic Stirring Plate: Yellowline IKA MST Mini Magnetic Stirrer, Lennox, Ireland.  
Microscope: The microscope used for electrode preparation was an Olympus SZ51, Mason 
Technology, Dublin.  
pH meter: S20 Seven Easy Multi pH Meter, Mason Technology, Dublin.  
Silica tubing: SGE Analytical Science supplied by VWR International Ltd; Dublin, 
Ireland. 
Solder and soldering iron: Weller - WTCP 51, Farnell, UK. 
Sonicator: Fisherbrand, FB11002, Fisher Scientific Ireland, Dublin. 
Stereotaxic frame: The stereotaxic frame used was sourced from Kopf, CA, USA. 
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Surgical Screws: Plastics One, VA, USA 
Teflon
®
 Pedestal: Plastics One, VA, USA. 
Temperature Probe:  For temperature experiments a magnetic stirrer/hotplate (IKA MST 
Basic C, Lennox Laboratory Supplies Ltd; Dublin, Ireland) was used. Solution temperature, 
were indicated was controlled using a TC1 temperature controller (IKA). 
Vortex: The Vortex (Reax Control, Heidolph, Essex, UK) was used to uniformly mix 
solutions by agitation.  
3.3 Chemicals, Enzymes, Composites and Solutions 
3.3.1 In Vitro Chemicals 
Acetone       Sigma-Aldrich Co. 
Bovine Serum Albumin (Fraction V)    Sigma-Aldrich Co. 
Collodion        Fluka  
Conductive Carbon Paste     SPI Supplies Inc.  
Epoxy Resin       Sigma-Aldrich Co.  
Graphite Powder      Sigma-Aldrich Co. 
L-α-phosphatidylethanolamine (PEA)   Sigma-Aldrich Co. 
Methyl Methacrylate (MMA)     Sigma-Aldrich Co. 
Nitrogen Gas       BOC, Ireland 
Chapter 3: Experimental 
58 
o-Phenylenediamine      Sigma-Aldrich Co. 
Oxygen Gas       BOC, Ireland 
Rhoplex
® 
      General Paints Ltd. 
Silicone oil       Aldrich Chemical Co. 
Sodium Chloride      Sigma-Aldrich Co. 
Sodium Hydroxide      Sigma-Aldrich Co. 
Sodium Phosphate      Sigma-Aldrich Co. 
3.3.2 In Vivo Chemicals 
Acetazolamide (Diamox)     Sigma-Aldrich Co. 
Buprenorphine hydrochloride  (Tamgestic)   Sigma-Aldrich Co. 
Chloral Hydrate      Sigma-Aldrich Co. 
Dental acrylate      Sigma-Aldrich Co. 
Dimethylsulfoxide (DMSO) for molecular biology  Sigma-Aldrich Co. 
Isoflurane       Abbott Laboratories. 
3.3.3 Enzymes 
Glucose oxidase (49180)     Sigma-Aldrich Co. 
Glucose oxidase (Aspergillus niger)    Sigma-Aldrich Co. 
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Glucose oxidase (Aspergillus niger)    Genzyme Chemical Co. 
Glucose oxidase (G2133 50KU)    Sigma-Aldrich Co. 
3.3.3.1 Enzyme substrates 
D-(+)-Glucose       Sigma-Aldrich Co. 
3.3.4 Solutions 
3.3.4.1 In Vitro Solutions 
Artificial Cerebro Spinal Fluid (aCSF) 
This was prepared by dissolving 8.9 g NaCl (0.15 M), 0.298 g KCL (0.004 M), 0.176 g 
CaCl2 (0.0016 M) and 0.204 g MgCl2 (0.021 M) in 1 L of H2O.   
Ascorbic Acid (AA) 
A 0.1 M standard solution was prepared by dissolving 0.176 g in 10 ml H2O.  The solution 
was N2 saturated and prepared freshly before use. 
Bovine Serum Albumin (BSA) 
A 10% (w/v) solution was prepared by dissolving 0.1g in 1 ml H2O. 
Glucose 
A 1 M standard solution was prepared by dissolving 9.01g of glucose in 50 ml H2O.  The 
solution was prepared 24 hours before use and stored at room temperature to allow 
complete mutarotation of the anomers. 
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L-α-phosphatidylethanolamine (PEA) 
A 10% solution was prepared by dissolving 0.140 g in 1 ml H2O. 
o-Phenylenediamine (o-PD) 
A 300 mM (saturated) solution was prepared by dissolving 0.324 g in 10 ml of N2 saturated 
PBS.  A sonic bath was used for a minimum of 10 minutes to agitate the solution and 
ensure maximum dissolution. 
o-Phenylenediamine /Glucose oxidase (o-PD/GOx) 
A 300 mM solution of o-PD was prepared as previously described.  5 mg/ml of GOx was 
incorporated into 5 ml of o-PD solution. 
Phosphate Buffer Saline (PBS) pH 7.4 
This was prepared by dissolving 8.9 g NaCl (0.15 M), 1.76 g NaOH (0.044 M) and 6.86 g   
NaH2PO4.2H2O (0.044 M) in 1 L of H2O.  The pH was adjusted to 7.4 as required and the 
solution was N2 saturated for a minimum of one hour. 
PBS pH 6.5 & 8 
This was prepared by dissolving 8.9 g NaCl (0.15 M), 1.76 g NaOH (0.044 M) and 6.86 g   
NaH2PO4.2H2O (0.044 M) in 1 L of H2O.  The pH was adjusted to pH 6.5 using NaH2PO4 
and pH 8 using NaOH. 
3.3.4.2 In Vivo Solutions 
Chloral Hydrate 
For systemic administration 350 mg/kg/1 ml was prepared in 0.9 % saline solution. 
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Acetazolamide (Diamox) 
For systemic administration 50 mg/kg/1.5 ml was prepared in 0.5 ml 0.9 % saline solution 
and 1 ml DMSO. 
Glucose soultion 
For systemic administration 250 mg/kg/1 ml was prepared in 0.9 % saline solution. 
Normal Saline Solution 
A 0.9% solution was prepared by dissolving 0.9 g NaCl in 100 ml H2O. 
3.3.5 Composites 
Carbon Paste 
0.71 g of graphite powder was mixed with 250 µl of silicone oil.  This was done by 
continuous mixing in a pestle and mortar for 3 hours to ensure that the two components 
were completely amalgamated. 
Carbon Polyvinyl Acetate (PVA) 
Three PVA based composites were used throughout this project with varying amounts of 
graphite powder.  
0.05 g PVA/0.01 g carbon 
0.05 g PVA/0.02 g carbon 
0.05 g PVA/0.03 g carbon 
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The graphite powder was weighed and mixed with PVA using a needle on a non-absorbent 
acetate sheet.  
Carbon Rhoplex
®
 
Rhoplex
®
 based composites were used throughout this project with varying amounts of 
graphite powder.  
0.05 g Rhoplex
®
/0.01 g carbon 
0.05g Rhoplex
®
/0.02 g carbon 
0.05 g Rhoplex
®
/0.03 g carbon 
0.01g Rhoplex
®
/0.05g carbon  
0.005g Rhoplex
®
/0.0125g carbon 
The graphite powder was weighed and mixed with Rhoplex
®
 using a needle on a non-
absorbent acetate sheet. 
3.4 Electrode Preparation 
3.4.1 Carbon Paste Electrodes 
All carbon paste electrodes (CPE) were prepared by trimming approximately 4.5 cm 
lengths of 200 µm Teflon
®
-
 
insulated silver wire (200 µm bare diameter, 270 µm coated 
diameter (8T), Advent Research Materials, Suffolk, UK).  The wire was carefully cut at 
both ends using a sharp scalpel to create an even disk surface.  3 mm of the wire was 
exposed by removing the Teflon
®
 from one end of the wire and the Teflon
®
 was carefully 
pushed up the wire to create a 2 mm cavity.  The cavity was then packed with carbon paste 
(Section 3.3.5) by dipping the tip of the electrode into a small amount of the paste which 
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was packed in using a bare silver wire as a plunger.  This process was repeated until the 
cavity was completely packed. A flat active surface at the tip of the electrode was obtained 
by gently tapping the electrode off a hard, flat surface.  The 3 mm of exposed wire was 
soldered into a gold clip for electrical conductivity and rigidity.  
 
 
Figure 3.1:  Schematic representation of a carbon paste electrode. 
3.4.2 Silver based carbon composite electrodes 
Carbon composite electrodes were prepared by trimming approximately 4.5 cm lengths of 
200 µm Teflon
®
-
 
insulated silver wire (200 µm bare diameter, 270 µm coated diameter 
(8T), Advent Research Materials, Suffolk, UK).  The wire was carefully cut at both ends 
using a sharp scalpel to create an even disk surface.  3 mm of the wire was exposed by 
removing the Teflon
®
 from one end of the wire and the Teflon
®
 was carefully pushed up 
the wire to create a 2 mm cavity.  The cavity was then packed with a carbon composite 
(section 3.3.5) by dipping the tip of the electrode into the paste.  This process was repeated 
until the cavity was completely packed.  A flat active surface at the tip of the electrode was 
obtained by gently tapping the electrode off a hard, flat surface.  The 3 mm of exposed wire 
was soldered into a gold clip for electrical conductivity and rigidity.  
 
 
Figure 3.2:  Schematic representation of a silver based carbon composite electrode. 
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3.4.3 Carbon Rhoplex® composite electrodes fMRI design (CRCEs) 
A 4.5 cm length of 200 µm Teflon
®
-insulated silver wire (200 µm bare diameter, 270 µm 
coated diameter (8T), Advent Research Materials, Suffolk, UK) was cut at both ends using 
a sharp scalpel to create an even disk surface.  The Teflon
®
 was carefully removed from the 
wire and a bundle of carbon fibres was inserted into the Teflon
®
.  The carbon fibres were 
trimmed at one end and pulled gently back through the Teflon
®
 creating a cavity of ~ 1 
mm.  The opposite end was glued with a small amount of superglue and left to dry.   
5 mm from both ends of a 20 cm length of coated copper was removed and a gold clip was 
soldered at one end for electrical contact and connection to the system.  An 11 cm length of 
polyamide coated carbon fibre was cut and 5 mm of coating removed from either end of the 
wire.  Using conductive silver epoxy the wire was adhered at one end to the Teflon
® 
containing the carbon fibres and to the copper wire at the other.  Both connections were 
carefully sealed avoiding the Teflon
®
 with clear heat shrink and a small amount of 
superglue.   
3.9 cm of polyamide coated carbon fibre was cut and the carbon fibre bundle was removed 
from the coating.  The Teflon
®
 containing the carbon fibres was then inserted into the 
polyamide coating and glued.  This was then sealed with heat shrink and glued. 
When dry a 1 cm length of silica (320 µm i.d./430 µm o.d.) was cut and both sides were 
polished with fine sandpaper.  A silver wire was pushed through the silica tubing to remove 
any residue on the inside of the tube.  The Teflon
®
 coating the carbon fibres was then 
inserted into the silica, with a small amount of the fibres visible at the cavity end of the 
Teflon
®
 and the silica was glued to the polyamide coating. 
The carbon Rhoplex
®
 composite was fabricated by mixing 0.03 g of carbon with 0.05 g of 
Rhoplex
®
.  This was mixed thoroughly and carefully packed by gently dipping the Teflon
®
 
cavity into the mixture.  The electrode was checked frequently through this process to 
ensure sufficient packing of the cavity.  When completed the tip of the electrode was tapped 
off a clean dry surface to ensure the active surface was a uniformly flat, smooth disk shape.  
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The electrodes were left to dry for 24 hours with the active surface flat against a hard 
surface to prevent the glue from displacing.  After 24 hours the packing was checked and 
any excess composite on the outer Teflon
®
 was removed carefully using a needle.  
 
Figure 3.3:  Schematic representation of a CRCE full fMRI design. 
 
3.4.4 Carbon Rhoplex® composite electrodes in vivo freely-moving design (CRCEs) 
A 3 cm length of 200 µm Teflon
®
-insulated silver wire wire (200 µm bare diameter, 270 
µm coated diameter (8T), Advent Research Materials, Suffolk, UK) was cut at both ends 
using a sharp scalpel to create an even disk surface.  The Teflon
®
 was carefully removed 
from the wire and a bundle of carbon fibres was inserted into the Teflon
®
.  The carbon 
fibres were trimmed at one end and pulled gently back through the Teflon
®
 creating a 
cavity of ~ 1 mm.  The opposite end was glued with a small amount of superglue and left to 
dry. 
1 mm from both ends of a 3 cm length of coated copper was removed and a gold clip was 
soldered at one end for electrical contact and connection to the system.  
Using conductive silver epoxy the copper wire was adhered to the carbon fibres.  This 
connection was carefully sealed avoiding the Teflon
®
 with clear heat shrink and a small 
amount of superglue.   3 cm of polyamide coated carbon fibre was cut and the carbon fibre 
bundle was removed from the coating.  The Teflon
®
 containing the carbon fibres was then 
inserted into the polyamide coating and glued to the heat shrink.  This was then sealed with 
heat shrink and glued. 
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When dry a 1 cm length of silica (320 µm i.d./430 µm o.d.) was cut and both sides were 
polished with fine sandpaper.  A silver wire was pushed through the silica tubing to remove 
any residue on the inside of the tube.  The Teflon
®
 coating the carbon fibres was then 
inserted into the silica, with a small amount of the fibres visible at the cavity end of the 
Teflon
®
 and the silica was glued to the polyamide coating. 
The carbon Rhoplex
®
 composite was fabricated by mixing 0.03 g of carbon with 0.05 g of 
Rhoplex
®
.  This was mixed thoroughly and carefully packed by gently dipping the Teflon
®
 
cavity into the mixture.  The electrode was checked frequently through this process to 
ensure sufficient packing of the cavity.  When completed the tip of the electrode was tapped 
off a clean dry surface to ensure the active surface was a uniformly flat, smooth disk shape.  
The electrodes were left to dry for 24 hours with the active surface flat against a hard 
surface to prevent the glue from displacing.  After 24 hours the packing was checked and 
any excess composite on the outer Teflon
®
 was removed carefully using a needle.  
 
Figure 3.4:  Schematic representation of a CRCE freely-moving design. 
 
3.4.5 Disk platinum electrodes 
Platinum based disk working electrodes were prepared by trimming approximately 4.5 cm 
lengths of 200 µm Teflon
®
-
 
insulated Pt/Ir (90%/10%) wire (125 µm bare diameter, 175 µm 
coated diameter (5T), Advent Research Materials, Suffolk, UK).  The wire was carefully 
cut at both ends using a sharp scalpel to create an even disk surface.  3 mm of the wire was 
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exposed by removing the Teflon
®
 from one end of the wire and this was soldered into a 
gold clip for electrical conductivity and rigidity. 
 
Figure 3.5:  Schematic representation of a Pt-disk electrode. 
3.5 Electrode Modifications 
3.5.1 Electropolymerisations 
To prevent interference from endogenous electroactive species such as ascorbic acid some 
electrodes were modified by generating a size exclusion polymer over the active surface of 
the electrodes.   
The electrodes were electropolymerised using a standard three-electrode cell consisting of 
four working electrodes, a bare platinum wire as an auxiliary electrode and a SCE reference 
electrode.  A nitrogen (N2) atmosphere was maintained throughout the polymerisation as 
the solution is liable to oxidation in air.  The cell was set up and N2 saturated prior to the 
preparation of the monomer.  The monomer solution was transferred to the cell and the lid 
replaced immediately.  When the polymerisation was complete the working electrodes were 
instantly removed from the monomer solution, dipped in H2O and allowed to dry for a 
minimum 1 hour before further use.   
3.5.1.1 Poly-o-phenylenediamine Modified Electrodes (PPD) 
A 300 mM solution of o-Phenylenediamine (o-PD) was prepared as described previously 
(section 3.3.4.1).  The solution was placed in a previously set up N2 saturated cell and a 
potential of +700 mV vs. SCE was applied to the working electrodes for 30 minutes.   The 
Chapter 3: Experimental 
68 
electrodes were removed from the monomer solution, rinsed in H2O and allowed to dry for 
1 hour before further use.  The electrodes were stored in the refrigerator at 4 ˚C when not in 
use. 
3.5.2 Metal based modified O2 electrodes 
3.5.2.1 MMA modified O2 electrodes 
A Pt disk electrode was placed in pure MMA monomer solution for a period of 5 s, 
removed and allowed to dry at room temperature for a minimum of 1 h before use.  The 
electrode was stored in the refrigerator at 4 ˚C when not in use. 
3.5.3 Enzyme based Electrodes 
3.5.3.1 Poly-o-phenylenediamine/Glucose Oxidase Modified Electrodes 
For the detection of the substrate glucose the enzyme glucose oxidase (GOx) was 
incorporated in to the PPD polymer by means of entrapment.  A 300 mM solution of o-PD 
was prepared as described (Section 3.3.4.1).  5mg/ml of GOx was added to the o-PD 
solution which was agitated using a vortex to amalgamate the monomer and the enzyme.  
Pt disk electrodes were usually polymerised using 5 ml of monomer with 25 mg of GOx to 
minimise the amount of enzyme for cost effective purposes.  
3.5.4 Electrode treatments and stability 
To determine the electrode’s viability in the in vivo environment the effects of proteins and 
lipids were investigated.  The proteins and lipids naturally occurring in endogenous tissue 
can have an effect on the sensitivity of the electrodes (Ormonde & O'Neill, 1989, 1990) .  
To determine if the electrodes are liable to a reduction in sensitivity they were exposed to 
bovine serum albumin (BSA), L-α-phosphatidylethanolamine (PEA) and ex-vivo brain 
tissue samples.   
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Stability was examined to investigate the shelf-life of the electrodes with respect to time.  
Electrodes were calibrated, stored in the refrigerator at 4 ˚C and repeatedly recalibrated for 
specified amounts of time (see individual electrodes) to determine if there was a reduction 
in the sensitivity. 
3.5.4.1 BSA treated electrodes 
Previously calibrated electrodes were immersed in a BSA 10% (w/v) solution (Section 
3.3.4.1).  The electrodes remained in the solution for 12 or 24 hours and were recalibrated 
an hour following removal from the BSA solution.  The electrodes were then re-immersed 
in the solution and calibrated after specified amounts of days. 
3.5.4.2 PEA treated electrodes 
Previously calibrated electrodes were immersed in a PEA 10% (w/v) solution (Section 
3.3.4.1).  The electrodes remained in the solution for 12 or 24 hours and were recalibrated 
an hour following removal from the PEA solution.  The electrodes were then re-immersed 
in the solution and calibrated after specified amounts of days 
3.5.4.3 Brain Tissue Treated Electrodes 
Previously calibrated electrodes were placed in a sample of ex-vivo brain tissue.  Small 
amounts of PBS, depending on the amount of sample present, were added to the tissue to 
prevent dehydration.  The active surface of the electrodes remained in contact with the 
brain tissue for 12 or 24 hours and were recalibrated an hour following removal from the 
tissue.  The electrodes were then re-immersed in the brain tissue sample and calibrated after 
a specified amount of days. 
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3.6 Electrochemical Experiments 
 
Figure 3.6:  In vitro electrochemical equipment set-up. 
3.6.1 In Vitro Experiments 
3.6.1.1 Three- Electrode Electrochemical Cell 
All of the in vitro experiments were performed using an in-house manufactured cell.  The 
cell itself was made of glass and a custom lid was used which was constructed using 
Teflon
®
.  The cap consisted of an opening for the reference, auxiliary and working 
electrodes.  The cap also had openings which served as gas and injection inlets.  A 
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magnetic stirring bead was also used when required and all experiments were performed at 
room temperature (21˚C) except when stated. 
 
Figure 3.7:  Schematic of a three-electrode cell set-up used in electrochemical experiments.  
3.6.1.2 Cyclic Voltammetry (CV)  
To determine the oxidation or reduction peak of a species CV is used.  A potential sweep is 
applied to the working electrode from an initial potential to a maximum potential. The 
sweep is inverted and then scanned back to the initial potential.  The parameters used for 
these experiments were between -1000 to +1000 mV vs. SCE at a scan rate of between 20 
to 100 mV/s, however the range used varied between types of electrodes.  All CV 
experiments were performed in a standard three-electrode electrochemical cell.  The 
reference electrode used was a saturated calomel electrode (SCE) and the auxiliary was a 
bare Pt wire.  CV experiments were performed in quiescent solution. 
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3.6.1.3 Constant Potential Amperometry (CPA) 
To calibrate the various types of working electrodes, CPA was used.   A fixed potential was 
applied throughout the experiment which varied according to each specific type of 
electrode and analyte. The applied potential was determined by CV. 
All CPA experiments were performed in a standard three-electrode electrochemical cell. 
The reference electrode used was a saturated calomel electrode and the auxiliary was a bare 
Pt wire.  The potential was applied to the working electrodes which were allowed to settle 
until a stable baseline was reached.  The amount of time for a stable baseline to occur 
varied depending on the working electrodes used. 
3.6.1.4 High concentration Oxygen (O2) Calibrations  
The potential applied to the O2 electrodes was -650 mV vs. SCE (unless otherwise stated). 
The electrodes were allowed to settle before being calibrated. Various concentrations of O2 
were used.  A 0 µM concentration of O2 was firstly obtained by deoxygenating the cell with 
N2 gas.  A 240 µM concentration of O2 was obtained by bubbling air through the buffer 
solution (Bourdillon et al., 1982; Foster et al., 1993).  A 1200 µM concentration of O2 was 
obtained by bubbling pure O2 through the buffer solution until it was saturated (Bourdillon 
et al., 1982). Each was bubbling and quiescent period was for approximately 40 minutes.  
The experiment was continuously recorded and in the absence of agitation steady states 
were chosen for analysis (unless otherwise stated). 
3.6.1.5 Low concentration O2 saturated PBS Calibrations 
To determine the O2 sensitivity of electrodes at low O2 concentrations (0-125 µM) 100 % 
O2 saturated PBS (1.2 mM) was used.  A potential of -650 mV vs. SCE (unless otherwise 
stated) was applied to the electrodes and the PBS was deoxygenated by vigorously 
bubbling N2 into the cell.  When the electrodes had reached a steady state, standard aliquots 
(+416, +425, +434, +443 and +452 ml) of a saturated O2 solution, each containing 25 mM 
O2, were injected into the cell.  The concentration range for the O2 calibrations were:  
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0, 25, 50, 75, 100, 125 µM 
3.6.1.6 Glucose Calibrations 
A potential of +700 mV vs. SCE was applied to the glucose electrodes. The electrodes were 
allowed to reach a steady baseline.  Aliquots of a 1 M glucose stock solution (section 
3.3.4.1) were injected into the PBS solution in the cell.  The PBS was briefly stirred using a 
magnetic stirring bead to uniformly mix the solution.  The concentration range for the 
glucose calibrations were: 
0, 1, 5, 10, 15, 20, 30, 50, 80, 100 mM 
3.6.1.7 Ascorbic Acid (AA) Calibrations 
Standard AA calibrations were performed at a potential of +700 mV vs. SCE.  Aliquots of a 
0.1 M AA stock solution was injected into the PBS solution in the cell.  The PBS was 
briefly stirred using a magnetic stirring bead to uniformly mix the solution.  The 
concentration range for the AA calibrations were: 
0, 200, 400, 600, 800, 1000 µM 
Calibrations involving a pre-injection of AA were performed at -650 mV vs. SCE.  A 500 
µM aliquot of 0.1 M AA stock solution was injected into the PBA solution in the cell once 
the electrodes had reached a steady-state.  The PBS solution was briefly stirred using a 
magnetic stirring bead to uniformly mix the solution.  The high concentration O2 
calibration was then performed in the presence of 500 µM AA. 
3.6.1.8 Post- implantation Calibrations  
Following removal of the headpiece the O2 electrodes were calibrated in 20 ml PBS as 
described previously (Section 3.6.1.4).  The headpiece was connected to the potentiostat via 
customised cables.  Glucose electrodes could not be calibrated as the polymer does not 
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withstand the removal process. However pre-calibration data can be used with these 
electorodes (Lowry et al., 2002).  The post-calibration process allowed for in vivo currents 
to be converted into concentrations for analysis purposes. 
3.7 In Vivo Experiments 
3.7.1 Animals 
Two strains of male rats were used during the course of this work.  The Wistar strain was 
used for characterisation of various electrodes and the Sprague Dawley strain was used for 
hippocampal characterisation and behavioural experiments.  Animals were obtained from 
Harlan (UK) and Charles River (UK) weighing between 200-300g.  Animals were housed 
in a temperature (17-23˚C), humidity and light (on 08:00, off 20:00) controlled 
environment with food available ad libitum (unless otherwise stated).   
3.7.2 Surgery Protocol 
To implant electrodes into the brain for continuous monitoring a sterile surgery was 
performed.  Firstly the rat was placed in an induction chamber connected to a vaporiser 
(Univentor) unit and anesthetised with the volatile anaesthetic Isoflurane.  Once the animal 
was anesthetised its weight was recorded and the top of the animal’s head was shaven.  The 
animal was immediately placed in a sterotaxic frame ensuring that the head is completely 
levelled between bregma and lambda.   
An Iodine solution was used as a pre-operative antiseptic and a midline incision of 
approximately 2 cm was made from the anterior to the posterior of the animal’s skull.  The 
skull was exposed by clamping the Periosteum at the top and bottom of each side of the 
incision.  Minor epidural haemorrhages occasionally occur upon removal of the skin but 
these are quickly minimised by cauterising the affected area. 
The steriotaxic coordinates used are from The Rat Brain in Steriotaxic Coordinates 
(Paxinos & Watson, 1998).  Bregma is the anatomical point on the skull at which the 
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coronal suture is intersected perpendicularly by the sagittal suture, and used as the zero 
reference point.  Bregma is used to obtain the anterior-posterior (A-P) and medial-lateral 
(M-L) coordinates where + A-P is anterior to bregma and + M-L is the right hemisphere.  
The dorsal-ventral (D-V) coordinates are obtained in respect to dura where - D-V is depth 
into the brain.  The coordinates in mm used for various regions are listed in Table 3.1. 
Brain Region A-P M-L D-V 
Striatum +1.0 ± 2.5 -5/-6 
Dorsal Hippocampus  -5.6 ± 4.6 -3.6 
 
Table 3.1: Steriotaxic coordinated for electrode for various brain regions in mm. 
 
 
Figure 3.8: Schematic representation of the bilateral placement of two working electrodes in the 
striatum as well as the location of clamps, support screws, reference and auxiliary electrodes. 
  
The location of bregma was confirmed and the working electrode’s coordinates were 
marked.  The skull was drilled to allow for the placement of four support screws, one of 
which was used for attachment of the auxiliary electrode (Figure 3.9(bottom)).  These 
support screws were used to aid the adhesion of cement to the skull.  The holes for the 
working electrodes were drilled next and the dura was pierced for a few seconds using a 
25G hypodermic needle.  Electrodes were implanted using D-V co-ordinates (Table 3.1), 
via the steriotaxic arm.  A thin layer of cement was placed around the working electrodes to 
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ensure that the electrodes remained firmly in place.  The reference electrode (Figure 
3.9(top)) was then implanted into the cortex in the same way and secured in place with 
cement.  The electrodes were carefully manoeuvred and bent against the cement layer and 
the gold clips were placed into a pedestal (Figure 3.10).  The level of anaesthetic was 
adjusted according to the procedure i.e. increased during the drilling procedure and 
decreased whilst cementing.   
 
Figure 3.9:  Schematic of a reference electrode (Top) and an auxiliary electrode (Bottom) for in vivo 
implantation. 
       
The gold clips were carefully cemented into the pedestal and when fully dry the wires were 
bent carefully to compact them as much as possible.  The electrodes were then completely 
covered using cement, this ensured that they were protected and gave support for the 
pedestal.  Care was taken not to place cement too far up the pedestal so that the cables 
could be attached securely to it.   When the cement was completely dry, the animal was 
removed from the sterotaxic frame and placed in an incubation unit for at least an hour to 
recover. Animals were post-surgically administered the analgesic Temgesic 
(Buprenorphine) via subcutaneous (s.c.) injection (0.1 mg/kg), and 1 ml normal saline to 
prevent dehydration. 
Animals were assessed post-surgery and daily thereafter for good health and were allowed 
to recover for at least 24 hours before being connected to the equipment.  
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Figure 3.10:  Schematic of a Teflon® pedestal used for in vivo experiments.  The electrodes were placed 
in the corresponding holes to allow for connection to the recording equipment. 
3.7.3 Freely-moving continuous monitoring 
Animals were connected to a potentiostat at least 24 hours following surgery.  The 
equipment was set up for constant potential amperometry and the animal was attached to an 
insulated cable via the pedestal.  The cable was then connected to the potentiostat and the 
required potential was applied to each electrode individually.   The electrodes were allowed 
to settle for the required amount of time which was dependent on the electrode type.   
3.7.4 Gaseous administrations 
O2 and N2 gases were administered to the animal to produce mild hyperoxic and hypoxic 
conditions.  This was achieved via plastic tubing which was connected to the relative 
cylinder and held closely to the animal’s snout for the required duration (3 or 5 min). 
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3.7.5 Neuronal Activation 
3.7.5.1 Tail pinch 
A tail pinch was performed using a paper clip or crocodile clip.  The clip was attached to 
the animal’s tail approximately 2 cm from the tip of the tail for 5 minutes.  The animal was 
given a piece of wood to encourage gnawing.   The gnawing action promoted by the 
stimulating tail pinch has been shown to increase motor activity (Antelman et al., 1975).  
After 5 minutes the clip was carefully removed. 
3.7.5.2 Restraint test 
A restraint test was performed by holding down the animal in its home bowl to restrict 
movement.  The animal was restrained this way for 5 minutes which induces a mild stress 
reaction.  
3.7.6 Drug administration via injection 
Drugs or drug vehicles were administered to the animal via two methods.  A subcutaneous 
(s.c.) injection under the skin, and intraperitoneal (i.p.) injection into the abdominal cavity 
(Wolfensohn & Lloyd, 2008). 
3.7.7 +-maze experiments 
Animals were housed in a plastic home bowl and connected to a Quadstat as previously 
described (Section 3.7.3).  Animals were administered via i.p. either saline or glucose 
solutions and after 30 mins animals were placed into the +-maze.  Animals were allowed to 
explore the +-maze for a duration of 20 mins.  All arm entries (the animal moved past the 
entry gate of any arm from the central region of the +-maze so that all four feet were in the 
arm) were recorded in the order in which they occurred and all +-maze experiments were 
recorded on a webcam to verify arm entry order.  
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Figure 3.11: Schematic representation of a +-maze representing the four arms and the centre area. 
3.7.8 End of in vivo experiments 
In vivo experiments were terminated by euthanising the animal with a 1 ml i.p. injection of 
Euthatal.  The brain was removed and stored in a solution of formaldehyde.  
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4.1 Introduction 
Carbon paste electrodes (CPEs) have been previously used successfully in vitro and in vivo 
for the detection and measurement of brain tissue oxygen in freely-moving animals (Lowry 
et al., 1996; Lowry et al., 1997; Bolger & Lowry, 2005; Bolger et al., 2011a).  CPEs are a 
popular choice due to their stability,  are less prone to surface poisoning than metal-based 
electrodes and therefore do not require protective membranes, although CPEs generally 
have a longer construction time than metal-based electrodes.  Pt-based electrodes have 
several advantages over CPEs including smaller probe size and ease of construction.  Pt-
based electrodes been shown to have the potential to provide a reliable alternative to CPEs 
to monitor brain tissue O2 in vivo (Bolger et al., 2011a).  This chapter details comparisons 
between CPEs and a Pt-based electrode modified with methyl methacrylate (MMA).  The 
polymer MMA was chosen as it is a widely used, commercially available polymer with 
FDA approval making it ideal for potential use in humans.  The electrodes can also be 
easily sterilised, which is of necessity in a clinical environment.  The polymer is used as a 
protective membrane due to the susceptibility of metal-based electrodes to surface 
poisoning.  This enables the sensor to function and ensures biocompatibility,  a necessity 
for safety reasons  which  have  previously been examined for several biomaterials (Wilkins 
& Radford, 1990). 
The in vitro characterisation of an electrode allows for the determination of the sensitivity, 
selectivity and stability of the sensor.  The sensor’s sensitivity was tested after exposure to 
proteins, lipids and brain tissue.  The effects of various temperatures, pH, ions, convection 
and interferents were also examined along with the stability of the sensors in relation to 
time.   
The brain’s tissue immunological mechanisms (Wisniewski et al., 2000) as well as its  
range of endogenous species can have an effect on the performance of the sensor (Lyne & 
O'Neill, 1990; Garguilo & Michael, 1994; Gifford et al., 2006).  Once the sensor is 
implanted the surface can change dramatically as observed with CPEs (Ormonde & O'Neill, 
1989, 1990).  The placement of sensors in tissue can also effect the sensor’s surface 
morphology (O'Neill, 1993) and in terms of mass transport, there is a restriction due to the 
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tissue matrix (Cheng et al., 1979; Dayton et al., 1983; Nicholson & Syková, 1998) which 
can have an effect in terms of sensitivity, stability and selectivity of the sensors.  The in 
vitro characterisation allows for an indication of the consequences of implantation of the 
sensor into tissue and how the response of the sensor may differ. 
4.2 Experimental In Vitro 
The instrumentation and software used are detailed in Section 3.2 and all chemicals and 
solutions are detailed in Section 3.3. 
Pt disk electrodes (125 µm bare diameter) were constructed as described in Section 3.4.5 
and modified using MMA as detailed in Section 3.5.2.1.  CPEs (200 µm bare diameter) 
were constructed as described in Section 3.4.1. 
Electrochemical experiments are detailed in Section 3.6 and electrode treatments in Section 
3.5.4. 
Data is represented as the mean ± SEM where n = number of electrodes used, unless 
otherwise stated.  The slope, nA/µM was obtained from calibration plots using linear 
regression analysis and is used to represent the sensitivity.  Goodness of fit is denoted by 
the R
2
 value.  Sensitivities were compared using unpaired t-tests and ANOVA.  To compare 
the different electrodes due to varying physical dimensions current values were converted 
to current densities (Section 2.8.3). 
4.3 Results and Discussion In Vitro 
4.3.1 Characterisation of CPEs 
The optimal reduction potential of O2 at the surface of CPEs has previously been 
determined using cyclic voltammetry (Lowry et al., 1996).  The chosen reduction potential 
was -650 mV and subsequent constant potential amperometry (CPA) experiments were 
carried out at this potential.  
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4.3.1.1 Oxygen calibrations  
O2 calibrations were performed on CPEs as described in Section 3.6.1.4.  A typical O2 
calibration trace can be seen in Figure 4.1 
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Figure 4.1:  An example of typical raw data for an O2 calibration in PBS using a CPE.  CPA performed 
at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
Average results obtained for high concentration O2 calibrations performed in PBS on CPEs 
(n=24) are presented below in Table 4.1 and plotted in Figure 4.2.  The mean background 
current of -3.00 ± 1.82 nA was subtracted. 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -285.9 10.0 
1200 -1255.1 44.5 
Table 4.1:  Table of results for O2 calibrations (0-1200 µM) for CPEs (n=24).  CPA performed at -650 
mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted.  
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Figure 4.2:  O2 calibration data (0-1200 µM) for CPEs (n=24).  CPA performed at -650 mV vs. SCE in 
PBS (pH 7.4) at 21˚C.   
Linear regression analysis shows that the electrodes have a sensitivity (slope value) of -
1.036 ± 0.030 nA/µM (n = 24).  The response was linear over the range with an R
2
 value of 
0.9992 (n = 24).  The average current value at the physiological O2 level of 50 µM was -
51.80 ± 1.50 nA (n = 24). 
To allow for an accurate comparison between the CPEs and Pt-MMA electrodes (Section 
4.3.2) due to the different dimensions of the electrodes the mean current values were 
converted to current densities presented in Table 4.2 and plotted in Figure 4.3. 
 Current Current Density 
[O2], µM Mean I, nA SEM J, µAmm
-2
 SEM 
0 0 0 0 0 
240 -285.9 10.0 -9.1 0.3 
1200 -1255.1 44.5 -40.0 1.4 
Table 4.2:  Table of results for O2 calibrations (0-1200 µM) for CPEs (n=24) converted to current 
density. CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted.  
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Figure 4.3:  O2 calibration data (0-1200 µM) in terms of current density for CPEs (n=24).  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
The average sensitivity for CPEs in terms of current density for high concentration O2 
calibrations was -0.033 ± 0.001 µAmm
-2
µM
-1
 (n=24).  The average current density value at 
the physiological O2 level of 50 µM was -1.65 ± 0.05 µAmm
-2
 (n = 24).  
4.3.1.2 Effect of temperature 
Membrane covered O2 sensors tend to have significant temperature dependence primarily 
due to the effects of temperature on the diffusion coefficient and the solubility of the gas in 
the membrane with temperature.  The signal typically increasing by 1-6% for a rise of 1˚C 
(Hitchman, 1978; Jeroschewski & Zur Linden, 1997).  In vitro experiments are routinely 
performed at a room temperature of ca. 21˚C.  The effect of an increase in the temperature 
of the PBS on the CPEs O2 sensitivity at the physiological temperate of 37˚C was 
investigated. O2 calibrations performed in PBS at 21°C and 37°C on CPEs are presented 
below in Table 4.3 and plotted in Figure 4.4.  The concentration of dissolved O2 was 
calculated to be 214 µM for air saturated PBS and 1020 µM for O2 saturated PBS at 37°C 
detailed in Section 2.8.4. 
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PBS 37˚C 
[O2], µM Mean I, nA SEM 
0 0 0 
214 -467.54 37.80 
1020 -1525.45 121.72 
 
 
PBS 21˚C 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -285.87 9.99 
1200 -1255.08 44.47 
Table 4.3:  Tables of results for O2 calibrations for CPEs.  CPA performed at -650 mV vs. SCE in PBS 
(pH 7.4) at 37˚C (0-1020 µM) (n=8) and 21˚C (0-1200 µM) (n=24).  Mean background subtracted. 
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Figure 4.4:  O2 calibration data for CPEs.  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 37˚C 
(0-1020 µM) & 21˚C (0-1200 µM).  
Linear regression analysis was performed on electrodes to compare sensitivities of CPEs 
calibrated in PBS solutions at the physiological temperature of 37˚C and room temperature, 
21˚C, presented in Table 4.4 and plotted in Figure 4.5. 
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Sensitivity (nA/µM) R
2
 n 
PBS 37˚C -1.445 ± 0.1501 0.9893 8 
PBS 21˚C -1.036 ± 0.02995 0.9992 24 
Table 4.4: Comparison of calculated sensitivity values of O2 calibrations for CPEs calibrated in PBS 
solutions of 37˚and 21˚C. 
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Figure 4.5:  Comparison graph of calculated sensitivity values for O2 calibrations for CPEs calibrated 
in PBS at 37˚C (n=8) & 21˚C (n=24). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is a significant 
difference in the sensitivities of CPEs calibrated at 37˚C and 21˚C with a P value of 0.0319.  
From the results obtained for CPEs it can be seen that the sensitivity increases by 39.48 ± 
22.14 % corresponding to a 2.47 ± 1.22 % for every 1˚C increase determining that CPEs 
exhibit significant temperature dependence at the physiological temperature. 
4.3.1.3 Effect of pH 
Changes in pH may occur during physiological experiments in vivo (Zimmerman & 
Wightman, 1991) these changes in pH could also affect the cathodic reduction of O2 at the 
electrode surface involving proton transfer.  Previous reports for carbon-based electrodes 
found that for pH 12-14 the reduction of O2 seems to be independent of pH, but as pH 
decreases the reduction becomes pH dependent (Taylor & Humffray, 1975; Yang & 
McCreery, 2000).  The effect of varying pH on the sensitivities of CPEs was investigated.  
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O2 calibrations performed in PBS (pH 6.5, 7 and 8) on CPEs are presented below in Table 
4.5 and plotted in Figure 4.6. 
 PBS pH 6.5 PBS pH 7.4 PBS pH 8 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 
240 -323.2 36.5 -344.6 23.4 -306.0 59.5 
1200 -1264.2 165.2 -1319.4 108.9 -965.8 153.7 
Table 4.5:  Table of results for O2 calibrations (0-1200 µM) for CPEs.  CPA performed at -650 mV vs. 
SCE in PBS pH 6.5 (n=4), pH 7.4 (n=8) and pH 8 (n=4) at 21˚C.  Mean background subtracted. 
250 500 750 1000 1250 1500
-1500
-1250
-1000
-750
-500
-250
0
PBS pH 7.4
PBS pH 6.5
PBS pH 8
[O2], M
I,
 n
A
 
Figure 4.6:  O2 calibration data (0-1200 µM) for CPEs.  CPA performed at -650 mV vs. SCE in PBS 
(pH 6.5, 7.4 & 8) at 21˚C.   
Linear regression analysis was performed on electrodes to compare sensitivities of CPEs 
calibrated in PBS solutions with a pH of 6.5, 7.4 and 8, presented in Table 4.6 and plotted 
in Figure 4.7. 
 Sensitivity (nA/µM) R
2
 n 
PBS pH 6.5 ˗1.076 ± 0.069 0.9962 4 
PBS pH 7.4 ˗1.033 ± 0.060 0.9991 8 
PBS pH 8 ˗0.771 ± 0.097 0.9934 4 
Table 4.6: Comparison of calculated sensitivity values of O2 calibrations (0-1200 µM) CPEs calibrated 
in PBS 6.5, 7.4 & 8. 
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Figure 4.7:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) CPEs 
calibrated in PBS pH 6.5 (n=4), 7.4 (n=8) and 8 (n=4).  
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities of CPEs calibrated in PBS pH 6.5 and 7.4 with a P value of 
0.6514.  There is a significant difference in the sensitivities between electrodes calibrated in 
PBS pH 8 and 7.4 with a P value of 0.0431. 
4.3.1.4 aCSF Cyclic Voltammetry 
The technique cyclic voltammetry (CV) was performed on the CPEs to confirm the 
diffusion limited reduction potential of O2 at the surface of these electrodes in aCSF.  This 
was performed as described in Section 3.6.1.2.  The results obtained are presented 
graphically in Figure 4.8 below. 
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Figure 4.8:  Cyclic voltammograms from -1 to 0 V vs. SCE at 100 mVs
-1
 performed in O2 saturated 
aCSF (21˚C) buffer solution, illustrating the reduction of O2 at a CPE. 
 
As with PBS - 650 mV vs. SCE is within the mass-transport limited region after the peak 
potential of O2 reduction at CPEs.  All experiments performed in aCSF were carried out at 
this potential.  This compares well with previous data shown by Lowry et al. (1996) who 
performed CV on Triton-X modified electrodes and found that the optimum reduction 
potential for O2 at the surface of these electrodes was -650 mV (Figure 4.9). 
 
Figure 4.9:  Typical cyclic staircase voltammograms recorded at 50 mVs
-l
 with a surfactant (0.2% 
Triton-X 100)-treated carbon paste electrode in N2-saturated (dashed line) and air-saturated (solid line) 
PBS (pH 7.4) (Lowry et al., 1996). 
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4.3.1.5 Effect of ion changes 
The media-dependence of redox reactions for several physiologically vital electroactive 
species (dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT) and 
5-hydroxyindoleacetic acid (5-HIAA)) have previously been investigated (Rice & 
Nicholson, 1995; Kume-Kick & Rice, 1998; Chen & Rice, 1999).  Fast cyclic voltammetry 
(FCV) sensitivities to DA and 5-HT at carbon fibre electrodes have been reported to be 2-3-
fold higher in non-physiological phosphate or HEPES-buffered saline compared to artificial 
cerebrospinal fluid (aCSF) which more accurately reflects the ionic composition of the 
brain and the reverse was observed for the acid metabolites DOPAC and 5-HIAA (Kume-
Kick & Rice, 1998; Chen & Rice, 1999).  Shifts in oxidation peaks and higher sensitivities 
using differential pulse voltammetry for aCSF that contained Ca
2+
 but not Mg
2+
, than in 
PBS that contained Mg
2+ 
but not Ca
2+
 have been reported (Crespi, 1996).  It has also been 
reported that Ca
2+
 concentrations can fall under conditions of electrical stimulation and 
intense tissue depolarisation (Rice & Nicholson, 1995).  Changes in ion concentrations are 
of interest as in vivo extracellular concentrations are in a continuous state of flux and can 
change significantly with disturbances to normal physiology also; electrode surface 
interactions differ for anions and cations, consistent with adsorption or repulsion effects at 
the modified electrode surfaces.  The effect of ion changes on the sensitivities of CPEs was 
investigated.  O2 calibrations performed in aCSF, aCSF no Ca
2+ 
and aCSF no Mg
2+ 
on 
CPEs are presented below in  
 
aCSF aCSF no Ca2+ aCSF no Mg2+ aCSF no Ca2+and Mg2+ 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 
240 -389.45 25.41 -403.73 33.02 -359.96 26.92 -403.86 63.35 
1200 -1947.23 127.05 -2018.66 165.08 -1799.81 134.59 -2210.20 309.99 
Table 4.7 and plotted in Figure 4.10. 
 
aCSF aCSF no Ca2+ aCSF no Mg2+ aCSF no Ca2+and Mg2+ 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 
240 -389.45 25.41 -403.73 33.02 -359.96 26.92 -403.86 63.35 
1200 -1947.23 127.05 -2018.66 165.08 -1799.81 134.59 -2210.20 309.99 
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Table 4.7:  Table of results for O2 calibrations (0-1200 µM) for CPEs.  CPA performed at -650 mV vs. 
SCE in aCSF (n=16), aCSF no Ca
2+
 (n=16), aCSF no Mg
2+
 (n=16) at 21˚C.  Mean background 
subtracted. 
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Figure 4.10:  O2 calibration data (0-1200 µM) for CPEs.  CPA performed at -650 mV vs. SCE in aCSF, 
aCSF no Ca
2+
, aCSF no Mg
2+
 at 21˚C. 
Linear regression analysis was performed on electrodes to compare sensitivities of CPEs 
calibrated in aCSF solutions in the presence and absence of ions, presented in Table 4.8 and 
plotted in Figure 4.11. 
CPE Sensitivity (nA/µM) R
2
 n 
aCSF -1.623 ± 0.106 0.9970 16 
aCSF no Ca
2+
 -1.682 ± 0.138 0.9989 16 
aCSF no Mg
2+
 -1.500 ± 0.112 0.9945 16 
Table 4.8: Comparison of calculated sensitivity values of O2 calibrations (0-1200 µM) CPEs calibrated 
in aCSF, aCSF no Ca
2+
, aCSF no Mg
2+
,at 21˚C. 
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Figure 4.11:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) CPEs 
calibrated in aCSF(n=16), aCSF no Ca
2+
 (n=16), aCSF no Mg
2
+ (n=16). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities of CPEs calibrated in aCSF with P values of 0.7343, (aCSF 
no Ca
2+
) and 0.4324 (aCSF no Mg
2+
).  There is an increase in the sensitivity CPEs 
calibrated in aCSF (-1.623 ± 0.106 nA/µM) compared to PBS (-1.036 ± 0.030 nA/µM) with 
a significant difference P < 0.0001.    
4.3.1.6 Effect of stirring 
The dependence of the O2 electrode’s signal on flow is commonly investigated by 
evaluating the signal sensitivity to fluid convection (Gotoh et al., 1961; Schneiderman & 
Goldstick, 1978).  Convection results in a reduced diffusion layer thickness at the sensor 
surface (Bard & Faulkner, 1980; Amatore et al., 2000) which causes an increase in current.  
However, in vivo we expect to see small changes in current, as it has been reported that O2 
electrodes in brain tissue do not show a dependence upon flow.  This is thought to be due to 
the movement of blood through the tissue which causes the diffusion layer effect to be 
negligible in vivo (Cooper, 1963).  It was found that the O2 concentration varies in 
accordance with the acceleration and not the velocity of the blood. 
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The reduction of O2 at the CPEs surface was examined in quiescent and stirred solutions 
with convection produced using a magnetic stirrer (Sharan et al., 2008).  Results are 
presented below in Table 4.9 and plotted in Figure 4.12. 
 Control: PBS Bubbling PBS Quiescent Stirring @ c.a 1 Hz Stirring @ c.a 10 Hz 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
240 -1101.0 86.2 -617.4 56.7 -643.0 61.9 -708.3 60.8 
1200 -3018.1 262.1 -3387.7 344.7 -2341.3 269.6 -2398.3 259.4 
Table 4.9:  Table of results for O2 calibrations (240-1200 µM) for CPEs (n=4).  CPA performed at -650 
mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted 
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Figure 4.12:  O2 calibration data (240-1200 µM) for CPEs (n=4).  CPA performed at -650 mV vs. SCE 
in PBS (pH 7.4) quiescent and in the presence of forced convection at 21˚C. 
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities between CPEs calibrated in quiescent PBS and agitated PBS 
stirred at approximately 1 Hz in the presence of 240 µM O2 with a P value of 0.7632.  
There was also no significant difference found between CPEs calibrated in quiescent PBS 
and agitated PBS stirred at approximately 10 Hz in the presence of 240 µM O2 with a P 
value of 0.2865. 
There is no significant difference in the sensitivities between CPEs calibrated in quiescent 
PBS and agitated PBS stirred at approximately 1 Hz in the presence of 1200 µM O2 with a 
P value of 0.0623.  There was also no significant difference found between CPEs calibrated 
in quiescent PBS and agitated PBS stirred at approximately 10 Hz in the presence of 1200 
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µM O2 with a P value of 0.0703.  From the results presented in Figure 4.12 it can be seen 
there is no significant increase on the current monitored using CPEs at 1 Hz in the presence 
240 µM O2 compared to quiescent conditions, concluding that there is no dependence on 
flow in vitro. 
4.3.1.7 Post- implantation calibrations 
The effect of the living brain on electrodes was investigated.  The effects of proteins and 
lipids on the electrooxidation of AA at CPEs was investigated (Kane & O’Neill, 1998) 
showing no evidence of fowling at CPEs unlike carbon fibre electrodes.  This resilience 
appears to be due to the silicone oil present in the paste mixture.  Post-implantation O2 
calibrations were performed when possible on CPEs upon removal from the brain 
(implanted for 6 ± 1 days), presented below in Table 4.10 and plotted in Figure 4.13.   
 CPE (pre-implantation) CPE (post-implantation) 
[O2], µM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 
240 -273.7 15.2 -377.9 86.1 
1200 -1237.9 53.4 -1206.9 106.2 
Table 4.10:  Table of results for O2 calibrations (0-1200 µM) for CPEs  pre-implantation and post-
implantation (n=13) for a standard O2 calibration.  CPA performed at -650 mV vs. SCE in PBS (pH 
7.4) at 21˚C.  Mean background subtracted.  
250 500 750 1000 1250 1500
-1500
-1250
-1000
-750
-500
-250
0
CPE pre-implantation
CPE post-implantation
[O2], M
I,
 n
A
 
Figure 4.13:   O2 calibration data (0-1200 µM) for CPEs pre-implantation and post-implantation (n=13) 
for a standard O2 calibration.  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C. 
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Linear regression analysis was performed on electrodes to compare sensitivities of CPEs 
calibrated before and after implantation, presented in Table 4.1and plotted in Figure 4.15. 
 Sensitivity (nA/µM) R
2
 n 
Pre-implantation ˗1.024 ± 0.022 0.9995 13 
Post-implantation ˗0.965 ± 0.117 0.9855 13 
Figure 4.14:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CPEs pre-
implantation and post-implantation. 
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Figure 4.15:  Graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for CPEs pre-
implantation and post-implantation (n=13). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities between CPEs calibrated pre and post-implantation with a P 
value of 0.6308.  There is no significant difference in the sensitivities of the electrodes 
post-implantation compared to pre-implantation.  There is a trend towards a lower 
sensitivity post-implantation which can be attributed to endogenous proteins and lipids 
present in the brain interacting with the CPEs active surface, causing a leaching of silicone 
oil from the carbon paste and changing the morphology of the surface to a carbon powder 
(Ormonde & O'Neill, 1989, 1990).   
Results above are verified by results presented by Bolger et al. (2011b) confirm that CPEs 
are stable in vivo.  Analysis of baseline levels show although there was a gradual decrease 
in the first three weeks (Week 1, −167.0 ± 1.5 nA; Week 2, −151.9 ± 2.3 nA; Week 3, 
−141.7 ± 0.9 nA), no significant variation was observed over the 21-day period (P = 0.89, 
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one-way ANOVA; n = 17–26, 12 animals).  Pooled data from 12 animals over a 12 week 
period are shown in Figure 4.16. 
 
Figure 4.16:  Figure from (Bolger et al., 2011b) showing: Average (±SEM) baseline in vivo data (pooled 
from 12 animals-striatum, hippocampus, prefrontal cortex and nucleus accumbens) for CPEs (n = 17-
26) recorded using CPA at −650mV over 21 days. Inset: average weekly baseline data recorded over the 
3 week period and extended to 3 months using data from 3 animals (n = 12).  All data taken from a six-
hour period covering morning/afternoon (10am–4pm). 
4.3.2 Characterisation of Pt-MMA electrodes In Vitro 
4.3.2.1 Cyclic Voltammetry 
CV was initially performed on the Pt-MMA electrodes to determine the diffusion limited 
reduction potential of O2 at the surface of these electrodes.  This was performed as 
described in Section 3.6.1.2.  The results obtained are presented graphically in Figure 4.17 
below. 
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Figure 4.17:  Cyclic voltammogram from -1 to +0.5 V vs. SCE at 100 mVs
-1
 performed in O2 saturated 
PBS (pH 7.4, 21˚C) buffer solution, illustrating the reduction of O2 at a Pt-MMA electrode. 
 
For the Pt-MMA electrodes an O2 reduction peak was observed at ca. -600 mV with the 
foot of the wave occurring at ca. -200 mV.  The chosen reduction potential was -650 mV 
and subsequent constant potential amperometry (CPA) experiments were carried out at this 
potential.  
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4.3.2.2 Oxygen calibrations  
4.3.2.2.1 High concentration O2 calibrations (0-1200 µM) 
High concentration O2 calibrations were performed on Pt-MMA electrodes as described in 
Section 3.6.1.4.  A typical O2 calibration trace can be seen in Figure 4.18. 
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Figure 4.18:  An example of typical raw data for an O2 calibration in PBS using a Pt-MMA electrode.  
CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
Average results obtained for high concentration O2 calibrations performed in PBS on Pt-
MMA electrodes (n=64) are presented below in Table 4.11 and plotted in Figure 4.19.  The 
mean background current -0.41 ± 1.19 nA was subtracted.  
[O2], µM Mean I, nA SEM 
0 0 0 
240 -322.5 16.3 
1200 -1388.9 66.7 
Table 4.11:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes (n=64).  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted 
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Figure 4.19:  O2 calibration data (0-1200 µM) for Pt-MMA electrodes (n=64).  CPA performed at -650 
mV vs. SCE in PBS (pH 7.4) at 21˚C.   
Linear regression analysis shows that the electrodes have a sensitivity (slope value) of -1.14 
± 0.01 nA/µM (n = 64).  The response was linear over the range with an R
2
 value of 0.9989 
(n = 64).  The average current value at the physiological O2 level of 50 µM was -57.20 ± 
0.19 nA (n = 64). 
The sensitivity for Pt-MMA compares favourably to O2 calibration data (0-1200 µM) for 
bare Pt electrodes (Bolger et al., 2011a) which gave a sensitivity of -1.12 ± 0.08 nA/µM 
(n=18),  P = 0.8058 showing no significant difference between the bare metal and the 
MMA coated electrodes. 
To allow for an accurate comparison between the Pt-MMA electrodes and CPEs (Section 
4.3.1) due to the different dimensions of the electrodes the mean current values were 
converted to current densities, presented in Table 4.12 and plotted in Figure 4.20. 
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 Current Current Density 
[O2], µM Mean I, nA SEM J, µAmm
-2
 SEM 
0 0 0 0 0 
240 -322.5 16.3 -26.3 1.3 
1200 -1388.9 66.7 -113.2 5.5 
Table 4.12:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes (n=64) converted 
to current density. CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background 
subtracted. 
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Figure 4.20:  O2 calibration data (0-1200 µM) in terms of current density for Pt-MMA electrodes (n= 
64).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
The average sensitivity for Pt-MMA electrodes in terms of current density for high 
concentration O2 calibrations was -0.093 ± 0.003 µAmm
-2
µM
-1
 (n=64).  The average 
current density value at the physiological O2 level of 50 µM was -4.66 ± 0.02 µAmm
-2
 (n = 
64). 
4.3.2.2.2 Low concentration O2 calibrations (0-125 µM) 
Low concentration O2 saturated PBS calibrations were performed on Pt-MMA electrodes as 
described in Section 3.6.1.5, to determine sensitivity at low concentrations of O2 similar to 
that of the in vivo environment. 
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Average results obtained for low concentration O2 calibrations performed in PBS on Pt-
MMA electrodes (n=15) are presented below in Table 4.13 and plotted in Figure 4.21.  The 
mean background current -10.86 ± 2.65 nA was subtracted.  
[O2], µM Mean I, nA SEM 
0 0 0 
25 -32.0 6.9 
50 -80.3 11.1 
75 -128.2 15.3 
100 -161.5 18.9 
125 -207.7 20.6 
Table 4.13:  Table of results for O2 calibrations (0-125 µM) for Pt-MMA electrodes (n=15).  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted.  
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Figure 4.21:  Low concentration O2 calibration data (0-125 µM) for Pt-MMA electrodes (n=15).  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
Linear regression analysis shows that the electrodes have a sensitivity of -1.69 ± 0.005 
nA/µM (n = 15).  The response was linear over the range with an R
2
 value of 0.9969 (n = 
15).  The average current value at the physiological O2 level of 50 µM was -84.30 ± 2.36 
nA (n = 15). 
The mean current values for low concentration O2 calibrations were converted to current 
density values, presented in Table 4.14 and plotted in Figure 4.22. 
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 Current Current Density 
[O2], µM Mean I, nA SEM J, µAmm
-2
 SEM 
0 0 0 0 0 
25 -31.95 6.87 -2.60 0.56 
50 -80.30 11.05 -6.54 0.90 
75 -128.18 15.26 -10.45 1.24 
100 -161.47 18.87 -13.16 1.54 
125 -207.72 20.61 -16.93 1.68 
Table 4.14:  Table of results for O2 calibrations (0-125 µM) for Pt-MMA electrodes (n=15) converted to 
current density.  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background 
subtracted.  
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Figure 4.22:  Low concentration O2 calibration data (0-125 µM) in terms of current density for Pt-
MMA electrodes (n=15).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
The average sensitivity for Pt-MMA electrodes in terms of current density for low 
concentration O2 calibrations was -0.137 ± 0.004 µAmm
-2
µM
-1
 (n=15).  The average 
current density value at the physiological O2 level of 50 µM was -6.87 ± 0.194 µAmm
-2
 (n 
= 15).  From the calibration data on Pt-MMA electrodes it can be seen that these electrodes 
can reliably detect O2 in vitro over a range of 0-125 µM.   
Now that the electrodes sensitivity to O2 has been confirmed the selectivity, stability and 
biocompatibility of the Pt-MMA electrodes was investigated. 
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4.3.2.3 Biocompatibility  
As previously discussed metal-based electrodes are more susceptible to surface poisoning 
than CPEs.  The presence of the polymer MMA serves to act as protective membrane to 
minimise fouling at the Pt electrode surface.  In this section the effects of proteins, lipids 
and brain tissue on the sensitivity of Pt-MMA electrodes was investigated, based on 
previous work (Ormonde & O'Neill, 1989, 1990) to determine if there is a significant 
reduction in the electrodes ability to remain sensitive to O2 in vivo.  
4.3.2.3.1 Protein (BSA) treated Pt-MMA electrodes 
The effect of exposure to the protein BSA (Section 3.5.4.1) on Pt-MMA electrodes with 
respect to time was investigated.  Untreated Pt-MMA electrodes (0 days) were calibrated 
and subsequently exposed to BSA for 24 hours, 3 days, 7 days and 14 days.  The results 
obtained for O2 calibrations on these treated electrodes are presented below in Table 4.15 
and plotted in Figure 4.23. 
 BSA (0 days) n=20 BSA (24 hrs) n=6 BSA (3 days) n=8 BSA (7 days) n=8 BSA (14 days) n=8 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 0 0 
240 -280.8 36.8 -345.2 31.8 -296.6 21.0 -308.4 20.8 -287.9 20.5 
1200 -1250.7 100.9 -1145.5 104.4 -929.6 57.4 -966.0 46.6 -892.2 51.1 
Table 4.15:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes exposed to BSA.  
CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 4.23:  O2 calibration data (0-1200 µM) for Pt-MMA electrodes untreated (0 days) and treated 
with BSA (12 hrs, 3 days, 7 days and 14 days).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 
21˚C.   
Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes before and after exposure to BSA, presented in Table 4.16 and plotted in 
Figure 4.24. 
BSA treatment Sensitivity (nA/µM) R
2
 n 
0 days ˗1.033 ± 0.026 0.9994 20 
24 hrs ˗0.920 ± 0.100 0.9884 6 
3 days ˗0.742 ± 0.095 0.9838 8 
7 days ˗0.771 ± 0.099 0.9838 8 
14 days ˗0.711 ± 0.094 0.9828 8 
Table 4.16: Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for Pt-MMA electrodes 
exposed to BSA. 
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Figure 4.24:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) at Pt-
MMA electrodes exposed to BSA.   
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities with a P value greater than 0.05 between untreated (0 days 
exposure) and electrodes exposed to BSA for 24 hrs (P = 0.3231).  There is a significant 
difference in the sensitivities between untreated (0 days exposure) and 3 days (P = 0.0184), 
7 days (P = 0.0335) and 14 days (P = 0.0109). 
One-way Analysis of Variance (ANOVA) was performed on Pt-MMA electrodes only 
exposed to BSA with a P value of 0.5118 showing no significant difference in the 
sensitivities between the electrodes once exposed to BSA over a period of 14 days.  From 
these results it can be seen that there is a significant initial reduction in the sensitivity of Pt-
MMA electrodes following exposure to BSA for a 24 hr period. However, it can be 
concluded following initial exposure that there is no further significant reduction in the 
sensitivity over a 14 day period.   
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4.3.2.3.2 Lipid (PEA) treated Pt-MMA electrodes 
The effect of exposure to the protein PEA (Section 3.5.4.2) on Pt-MMA electrodes with 
respect to time was investigated.  Untreated Pt-MMA electrodes (0 days) were calibrated 
and subsequently exposed to PEA for 24 hours, 3 days and 14 days.  The results obtained 
for O2 calibrations on these treated electrodes are presented below in Table 4.17 and plotted 
in Figure 4.25. 
 PEA (0 days) n=15 PEA (24 hrs) n=4 PEA (3 days) n=7 PEA (14 days) n=6 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 
240 -360.2 15.4 -342.7 11.7 -315.9 14.9 -327.5 14.1 
1200 -1305.7 57.8 -1197.5 53.9 -1006.0 40.8 -1197.6 70.2 
Table 4.17:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes exposed to PEA.  
CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 4.25:  O2 calibration data (0-1200 µM) for Pt-MMA electrodes untreated (0 days) and treated 
with PEA (24 hrs, 3 days and 14 days).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes before and after exposure to PEA, presented in Table 4.18 and plotted in 
Figure 4.26. 
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PEA treatment Sensitivity (nA/µM) R
2
 n 
0 days ˗1.059 ± 0.085 0.9936 15 
24 hrs ˗0.967 ± 0.089 0.9917 4 
3 days ˗0.804 ± 0.099 0.9852 7 
14 days ˗0.972 ± 0.076 0.9940 6 
Table 4.18:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for Pt-MMA 
electrodes exposed to PEA. 
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Figure 4.26:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) Pt-
MMA electrodes exposed to PEA.  
  
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
different in the sensitivities with P values greater than 0.05 between untreated (0 days 
exposure) and PEA treated electrodes with P values of 0.4742 (24 hrs), 0.0707 (3 days) and 
0.4552 (14 days). 
One-way Analysis of Variance (ANOVA) was performed on Pt-MMA electrodes only 
exposed to PEA with a P value of 0.3370 showing no significant difference in the 
sensitivities between the electrodes once exposed to PEA over a period of 14 days.  From 
these results it can be seen that there is small but non-significant reduction in the sensitivity 
of Pt-MMA electrodes following exposure to PEA over a period of 14 days.  
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4.3.2.3.3 Brain tissue (BT) treated Pt-MMA electrodes 
The effect of exposure to a sample of ex-vivo BT (Section 3.5.4.3) on Pt-MMA electrodes 
with respect to time was investigated.  Untreated Pt-MMA electrodes (0 days) were 
calibrated and subsequently exposed to BT for 24 hours, 3 days and 14 days.  The results 
obtained for O2 calibrations on these treated electrodes are presented below in Table 4.19 
and plotted in Figure 4.27.  
 BT (0 days) n=17 BT (24 hrs) n=4 BT (3 days) n=4 BT (14 days) n=4 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 
240 -335.2 19.5 -331.9 18.3 -339.1 28.9 -380.1 42.5 
1200 -1266.0 54.6 -1107.4 56.3 -1088.4 85.1 -1141.7 110.5 
Table 4.19:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes exposed to BT.  
CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 4.27: O2 calibration data (0-1200 µM) for Pt-MMA electrodes untreated (0 days) and treated 
with BT (24 hrs, 3 days and 14 days).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes before and after exposure to BT, presented in Table 4.20 and plotted in 
Figure 4.28.   
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BT treatment Sensitivity (nA/µM) R
2
 n 
0 days ˗1.031 ± 0.070 0.9953 17 
24 hrs ˗0.890 ± 0.095 0.9888 4 
3 days ˗0.871 ± 0.104 0.9859 4 
14 days ˗0.906 ± 0.130 0.9797 4 
Table 4.20:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for Pt-MMA 
electrodes exposed to BT. 
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Figure 4.28:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for Pt-
MMA electrodes exposed to BT.   
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities with P values greater than 0.05 between untreated (0 days 
exposure) and BT treated electrodes with P values of 0.1163 (24 hrs), 0.0877 (3 days) and 
0.2201 (14 days). 
One-way Analysis of Variance (ANOVA) was performed on Pt-MMA electrodes only 
exposed to BT with a P value of 0.9044 showing no significant difference in the 
sensitivities between the electrodes once exposed to BT over a period of 14 days.  From 
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these results it can be seen that there is a small but non-significant reduction in the 
sensitivity of Pt-MMA electrodes following exposure to BT over a period of 14 days.  
4.3.2.4 Stability 
The stability of Pt-MMA electrodes with respect to time was investigated.  Pt-MMA 
electrodes (0 days) were calibrated, refrigerated and re-calibrated after 7 days, 21 days, 28 
days, 35 days, 48 days and 56 days.  The results obtained for O2 calibrations on these 
electrodes are presented below in Table 4.21 and Figure 4.29. 
 0 days n=4 7 days n=4 21 days n=4 28 days n=4 35 days n=4 48 days n=4 56 days n=4 
[O2], 
µM 
Mean I, 
nA 
SE
M 
Mean I, 
nA 
SE
M 
Mean I, 
nA 
SE
M 
Mean I, 
nA 
SE
M 
Mean I, 
nA 
SE
M 
Mean I, 
nA 
SE
M 
Mean I, 
nA 
SE
M 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
240 -290.6 25.7 -284.3 19.3 -310.0 6.0 -338.2 14.4 -270.3 14.8 -256.9 14.1 -272.8 13.7 
1200 -1130.2 75.4 -1219.2 65.7 -1147.4 45.2 -1283.8 38.7 -1004.7 56.5 -963.9 50.9 -992.7 37.5 
Table 4.21:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes stored in the 
refrigerator at 4˚C and re-calibrated on given days.  CPA performed at -650 mV vs. SCE in PBS (pH 
7.4) at 21˚C.  Mean background subtracted. 
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Figure 4.29:  O2 calibration data (0-1200 µM) for Pt-MMA electrodes (0 days) stored in the refrigerator 
(4˚C) and re-calibrated after (7 days, 21 days, 28 days, 35 days, 48 days and 56 days).  CPA performed 
at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
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Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes stored at 4˚C and re-calibrated over 56 days, presented in Table 4.22 and 
plotted in Figure 4.30. 
 Sensitivity (nA/µM) R
2
 n 
0 days ˗0.923 ± 0.055 0.9964 4 
7 days ˗1.004 ± 0.035 0.9988 4 
21 days ˗0.932 ± 0.069 0.9945 4 
28 days ˗1.046 ± 0.070 0.9955 4 
35 days ˗0.817 ± 0.060 0.9947 4 
48 days ˗0.784 ± 0.055 0.9951 4 
56 days ˗0.805 ± 0.064 0.9938 4 
Table 4.22:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) Pt-MMA electrodes 
calibrated over 56 days. 
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Figure 4.30:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) Pt-
MMA (0 days), stored at 4˚C and re-calibrated after (7 days, 21 days, 28 days, 35 days, 48 days and 56 
days). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities with P values of 0.2686 (7 days), 0.9180 (21 days), 0.2254 
(28 days), 0.2497 (35 days), 0.1367 (48 days) and 0.2233 (56 days), all less than 0.05 
between electrodes calibrated on day 0 and electrodes re-calibrated 6 times over a period of 
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56 days.  From these results it can be concluded that Pt-MMA electrodes are stable with 
respect to time displaying a shelf-life of at least  of 56 days (current study) when stored at 
4˚C.  
4.3.2.5 Effect of temperature 
The effect of temperature on membrane covered O2 sensors has been previously discussed 
in Section 4.3.1.2.  The effect of an increase in the temperature of the PBS on the Pt-MMA 
electrodes O2 sensitivity at the physiological temperate of 37˚C was investigated. O2 
calibrations performed in PBS at 21°C and 37°C on Pt-MMA electrodes are presented 
below in Table 4.23 and plotted in Figure 4.31. The concentration of dissolved O2 was 
calculated to be 214 µM for air saturated PBS and 1020 µM for O2 saturated PBS at 37°C 
detailed in Section 2.8.4. 
 
PBS 37˚C 
[O2], µM Mean I, nA SEM 
0 0 0 
214 -467.55 28.61 
1020 -1706.64 83.28 
 
 
PBS 21˚C 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -311.06 14.94 
1200 -1365.89 51.54 
Table 4.23:  Tables of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes.  CPA performed 
at -650 mV vs. SCE in PBS (pH 7.4) at 37˚C (0-1020 µM) (n=5) and 21˚C (0-1200 µM) (n=10).  Mean 
background subtracted.  
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Figure 4.31:  O2 calibration data for Pt-MMA electrodes.  CPA performed at -650 mV vs. SCE in PBS 
(7.4) at 37˚C (0-1020 µM) & 21˚C (0-1200 µM). 
Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes calibrated in PBS solutions at the physiological temperature of 37˚C and 
room temperature, 21˚C, presented in Table 4.24 and plotted in Table 4.32. 
 
Sensitivity (nA/µM) R
2
 n 
PBS 37˚C -1.636 ± 0.1114 0.9954 5 
PBS 21˚C -1.127 ± 0.03255 0.9992 10 
Table 4.24: Comparison of calculated sensitivity values of O2 calibrations for Pt-MMA electrodes 
calibrated in PBS solutions of 37˚and 21˚C. 
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Figure 4.32:  Comparison graph of calculated sensitivity values for O2 calibrations for Pt-MMA 
electrodes calibrated in PBS at 37˚C (n=5) & 21˚C (n=10). 
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Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities of Pt-MMA electrodes calibrated at 37˚C and 21˚C with a P 
value of 0.0118. 
For O2 calibrations on bare Pt electrodes there was found to be a significant difference in 
the sensitivity of the electrodes calibrated at 22˚C and 37˚C with sensitivities of  -1.12 ± 
0.08 nA/µM, R
2
 = 0.995 (n = 18) and -1.57 ± 0.06 nA/µM, R
2
 = 0.9963 (n = 12), P = 
0.0002) (Bolger et al., 2011a).  From the results obtained for Pt-MMA it can be concluded 
that in the presence of the polymer MMA, the sensitivity increases by 45.16 ± 9.88 % 
corresponding to a 2.82 ± 0.44 % for every 1˚C increase.   
4.3.2.6 Effect of pH 
Changes in pH may occur during physiological experiments in vivo as discussed in Section 
4.3.1.3.  The effect of varying pH on the sensitivities of Pt-MMA electrodes was 
investigated.  O2 calibrations performed in PBS (pH 6.5, 7 and 8) on Pt-MMA electrodes 
are presented below in Table 4.25 and plotted in Figure 4.33. 
 PBS pH 6.5 PBS pH 7.4 PBS pH 8 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 
240 -289.8 12.2 -299.1 15.1 -328.2 10.8 
1200 -1119.4 22.6 -1307.9 43.2 -1185.8 41.8 
Table 4.25:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes.  CPA performed 
at -650 mV vs. SCE in PBS: pH 6.5 (n=4), 7.4 (n=8) & 8 (n=4) at 21˚C.  Mean background subtracted.  
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Figure 4.33:  O2 calibration data (0-1200 µM) for Pt-MMA electrodes.  CPA performed at -650 mV vs. 
SCE in PBS (pH 6.5, 7.4 & 8) at 21˚C.   
Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes calibrated in PBS solutions with a pH of 6.5, 7.4 and 8, presented in Table 
4.26 and plotted in Figure 4.34. 
 Sensitivity (nA/µM) R
2
 n 
PBS pH 6.5 ˗0.913 ± 0.057 0.9962 4 
PBS pH 7.4 ˗1.079 ± 0.032 0.9991 8 
PBS pH 8 ˗0.961 ± 0.078 0.9934 4 
Table 4.26:  Comparison of calculated sensitivity values of O2 calibrations (0-1200 µM) for Pt-MMA 
electrodes calibrated in PBS 6.5, 7.4 & 8. 
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Figure 4.34: Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for Pt-
MMA electrodes calibrated in PBS pH 6.5 (n=4), 7.4 (n=8) and 8 (n=4). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities of Pt-MMA electrodes calibrated in PBS pH 6.5 and 7.4 with 
a P value of 0.0516 and there is no significant difference in the sensitivities between 
electrodes calibrated in PBS pH 8 and 7.4 with a P value of 0.2355.   
These results are similar to data observed with O2 calibrations on bare Pt electrodes 
calibrated in PBS pH 7.4 (-1.12 ± 0.08 nA/µM, R
2
 = 0.995, n = 18), pH 6.5 (-1.06 ± 0.04 
nA/µM, R
2
 = 0.9987, n = 8) and pH 8 (-1.07 ± 0.04 nA/µM, R
2
 = 0.9951, n = 8), where a 
small decrease in the sensitivity was observed with pH 6.5 and 8 compared to 7.4. (Bolger 
et al., 2011a). 
4.3.2.7 aCSF CV 
CV was performed on the Pt-MMA electrodes to confirm the diffusion limited reduction 
potential of O2 at the surface of these electrodes in aCSF.  This was performed as described 
in Section 3.6.1.2.  The results obtained are presented graphically in Figure 4.35 below. 
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Figure 4.35:  Cyclic voltammograms from -1 to 0 V vs. SCE at 100 mVs
-1
 performed in O2 saturated 
aCSF (21˚C) buffer solution, illustrating the reduction of O2 at a Pt-MMA electrode. 
 
As with PBS - 650 mV vs. SCE (see Figure 4.17) is in the mass-transport limited region 
after the peak potential of O2 reduction at Pt-MMA electrodes.  All experiments performed 
in aCSF were carried out at this potential. 
4.3.2.8 Effect of ion changes 
Changes in ion concentrations are of interest in vivo as previously discussed in Section 0.  
The effect of ion changes on the sensitivities of Pt-MMA electrodes was investigated.  O2 
calibrations performed in aCSF, aCSF no Ca
2+ 
and aCSF no Mg
2+ 
on Pt-MMA electrodes 
are presented below in Table 4.27 and plotted in Figure 4.36 . 
 aCSF (n=7) aCSF no Ca
2+
 (n=4) aCSF no Mg
2+
(n=4) 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 
240 -626.7 106.8 -352.5 22.6 -158.8 3.1 
1200 -1866.3 173.7 -1102.9 84.2 -890.9 24.9 
Table 4.27:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes.  CPA performed 
at -650 mV vs. SCE in aCSF (n=7), aCSF no Ca
2+
 (n=4), aCSF no Mg
2+
 (n=4) at 21˚C.  Mean 
background subtracted. 
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Figure 4.36:  O2 calibration data (0-1200 µM) for Pt-MMA electrodes.  CPA performed at -650 mV vs. 
SCE in aCSF, aCSF no Ca
2+
 and aCSF no Mg
2 
at 21˚C. 
Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes calibrated in aCSF solutions in the presence and absence of ions, 
presented in Table 4.28 and plotted in Figure 4.37. 
 Sensitivity (nA/µM) R
2
 n 
aCSF ˗1.480 ± 0.218 0.9788 7 
aCSF no Ca
2+
 ˗0.880 ± 0.113 0.9837 4 
aCSF no Mg
2+
 ˗0.748 ± 0.017 0.9995 4 
Table 4.28:  Comparison of calculated sensitivity values of O2 calibrations (0-1200 µM) for Pt-MMA 
electrodes calibrated in aCSF, aCSF no Ca
2+
, aCSF no Mg
2+
 at 21˚C. 
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Figure 4.37:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for Pt-
MMA electrodes calibrated in aCSF (n=7), aCSF no Ca
2+
 (n=4), aCSF no Mg
2
+ (n=4). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is a significant 
difference in the sensitivities of Pt-MMA electrodes calibrated in aCSF and aCSF with no 
Ca
2+
or Mg
2+ 
with P values of 0.0402 (aCSF no Ca
2+
) and 0.0154 (aCSF no Mg
2+
).  
There is an increase in the sensitivity for Pt-MMA electrodes calibrated in aCSF (˗1.480 ± 
0.218 nA/µM) compared to PBS (-1.140 ± 0.004 nA/µM) although the difference is not 
significant P = 0.1699.   The significant differences observed in the sensitivities of Pt-
MMA electrodes plotted in Figure 4.37, with and without the presence of ions are 
unexpected as there were no significant differences seen with bare Pt electrodes (Bolger et 
al., 2011a).  
4.3.2.9 Effect of stirring 
The reduction of O2 at the Pt-MMA electrode was examined in quiescent and stirred 
solutions as discussed previously in Section 4.3.1.6.  Results are presented below in Table 
4.29 and plotted in Figure 4.38. 
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 Control: PBS Bubbling PBS Quiescent Stirring @ c.a 1 Hz Stirring @ c.a 10 Hz 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
240 -651.9 93.6 -447.6 97.4 -561.6 153.7 -680.7 193.6 
1200 -2452.2 99.4 -1517.6 43.2 -1688.0 55.8 -1774.1 62.3 
Table 4.29:  Table of results for O2 calibrations (240-1200 µM) for Pt-MMA electrodes (n=4).  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted.  
[O2], 240 M [O2], 1200 M
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Figure 4.38:  O2 calibration data (240-1200 µM) for Pt-MMA electrodes (n=4).  CPA performed at -650 
mV vs. SCE in PBS (pH 7.4) quiescent and in the presence of forced convection at 21˚C.  
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities between Pt-MMA electrodes calibrated in quiescent PBS and 
agitated PBS stirred at approximately 1 Hz in the presence of 240 µM O2 with a P value of 
0.5585.  There was also no significant difference found between Pt-MMA electrodes 
calibrated in quiescent PBS and agitated PBS stirred at approximately 10 Hz in the 
presence of 240 µM O2 with a P value of 0.3426. 
There is no significant difference in the sensitivities between Pt-MMA electrodes calibrated 
in quiescent PBS and agitated PBS stirred at approximately 1 Hz in the presence of 1200 
µM O2 with a P value of 0.0605.  There was a significant difference found between Pt-
MMA electrodes calibrated in quiescent PBS and agitated PBS stirred at approximately 10 
Hz in the presence of 1200 µM O2 with a P value of 0.0196.   From the results presented in 
Figure 4.38 it can be seen that there is no significant increase in the current monitored using 
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Pt-MMA electrodes at 1 Hz in the presence 240 µM O2 compared to quiescent conditions, 
concluding that there is no dependence on flow in vitro. 
4.3.2.10 Selectivity 
4.3.2.10.1 Ascorbic Acid (AA) calibrations 
The effect of the most abundant interferent in the brain ascorbic acid (AA) was investigated 
(Miele & Fillenz, 1996).  Calibrations were performed as described in Section 3.6.1.7.  The 
addition of a 500 µM aliquot of AA prior to a high concentration (0-1200 µM) O2 
calibration allows for the determination of the effect of AA on the O2 signal.   O2 
calibrations performed in PBS with and without 500 µM AA present on Pt-MMA 
electrodes are presented below in Table 4.30 and plotted in Figure 4.39. 
 Pt-MMA (n=4) Pt-MMA: 500 µM AA (n=4) 
[O2], µM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 
240 -342.9 39.7 -224.1 12.2 
1200 -1425.8 150.0 -959.2 67.1 
Table 4.30:  Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes (n=4) for a 
standard O2 calibration and re-calibration in the presence of 500 µM AA.  CPA performed at -650 mV 
vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted.  
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Figure 4.39:  O2 calibration data (0-1200 µM) for Pt-MMA electrodes (n=4) for a standard O2 
calibration and re-calibration in the presence of 500 µM AA.  CPA performed at -650 mV vs. SCE in 
PBS (pH 7.4) at 21˚C.   
Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes calibrated with and without 500 µM of AA present, presented in Table 
4.13 and plotted in Figure 4.40. 
 Sensitivity (nA/µM) R
2
 n 
Pt-MMA ˗1.171 ± 0.050 0.9982 4 
Pt-MMA: 500 µM AA ˗0.790 ± 0.028 0.9988 4 
Table 4.31:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for Pt-MMA 
electrodes with and without 500 µM of AA present. 
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Figure 4.40: Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) Pt-
MMA electrodes with and without 500 µM of AA present (n=4). 
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Unpaired t-test statistical analysis was performed and it can be seen there is a significant 
difference in the sensitivities of Pt-MMA electrodes calibrated with and without the 
presence of 500 µM AA with a P value of 0.0026.   
The significant difference in the sensitivities between Pt-MMA electrodes and Pt-MMA 
electrodes calibrated in the presence of 500 µM AA is thought to be due to the AA 
accumulating at the electrode surface and decreasing the surface area resulting in a 
reduction in sensitivity to O2. Results for a 500 µM AA injection looked at the current 
response (Bolger et al., 2011a).  This experiment showed that the signal recorded in a N2 
atmosphere did not deviate from the typical baseline current. 
4.3.2.11 Post- implantation calibrations 
The effects of proteins, lipids and brain tissue on the sensitivity of Pt-MMA electrodes in 
vitro was investigated (Section 4.3.2.3).  Although this gives an indication as to the effect 
that proteins, lipids and ex-vivo brain tissue has on the sensitivity of the electrodes the 
effect of the living brain with endogenous species present was investigated by performing 
post implantation calibrations where possible on the Pt-MMA electrodes (implanted for 19 
± 3 days) once removed from the brain, presented in Table 4.32 and plotted in Figure 4.41. 
These calibrations are described in Section 3.6.1.8. 
 Pt-MMA (pre-implantation) Pt-MMA (post-implantation) 
[O2], µM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 
240 -312.0 13.9 -247.6 72.2 
1200 -1403.4 74.0 -1038.2 121.3 
Table 4.32: Table of results for O2 calibrations (0-1200 µM) for Pt-MMA electrodes pre-implantation 
and post-implantation (n=4) for a standard O2 calibration.  CPA performed at -650 mV vs. SCE in PBS 
(pH 7.4) at 21˚C.  Mean background subtracted.  
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Figure 4.41:  O2 calibration data (0-1200 µM) for Pt-MMA electrodes pre-implantation and post-
implantation (n=4) for a standard O2 calibration).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) 
at 21˚C. 
 
Linear regression analysis was performed on electrodes to compare sensitivities of Pt-
MMA electrodes calibrated before and after implantation, presented in Table 4.33 and 
plotted in Figure 4.42. 
 Sensitivity (nA/µM) R
2
 n 
Pre-implantation ˗1.160 ± 0.027 0.9995 4 
Post-implantation ˗0.853 ± 0.034 0.9984 4 
Table 4.33:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for Pt-MMA 
electrodes pre-implantation and post-implantation. 
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Figure 4.42:  Graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for Pt-MMA 
electrodes pre-implantation and post-implantation (n=4). 
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Unpaired t-test statistical analysis was performed and it can be seen there is a significant 
difference in the sensitivities between Pt-MMA electrodes calibrated pre and post-
implantation with a P value of 0.0009.  From the results presented in Error! Reference 
source not found. it can be seen that the brain has a detrimental effect on the sensitivity of 
the Pt-MMA electrodes to O2.  This represents a decrease in sensitivity of 26.44 ± 2.96 % 
for the electrodes post-implantation compared to pre-implantation.  This decrease is 
thought to be due to fouling and even an accumulation of tissue at the electrode surface 
preventing O2 from reaching the active surface of the electrode. 
4.3.3 CPE and Pt-MMA Electrode Comparisons 
To allow for an accurate comparison between the CPEs and Pt-MMA electrodes due to the 
different dimensions of the electrodes the mean sensitivity values were converted to current 
densities. 
4.3.3.1 Oxygen calibrations 
The average sensitivity for CPEs in terms of current density for high concentration O2 
calibrations was -0.033 ± 0.001 µAmm
-2
µM
-1
 (n=24).  The average current density value at 
the physiological O2 level of 50 µM was -1.65 ± 0.05 µAmm
-2
 (n = 24).   
The average sensitivity for Pt-MMA electrodes in terms of current density for high 
concentration O2 calibrations was -0.093 ± 0.003 µAmm
-2
µM
-1
 (n=64).  The average 
current density value at the physiological O2 level of 50 µM was -4.66 ± 0.02 µAmm
-2
 (n = 
64).   Current density comparisons were made between CPEs and Pt-MMA electrodes for 
O2 calibrations, plotted in Figure 4.43. 
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Figure 4.43: Comparison graph of calculated current density sensitivity values for O2 calibrations (0-
1200 µM) CPEs and Pt-MMA electrodes calibrated in PBS (pH 7.4) at 21˚C. 
  
From these results it can be seen that the Pt-MMA electrodes exhibit a higher sensitivity to 
O2 at the physiological concentration of 50 µM O2 than CPEs. 
4.3.3.2 Temperature dependence comparisons 
The average sensitivity for CPEs in terms of current density for high concentration O2 
calibrations at 37°C was -0.046 ± 0.005 µAmm
-2
µM
-1 
(n=8)  and at 21°C  was -0.033 ± 
0.001 µAmm
-2
µM
-1 
(n=24).   
The average sensitivity for Pt-MMA electrodes in terms of current density for high 
concentration O2 calibrations at 37°C was -0.133 ± 0.009 µAmm
-2
µM
-1  
(n=5) and at 21°C  
was -0.092 ± 0.003 µAmm
-2
µM
-1 
(n=10).  Current density comparisons were made between 
CPEs and Pt-MMA electrodes for O2 calibrations in PBS at 21°C and 37°C, plotted in 
Figure 4.44. 
Chapter 4: In Vitro Oxygen 
130 
C
37
C
21
-0.15
-0.10
-0.05
0.00
Pt-MMA
CPE
J
, 
µ
A
 m
m
-2

M
-1
 
Figure 4.44:  Comparison graph of calculated current density sensitivity values for O2 calibrations (0-
1200 µM) CPEs and Pt-MMA electrodes calibrated in PBS (pH 7.4) at 21˚C and 37 ˚C.  
 
The Pt-MMA electrodes give a higher sensitivity in terms of current density at the 
physiological temperature of 37°C at 50 µM (-6.665 ± 0.454 µAmm
-2
) than CPEs (-2.300 ± 
0.239 µAmm
-2
).  However there is an increase of 2.47 ± 1.22 % for every 1˚C increase for 
CPEs and a 2.82 ± 0.44 % for every 1˚C increase for Pt-MMA electrodes showing that the 
electrodes behave similarly in terms of temperature dependence.   
4.3.3.3  Convection comparisons 
The average sensitivity for CPEs in terms of current density for O2 calibrations at stirred  
(ca.) 1 Hz was -0.060  ±  0.005 µAmm
-2
µM
-1 
(n=12 (240 µM) n=4 (1200 µM)) and at ca. 
10 Hz was -0.061 ± 0.006 µAmm
-2
µM
-1 
(n=12 (240 µM) n=4 (1200 µM)).  There is a 33.15 
± 5.28 % decrease in the sensitivity of CPEs stirred at ca. 1 Hz compared to no stirring (-
0.090 ± 0.002 µAmm
-2
µM
-1 
(n=12 (240 µM) n=4 (1200 µM)) and a decrease of 32.10 ± 
6.91 % for CPEs stirred at ca. 10 Hz. 
The average sensitivity for Pt-MMA electrodes in terms of current density for O2 
calibrations at stirred at ca. 1 Hz was -0.109  ±  0.016 µAmm
-2
µM
-1 
(n=4) and at ca. 10 Hz 
was -0.113 ± 0.023 µAmm
-2
µM
-1 
(n=4).  There is a 9.68 ± 15.75 % increase in the 
sensitivity of Pt-MMA electrodes stirred at ca. 1 Hz compared to no stirring (-0.100 ± 
0.010 µAmm
-2
µM
-1 
(n=4)) and an increase of 13.10 ± 22.92 % for Pt-MMA electrodes 
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stirred at ca. 10 Hz.  Current density comparisons were made between CPEs and Pt-MMA 
electrodes for O2 calibrations in quiescent and agitated solutions of PBS, plotted in Figure 
4.45. 
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Figure 4.45:  Comparison graph of calculated current density sensitivity values for O2 calibrations on 
CPEs and Pt-MMA electrodes calibrated in PBS (pH 7.4) quiescent and in the presence of forced 
convection at 21˚C.  
From the results it can be seen that convection has less of an effect on the sensitivity of Pt-
MMA electrodes than CPEs.  These results have little bearing on in vivo experiments but 
would be more relevant to brain slice or tissue culture experiments as discussed previously 
in Section 4.3.1.6.   
4.3.3.4 Post implantation comparisons 
The average sensitivity for CPEs in terms of current density for O2 calibrations (0-1200 
µM) post-implantation was -0.031 ± 0.004 µAmm
-2
µM
-1
 (n=13) corresponding to a 5.75 ± 
11.46 % decrease when compared to pre-implantation calibrations (-0.033 ± 0.001 µAmm
-
2
µM
-1
 (n=13)).   
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The average sensitivity for Pt-MMA electrodes in terms of current density for O2 
calibrations (0-1200 µM) post-implantation was -0.070 ± 0.003 µAmm
-2
µM
-1
 (n=4) 
corresponding to a 26.44 ± 2.96 % decrease when compared to pre-implantation 
calibrations (-0.095 ± 0.002 µAmm
-2
µM
-1
 (n=4)).  Current density comparisons were made 
between CPEs and Pt-MMA electrodes pre and post-implantation, plotted in Figure 4.46. 
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Figure 4.46:  Comparison graph of calculated current density sensitivity values for O2 calibrations on 
CPEs and Pt-MMA electrodes calibrated before and after implantation in PBS (pH 7.4) at 21°C.  
 
From the results it can be seen that implantation has less of an effect on the sensitivity of 
CPEs than Pt-MMA electrodes when compared to pre-implantation calibrations.  This is 
thought to be due to fowling of the Pt-MMA electrodes, characteristic of noble metal 
electrodes. However the CPEs were only implanted for a period of 6 ± 1 days compared to 
Pt-MMA electrodes which were implanted for a period of 19 ± 3 days.  There is an 
approximate 2 week difference in the length of implantation which could account for the 
vast difference in sensitivities.  The stability of CPEs have been investigated in vivo 
indicating a stable baseline signal over 12 weeks (Bolger et al., 2011b), showing that CPEs 
are suitable for long-term recording of brain tissue O2 compared to Pt-MMA electrodes 
which exhibit a significant drop in sensitivity of 26.44 ± 2.96 % after 19 ± 3 days.   
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4.4 Conclusions 
The in vitro characterisation of an electrode allows for the determination of the sensitivity, 
selectivity and stability of the sensor. This chapter examines the effect of changes in 
temperature, pH, ions, convection and implantation on the sensitivity of CPEs to O2 
(Section 4.3.1).  Pt-MMA electrodes were fully characterised in vitro by determining the 
sensitivity of the sensor to O2 and the effects on the sensitivity following exposure to 
proteins, lipids and brain tissue. The effects of temperatures, pH, ions, convection, 
interferents and implantation were also examined along with the stability of the sensors in 
relation to time (Section 4.3.2.4). 
From the results observed in this chapter it can be concluded that Pt-MMA electrodes have 
a higher sensitivity to O2 than CPEs (Section 4.3.3.1).  The physiological temperature 
(37°C) affects the sensitivity of CPEs and Pt-MMA electrodes similarly (Section 4.3.3.2) 
and although convection experiments show that Pt-MMA electrodes are less affected by 
stirring than CPEs (Section 4.3.3.3) these results only prove to be relevant for in vitro 
experiments.  The effect of implantation of the sensors into the living brain showed that 
implantation has less of an effect on CPEs than Pt-MMA electrodes although there was a 
difference of the period implanted of approximately 2 weeks (Section 4.3.3.4). Our 
previously published data shows that CPEs have a stable baseline over 12 (Bolger et al., 
2011b). These results indicate that Pt-MMA electrodes are an ideal choice for detection of 
brain tissue O2 in vivo over short periods of time but CPEs would be the sensor of choice 
for long-term monitoring of brain tissue O2. 
 
 
 
 
 
 
 
 
 
Chapter 4: In Vitro Oxygen 
134 
References 
 
Amatore C, Szunerits S, Thouin L & Warkocz J-S. (2000). Mapping concentration profiles 
within the diffusion layer of an electrode: Part III. Steady-state and time-dependent 
profiles via amperometric measurements with an ultramicroelectrode probe. 
Electrochemistry Communications 2, 353-358. 
 
Bard AJ & Faulkner LR. (1980). Electrochemical Methods: Fundamentals and 
Applications. John Wiley & Sons. 
 
Bolger F & Lowry J. (2005). Brain Tissue Oxygen: In Vivo Monitoring with Carbon Paste 
Electrodes. Sensors 5, 473-487. 
 
Bolger FB, Bennett R & Lowry JP. (2011a). An in vitro characterisation comparing carbon 
paste and Pt microelectrodes for real-time detection of brain tissue oxygen. The 
Analyst 136, 4028-4035. 
 
Bolger FB, McHugh SB, Bennett R, Li J, Ishiwari K, Francois J, Conway MW, Gilmour G, 
Bannerman DM, Fillenz M, Tricklebank M & Lowry JP. (2011b). Characterisation 
of carbon paste electrodes for real-time amperometric monitoring of brain tissue 
oxygen. Journal of neuroscience methods 195, 135-142. 
 
Chen BT & Rice ME. (1999). Calibration Factors for Cationic and Anionic 
Neurochemicals at Carbon-Fiber Microelectrodes are Oppositely Affected by the 
Presence of Ca
2+
and Mg
2+
. Electroanalysis 11, 344-348. 
 
Cheng HY, Schenk J, Huff R & Adams RN. (1979). In vivo electrochemistry: behavior of 
micro electrodes in brain tissue. Journal of Electroanalytical Chemistry and 
Interfacial Electrochemistry 100, 23-31. 
 
Cooper R. (1963). Local changes of intra-cerebral blood flow and oxygen in humans. 
Medical and Biological Engineering and Computing 1, 529-536. 
 
Crespi F. (1996). Carbon fibre micro-electrode and in vitro or in brain slices voltammetric 
measurement of ascorbate, catechol and indole oxidation signals: influence of 
temperature and physiological media. Biosensors and Bioelectronics 11, 743-749. 
 
Chapter 4: In Vitro Oxygen 
135 
Dayton MA, Ewing AG & Wightman RM. (1983). Diffusion processes measured at 
microvoltammetric electrodes in brain tissue. Journal of Electroanalytical 
Chemistry and Interfacial Electrochemistry 146, 189-200. 
 
Garguilo MG & Michael AC. (1994). Quantitation of Choline in the Extracellular Fluid of 
Brain Tissue with Amperometric Microsensors. Analytical chemistry 66, 2621-
2629. 
 
Gifford R, Kehoe JJ, Barnes SL, Kornilayev BA, Alterman MA & Wilson GS. (2006). 
Protein interactions with subcutaneously implanted biosensors. Biomaterials 27, 
2587-2598. 
 
Gotoh F, Tazaki Y & Meyer JS. (1961). Transport of gases through brain and their 
extravascular vasomotor action. Experimental Neurology 4, 48-58. 
 
Hitchman ML. (1978). Measurement of dissolved oxygen. John Wiley and Sons, New York 
N Y 1978 255. 
 
Jeroschewski P & Zur Linden D. (1997). A flow system for calibration of dissolved oxygen 
sensors. Fresenius' Journal of Analytical Chemistry 358, 677-682. 
 
Kane DA & O’Neill RD. (1998). Major differences in the behaviour of carbon paste and 
carbon fibre electrodes in a protein–lipid matrix: implications for voltammetry in 
vivo. The Analyst 123, 2899-2903. 
 
Kume-Kick J & Rice ME. (1998). Dependence of dopamine calibration factors on media 
Ca
2+
 and Mg
2+
 at carbon-fiber microelectrodes used with fast-scan cyclic 
voltammetry. Journal of neuroscience methods 84, 55-62. 
 
Lowry JP, Boutelle MG & Fillenz M. (1997). Measurement of brain tissue oxygen at a 
carbon paste electrode can serve as an index of increases in regional cerebral blood 
flow. Journal of neuroscience methods 71, 177-182. 
 
Lowry JP, Boutelle MG, O'Neill RD & Fillenz M. (1996). Characterization of carbon paste 
electrodes in vitro for simultaneous amperometric measurement of changes in 
oxygen and ascorbic acid concentrations in vivo. The Analyst 121, 761-766. 
 
Chapter 4: In Vitro Oxygen 
136 
Lyne PD & O'Neill RD. (1990). Stearate-modified carbon paste electrodes for detecting 
dopamine in vivo: decrease in selectivity caused by lipids and other surface-active 
agents. Analytical Chemsitry 62, 2347-2351. 
 
Miele M & Fillenz M. (1996). In vivo determination of extracellular brain ascorbate. 
Journal of neuroscience methods 70, 15-19. 
 
Nicholson C & Syková E. (1998). Extracellular space structure revealed by diffusion 
analysis. Trends Neuroscience 21, 207-215. 
 
O'Neill RD. (1993). Sensor-tissue interactions in neurochemical analysis with carbon paste 
electrodes in vivo. The Analyst 118, 433-438. 
 
Ormonde DE & O'Neill RD. (1989). Altered response of carbon paste electrodes after 
contact with brain tissue: Implications for modified electrode use in vivo. Journal of 
Electroanalytical Chemistry and Interfacial Electrochemistry 261, 463-469. 
 
Ormonde DE & O'Neill RD. (1990). The oxidation of ascorbic acid at carbon paste 
electrodes: Modified response following contact with surfactant, lipid and brain 
tissue. Journal of Electroanalytical Chemistry and Interfacial Electrochemistry 279, 
109-121. 
 
Rice ME & Nicholson C. (1995). Diffusion and ion shifts in the brain extracellular 
microenvironment and their relevance for voltammetric measurements. 
Voltammetric Methods in Brain Systems Neuromethods 27, 27-79. 
 
Schneiderman G & Goldstick T. (1978). Oxygen electrode design criteria and performance 
characteristics: recessed cathode. Journal of Applied Physiology: Respiratory, 
Environmental and Exercise Physiology 45, 145. 
 
Sharan M, Vovenko EP, Vadapalli A, Popel AS & Pittman RN. (2008). Experimental and 
theoretical studies of oxygen gradients in rat pial microvessels. Journal of Cerebral 
Blood Flow & Metabolism 28, 1597-1604. 
 
Taylor R & Humffray A. (1975). Electrochemical studies on glassy carbon electrodes:: III. 
Oxygen reduction in solutions of low pH (pH< 10). Journal of Electroanalytical 
Chemistry and Interfacial Electrochemistry 64, 85-94. 
 
Chapter 4: In Vitro Oxygen 
137 
Wilkins E & Radford W. (1990). Biomaterials for implanted closed loop insulin delivery 
system: A review. Biosensors and Bioelectronics 5, 167-213. 
 
Wisniewski N, Moussy F & Reichert WM. (2000). Characterization of implantable 
biosensor membrane biofouling. Fresenius' Journal of Analytical Chemistry 366, 
611-621. 
 
Yang HH & McCreery RL. (2000). Elucidation of the mechanism of dioxygen reduction on 
metal-free carbon electrodes. Journal of The Electrochemical Society 147, 3420-
3428. 
 
Zimmerman JB & Wightman RM. (1991). Simultaneous electrochemical measurements of 
oxygen and dopamine in vivo. Analytical Chemsitry 63, 24-28. 
 
 
 5.  RESULTS: 
CHARACTERISATION OF A 
PT-BASED SENSOR FOR THE 
DETECTION OF BRAIN TISSUE 
OXYGEN IN VIVO 
  
Chapter 5: In Vivo Oxygen 
139 
5.1      Introduction 
Brain tissue oxygen (O2) is one of the most important energy substrates for brain energy 
metabolism.  Molecular O2 was one of the first substances to be detected voltammetrically 
in vivo in the brain (Clark et al., 1958; Clark Jr & Lyons, 1965) and in peripheral tissue 
(Clark Jr & Clark, 1964). O2 is delivered by the blood and the tissue concentration is 
determined by the balance of supply and utilisation.  In different brain regions the O2 
turnover rate varies and it has been established that the cerebral cortex has a higher 
turnover rate than others (Nair et al., 1987).  The concentration of O2 in the brain varies as 
supply is altered in different layers of the brain tissue (Baumgärtl et al., 1989) and depends 
on the tissue heterogeneity (Murr et al., 1994; Lubbers & Baumgärtl, 1997).  O2 tissue 
concentrations have been reported to range from 40 µM (Murr et al., 1994),  50 µM 
(Zimmerman & Wightman, 1991), 60 µM (Zauner et al., 1995) to 80 µM (McCreery et al., 
1990). 
Carbon-based electrodes such as glassy carbon (Clark Jr & Clark, 1964), carbon fiber 
electrodes (Zimmerman & Wightman, 1991; Zimmerman et al., 1992; Venton et al., 2003), 
carbon epoxy (Bazzu et al., 2009) and carbon paste electrodes (Lowry et al., 1996; Lowry 
et al., 1997; Bolger & Lowry, 2005; Bolger et al., 2011b) are commonly used  for detecting 
changes in tissue O2.  Carbon electrodes have their advantages and disadvantages over 
noble metal electrodes.  The main advantage of carbon fibre electrodes (CFEs) and carbon 
paste electrodes (CPEs) for use in vivo are that they are less susceptible to surface 
poisoning than noble metal electrodes, which usually require the addition of a protective 
membrane (Wisniewski et al., 2000; Zhao et al., 2001; Gifford et al., 2006).  CFEs 
(Zimmerman & Wightman, 1991) are advantageous due to their small diameter (5-50 µm), 
however if placed closely to blood vessels or  metabolically active sites the O2 
concentration can vary (Lowry et al., 1997).  CPEs are advantageous as in vivo they are 
stable over long periods (O'Neill, 1993; O'Neill & Lowry, 1995; O’Neill, 2005; Bolger et 
al., 2011b).  CPEs have a diameter of 200 µm greater than the scale of the capillary zone 
(<100 µm) (Silver, 1965) which allows detection of average tissue O2 levels.  However due 
to their size they do cause greater tissue damage than noble metal electrodes.   
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Platinum(Pt)-based electrodes have been shown to be a potential alternative to CPEs to 
monitor brain tissue O2 (Bolger et al., 2011a).  Pt electrodes are easier to manufacture than 
CPEs and have a smaller diameter (125 µm) resulting in less tissue damage.    
This chapter investigates and characterises the use of Pt-coated in methyl methacrylate 
(MMA) for the detection of brain tissue O2 in the striatum following on from the previous 
chapter (Chapter 4) where the Pt-MMA electrodes were fully characterised in vitro.  As 
previously discussed in Section 4.1 the in vitro characterisation allows for an indication of 
the potential consequences of implantation of the sensor into tissue but does not allow us to 
know the full extent of the effect of the brain on the sensitivity, selectivity and stability of 
the sensor.   
5.2 Experimental In Vivo 
The instrumentation and software used are detailed in Section 3.2 and all chemicals and 
solutions are detailed in Section 3.3. 
Pt disk electrodes (125 µm bare diameter) were constructed as described in Section 3.4.5 
and modified using MMA as detailed in Section 3.5.2.1.  A potential of -650 mV vs. SCE 
was applied to the working electrodes and all experiments were performed on freely-
moving Wistar rats. 
In vivo procedures are detailed in Section 3.7.  Pt-MMA electrodes were implanted in the 
striatum.  
Data is represented via the mean ± SEM where n = number of administrations, unless 
otherwise stated.  Significant differences were calculated using two-tailed unpaired t-tests 
unless otherwise stated. 
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5.3 Results and Discussion In Vivo 
5.3.1 Characterisation of Pt-MMA electrodes In Vivo 
5.3.2 Gaseous Administrations 
5.3.2.1 Hyperoxia 
Mild hyperoxia was achieved by administration of O2 gas to the snout of the animal.  The 
flow was maintained at a slow steady rate similar to the method used previously (Lowry et 
al., 1998) and as described in Section 3.7.4.   The inhalation of the O2 gas for 3 minutes 
resulted in a change from baseline levels for the O2 signals, monitored using Pt-MMA 
electrodes as can be seen in Figure 5.1 below. 
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Figure 5.1 : A typical example of a 3-min period of mild hyperoxia (administration of O2 gas) monitored in vivo 
using a Pt-MMA electrode implanted in the striatum of a freely-moving rat.  The bar indicates the period of 
gaseous administration. 
 
A 3-min period of mild hyperoxia shows an average immediate increase in current from the 
baseline level of -93.70 ± 3.57 nA (n=51, 4 animals) to -133.51 ± 6.14 nA (n=51, 4 
animals).  This increase was found to be significant (P < 0.0001).  The percentage increase 
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was found to be 43.25 ± 4.01 % (n=51, 4 animals).  Changes were immediate and on 
cessation of inhalation the signals quickly returned to baseline levels of -94.86 ± 3.55 nA 
after 4.51 ± 0.63 min (n=41, 4 animals) (P=0.8183), indicating a rapid return to normoxic 
conditions. A summary of these results can be seen in Table 5.1. 
Hyperoxia 
Baseline (nA) -93.70 ± 3.57 
Max Increase (nA) -133.51 ± 6.14 
% Increase 43.25 ± 4.01 
Post-baseline (nA) -94.86 ± 3.55 
t to post-baseline (min) 4.51 ± 0.63 
Table 5.1 : Summary of results for a 3-min period of mild hyperoxia monitored in vivo using Pt-MMA 
electrodes (n = 41, 4 animals), implanted in the striatum of freely-moving rats. 
 
From these results it can be seen that there is a significant increase in striatal tissue O2 upon 
administration of O2 gas to the animal’s snout and this change can be reliably monitored 
using Pt-MMA electrodes. 
5.3.2.2 Hypoxia  
Mild hypoxia was achieved by administration of N2 gas to the snout of the animal.  The 
flow was maintained at a slow steady rate similar to the method used previously (Lowry et 
al., 1998) and as described in Section 3.7.4.   The inhalation of the N2 gas for 3 minutes 
resulted in a change from baseline levels for the O2 signals, monitored using Pt-MMA 
electrodes as can be seen in Figure 5.2 below. 
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Figure 5.2 : A typical example of a 3-min period of mild hypoxia (administration of N2 gas) monitored 
in vivo using a Pt-MMA electrode implanted in the striatum of a freely-moving rat.  The bar indicates 
the period of gaseous administration. 
 
A 3-min period of mild hypoxia shows an average immediate decrease in current from the 
baseline level of -89.62 ± 3.89 nA (n=42, 4 animals) to -63.87 ± 3.91 nA (n=42, 4 animals).  
This decrease was found to be significant (P < 0.0001).  The percentage decrease was 
found to be 28.13 ± 2.05 % (n=42, 4 animals). Changes were immediate and on cessation of 
inhalation the signals quickly returned to baseline levels of -90.16 ± 6.37 nA after 2.95 ± 
0.11 min (n=34, 4 animals) (P= 0.9426), indicating a rapid return to normoxic conditions. 
A summary of these results can be seen in Table 5.2. 
Hypoxia 
Baseline (nA) -89.62 ± 3.89 
Max Decrease (nA) -63.87 ± 3.91 
% Decrease 28.13 ± 2.05 
Post-baseline (nA) -90.16 ± 6.37 
t to post-baseline (min) 2.95 ± 0.11 
Table 5.2:  Summary of results for a 3-min period of mild hypoxia monitored in vivo using Pt-MMA 
electrodes (n = 42, 4 animals), implanted in the striatum of freely-moving rats. 
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From these results it can be seen that there is a significant decrease in striatal tissue O2 
upon administration of N2 gas to the animal’s snout and this change can be reliably 
monitored using Pt-MMA electrodes. 
5.3.3 Neuronal Activation 
5.3.3.1 Tail Pinch 
Neuronal activation was stimulated physiologically by means of a tail pinch.  A tail pinch 
induces a well characterised behaviour pattern consisting of gnawing, licking, eating and a 
general increase in the level of motor activity (Antelman et al., 1975).  The tail pinch was 
performed for a duration of 5 minutes similar to methods used previously (Bolger & 
Lowry, 2005) and as described in Section 3.7.5.1.  Induced neuronal activation for 5 
minutes resulted in a change from baseline levels for the O2 signals, monitored using Pt-
MMA electrodes as can be seen in Figure 5.3. 
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Figure 5.3:  A typical example of a 5-min tail pinch (neuronal activation) monitored in vivo using a Pt-
MMA electrode implanted in the striatum of a freely-moving rat. .  The bar indicates the duration of 
the tail pinch.  
 
A 5-min period of neuronal activation shows an average increase in current from baseline 
level of -106.22 ± 5.36 nA (n=14, 3 animals) to -121.26 ± 6.66 nA (n=14, 3 animals) after 
Chapter 5: In Vivo Oxygen 
145 
2.04 ± 0.41 min, representing a significant increase of  15.33 ± 1.96 % (n=14, 3 animals) 
compared to baseline levels (P< 0.0001 (paired t-test)). Upon cessation of the tail pinch, the 
current increased to -117.71 ± 5.86 nA (n=14, 3 animals) corresponding to a mean 
percentage increase of 11.16 ± 1.77 % (n=14, 3 animals) from baseline levels. The post-tail 
pinch current returned to baseline levels of -103.03 ± 8.47 nA (n=14, 3 animals) 
(P=0.7534) after 10.91 ± 4.16 min. A summary of these results can be seen in Table 5.3. 
Tail pinch 
Baseline (nA) -106.22 ± 5.36 
Max Increase (nA) -121.26 ± 6.66 
% Increase 15.33 ± 1.96 
Post-baseline (nA) -103.03 ± 8.47 
t to post-baseline (min) 10.91 ± 4.16 
Table 5.3:  Summary of results for a 5-min tail pinch monitored in vivo using Pt-MMA electrodes (n = 
14, 3 animals), implanted in the striatum of freely-moving rats. 
 
From these results it can be seen that there is an increase in striatal tissue O2 upon neuronal 
activation and this change can be reliably monitored using Pt-MMA electrodes.  The 
percentage increase however is low which is thought to be due to variations in the stress 
score between experiments and habituation of the animal to the tail pinch.   
5.3.4 Control Administrations 
5.3.4.1 Saline 
The effect of i.p. injections of saline (0.9% NaCl) on the O2 signal was investigated.  Saline 
serves as a vehicle for drug administration so the effects of saline and the i.p. injection on 
the O2 signal, monitored using Pt-MMA electrodes can be seen in Figure 5.4 below. 
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Figure 5.4:  A typical example of an i.p. administration of saline (0.9% NaCl) monitored in vivo using a 
Pt-MMA electrode implanted in the striatum of a freely-moving rat.  The arrow indicates the point of 
injection. 
 
An i.p. injection of saline shows an average immediate increase in the O2 signal from 
baseline levels of -93.51 ± 5.89 nA (n=14, 3 animals) to -105.63 ± 7.05 nA after 25.80 ± 
3.34 seconds (n=14, 3 animals) this sharp increase in current of 13.35 ± 2.42 % can be 
attributed to injection stress.  A maximum increase of -109.58 ± 7.68 nA (n=14, 3 animals) 
was observed after 3.57 ± 0.77 min representing a non-significant increase of 19.84 ± 
3.30% (n=14, 3 animals) compared to baseline levels (P= 0.1118).  The current returned to 
post-injection baseline levels of -95.43 ± 5.92 nA (n=14, 3 animals) (P= 0.8214) after 5.21 
± 1.09 min.  A summary of these results can be seen in Table 5.4. 
Saline i.p. 
Baseline (nA) -93.51 ± 5.89 
Max Increase (nA) -109.58 ± 7.68 
t to max increase (min) 3.57 ± 0.77 
% Increase 19.84 ± 3.30 
Post-baseline (nA) -95.43 ± 5.92 
t to post-baseline (min) 5.21 ± 1.09 
Table 5.4:  Summary of results for i.p. administrations of saline (0.9% NaCl) monitored in vivo using 
Pt-MMA electrodes (n = 14, 3 animals), implanted in the striatum of freely-moving rats. 
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From these results it can be seen that there is no significant effect on striatal tissue O2 levels 
upon administration of a saline (0.9%) i.p. injection monitored using Pt-MMA electrodes. 
The increase observed can be attributed to injection stress. It can therefore be concluded 
that any increase seen using saline as a vehicle for drug administrations is a drug effect. 
5.3.4.2 Dimethyl sulfoxide (DMSO) 
The effect of i.p. injections of DMSO (2%) on the O2 signal was investigated.  DMSO 
serves as a vehicle for drug administration so the effects of DMSO and the i.p. injection on 
the O2 signal, monitored using Pt-MMA electrodes can be seen in Figure 5.5 below. 
0 5 10 15 20 25 30
-130
-120
-110
-100
-90
-80
Time (mins)
I,
 n
A
 
Figure 5.5:  A typical example of an i.p. administration of DMSO (2%) monitored in vivo using a Pt-
MMA electrode implanted in the striatum of a freely-moving rat.  The arrow indicates the point of 
injection. 
 
An i.p. injection of DMSO shows an average immediate increase in the O2 signal from 
baseline levels of -85.30 ± 10.03 nA (n=6, 3 animals) to -97.31 ± 11.78 nA after 32.63 ± 
6.42 seconds (n=6, 3 animals) this sharp increase in current of 13.28 ± 2.80 % can be 
attributed to injection stress.  A maximum increase of -92.94 ± 8.92 nA (n=6, 3 animals) 
was observed after 13.64 ± 4.79 min representing a non-significant increase of 6.98 ± 1.83 
% (n= 6, 3 animals) compared to baseline levels (P= 0.5832).  The current returned to post-
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injection baseline levels of -87.10 ± 10.24 nA (n=6, 3 animals) (P= 0.9028) after 11.44 ± 
4.24 min.  A summary of these results can be seen in Table 5.5. 
DMSO i.p. 
Baseline (nA) -85.30 ± 10.03 
Max Increase (nA) -92.94 ± 8.92 
t to max increase (min) 13.64 ± 4.79 
% Increase 6.98 ± 1.83 
Post-baseline (nA) -87.10 ± 10.24 
t to post-baseline (min) 11.44 ± 4.24 
Table 5.5: Summary of results for i.p. administrations of DMSO (2%) monitored in vivo using  Pt-
MMA electrodes (n = 6, 3 animals), implanted in the striatum of freely-moving rats. 
 
From these results it can be seen that there is no significant effect on striatal tissue O2 levels 
upon administration of a DMSO (2 %) i.p. injection monitored using Pt-MMA electrodes. 
It can therefore be concluded that any increase seen using DMSO as a vehicle for drug 
administrations is a drug effect.  
5.3.5 Drug Administration 
5.3.5.1 The Effect of Acetazolamide  
Acetazolamide (Diamox) is a carbonic anhydrase inhibitor and when administered 
systematically has been shown to increase brain tissue oxygen concentrations (Clark Jr & 
Lyons, 1965; Dixon et al., 2002; Bolger & Lowry, 2005).  Acetazolamide acts by inhibiting 
the carbonic anhydrase enzymes whose function is to catalyse the conversion of CO2 and 
H2O2 to bicarbonate (HCO3
-
).  This increase in CO2 and a subsequent decrease in pH 
results in vasodilatation and an increase in tissue O2.  The effect of acetazolamide on the O2 
signal, monitored with Pt-MMA electrodes can be seen in Figure 5.6 below. 
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Figure 5.6:  A typical example of an i.p. administration of Diamox (50 mg/kg) monitored in vivo using a 
Pt-MMA electrode implanted in the striatum of a freely-moving rat.  The arrow indicates the point of 
injection. 
 
An i.p. injection of Diamox shows an immediate sharp increase in the O2 signal from 
average baseline levels of -85.93 ± 9.11 nA (n=8, 3 animals) to -109.18 ± 11.34 nA (n=8, 3 
animals) after 1.06 ± 0.12 min this sharp increase in current of 29.32 ± 6.19 % can be 
attributed to injection stress.  The subsequent rapid decrease was followed by a sustained 
maximum increase in the O2 signal to -120.03 ± 11.65 nA (n=8, 3 animals) after 47.85 ± 
5.15 min, representing a significant increase of 37.57 ± 5.40 % (n=8, 3 animals) compared 
to baseline levels (P= 0.0382).  The current returned to post-injection baseline levels of -
94.10 ± 10.01 nA (n=8, 3 animals) (P= 0.5565) after 2.62 ± 0.40 hrs.  A summary of these 
results can be seen in Table 5.6. 
Diamox i.p. 
Baseline (nA) -85.93 ± 9.11 
Max Increase (nA) -120.03 ± 11.65 
t to max increase (min) 47.85 ± 5.15 
% Increase 37.57 ± 5.40 
Post-baseline (nA) -94.10 ± 10.01 
t to post-baseline (hrs) 2.62 ± 0.40 
Table 5.6:  Summary of results for i.p. administrations of Diamox (50mg/kg)) monitored in vivo using 
Pt-MMA electrodes (n = 8, 3 animals), implanted in the striatum of freely-moving rats. 
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From these results it can be seen that there is a significant increase in striatal tissue O2 upon 
administration of Diamox (50 mg/kg) and this change can be reliably monitored using Pt-
MMA electrodes. 
5.3.6 Effect of Anesthesia 
5.3.6.1 Chloral Hydrate 
Chloral hydrate was amongst one of the first CNS depressants used in veterinary medicine. 
Chloral hydrate is metabolised by alcohol dehydrogenase to trichloroethanol and 
trichloroacetic acid (Butler, 1948).  Although the precise mechanism is unknown (Sourkes, 
1992), trichloroethanol is the active metabolite (Tao & Auerbach, 1994; Gauillard et al., 
2002) and it’s thought its binding site is at the exogenous γ-aminobutyric acid (GABA) 
receptor resulting in an influx of chloride ions causing it to potentiate the function of 
GABA in a way similar to that of barbitutes (Lovinger et al., 1993). 
Chloral hydrate has been previously used to increase brain tissue O2 (Lowry & Fillenz, 
2001; Bolger & Lowry, 2005).  This increase in O2 is thought to be due to an increase in 
rCBF.  The effect of chloral hydrate on the O2 signal, monitored with Pt-MMA electrodes 
can be seen in Figure 5.7 below. 
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Figure 5.7:  A typical example of an i.p. administration of chloral hydrate (350 mg/kg), monitored in 
vivo using a Pt-MMA electrode implanted in the striatum of a freely-moving rat.  The arrow indicates 
the point of injection. 
 
An i.p. injection of chloral hydrate shows an immediate sharp increase in the O2 signal from 
average baseline levels of -97.80 ± 7.83 nA (n=12, 4 animals) to -107.94 ± 6.42 nA (n=12, 
4 animals) after 47.25 ± 12.60 seconds this sharp increase in current of 38.90 ± 4.78 % can 
be attributed to injection stress.  This initial increase rapidly decreases and there is a 
sustained maximum increase in the O2 signal to -137.19 ± 12.91 nA (n=12, 4 animals) after 
24.60 ± 5.11 min, representing a significant increase of 38.90 ± 4.78 % (n=12, 4 animals) 
compared to baseline levels (P=0.0178).  The current returned to post- injection baseline 
levels of -100.30 ± 7.94 nA (n=12, 4 animals) (P= 0.8248) after 3.43 ± 0.35 hrs. A 
summary of these results can be seen in Table 5.7. 
Chloral Hydrate i.p. 
Baseline (nA) -97.80 ± 7.83 
Max Increase (nA) -137.19 ± 12.91 
t to max increase (min) 24.60 ± 5.11 
% Increase 38.90 ± 4.78 
Post-baseline (nA) -100.30 ± 7.94 
t to post-baseline (hrs) 3.43 ± 0.35 
Table 5.7:  Summary of results for i.p. administrations of chloral hydrate (350mg/kg) monitored in vivo 
using Pt-MMA electrodes (n = 12, 4 animals), implanted in the striatum of freely-moving rats. 
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From these results it can be seen that there is a significant increase in striatal tissue O2 upon 
administration of chloral hydrate (350 mg/kg) and this change can be reliably monitored 
using Pt-MMA electrodes. 
5.3.7 Comparisons 
To allow for an accurate comparison between Pt-MMA electrodes and the CPEs due to the 
different dimensions of the electrodes, ∆I, nA values were converted to current densities 
(∆J, µA mm-2) for both types of electrodes. 
Carbon paste electrodes have been previously characterised in vivo by our group (Bolger & 
Lowry, 2005).  The results from this publication were used to make comparisons. 
5.3.7.1 Gaseous administrations 
The ∆J, µA mm-2 for 3-min periods of hyperoxia and hypoxia are 3.43 ± 0.35 ∆J, µA mm-2 
(n=51, 4 animals) and 2.32 ± 0.13 ∆J, µA mm-2 (n=42, 4 animals) respectively for Pt-MMA 
electrodes. The ∆J, µA mm-2 for a 3 min period of hyperoxia and hypoxia are 0.87 ± 0.13 
∆J, µA mm-2 (n=4) and 0.88 ± 0.09 ∆J, µA mm-2 (n=4) respectively for CPEs (Bolger & 
Lowry, 2005). The current change (∆I) in terms of current densities (∆J, µA mm-2) for Pt-
MMA electrodes and CPEs for mild hyperoxia and hypoxia are plotted in Figure 5.8. 
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Figure 5.8:  Comparison graph of calculated current density ∆J, µA mm-2 values for hyperoxia and 
hypoxia administrations, monitored using Pt-MMA and CPEs implanted in the striatum of freely-
moving rats. 
 
From these results it can be seen that the Pt-MMA electrodes exhibit a greater change in O2 
current in terms of current density compared to CPEs when monitoring 3-min periods of 
hyperoxia and hypoxia in the striatum of freely-moving rats. 
5.3.7.2 Neuronal Activation 
The ∆J, µA mm-2 for a 5-min tail pinch are 1.53 ± 0.33 ∆J, µA mm-2 (n=14, 3 animals) for 
Pt-MMA electrodes and 0.34 ± 0.06 ∆J, µA mm-2 (n=8, 2 animals) for CPEs (Bolger & 
Lowry, 2005).  The current changes (∆I) in terms of current densities (∆J, µA mm-2) for Pt-
MMA electrodes and CPEs for neuronal activation in the form of a tail pinch are plotted in 
Figure 5.9. 
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Figure 5.9:  Comparison graph of calculated current density ∆J, µA mm-2 values for a 5-min tail pinch, 
monitored using Pt-MMA and CPEs implanted in the striatum of freely-moving rats. 
 
From these results it can be seen that the Pt-MMA electrodes exhibit a greater change in O2 
current in terms of current density compared to CPEs when monitoring a 5-min tail pinch in 
the striatum of freely-moving rats. This difference is thought to be due to variations in the 
stress score of the animals and habituation to the tail pinch. 
5.3.7.3 Saline administrations 
The ∆J, µA mm-2 for saline (0.9%) i.p. administrations are 1.53 ± 0.33 ∆J, µA mm-2 (n=14, 
3 animals) for Pt-MMA electrodes and 0.43 ± 0.12 ∆J, µA mm-2 (n=4) for CPEs (Bolger & 
Lowry, 2005). The current changes (∆I) in terms of current densities (∆J, µA mm-2) for Pt-
MMA electrodes and CPEs for an i.p saline (0.9%) injection are plotted in Figure 5.10. 
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Figure 5.10:  Comparison graph of calculated current density ∆J, µA mm-2 values for an i.p. 
administration of saline (0.9% NaCl), monitored using Pt-MMA and CPEs implanted in the striatum of 
freely-moving rats. 
 
From these results it can be seen that the Pt-MMA electrodes exhibit a greater change in O2 
current in terms of current density compared to CPEs when monitoring an i.p. 
administration of saline (0.9% NaCl) in the striatum of freely-moving rats.  In terms of the 
time course of these increases Pt-MMA electrodes and CPEs are similar. For Pt-MMA 
electrodes the max increase was observed after 3.57 ± 0.77 min (n=14, 3 animals) with a 
return to baseline after 5.21 ± 1.09 min (n=14, 3 animals) and for CPEs the max increase 
was observed after 2.5 ± 0.4 min (n=4) with a return to baseline after 4.1 ± 3.7 min (n=4). 
5.3.7.4 Acetazolamide (Diamox) 
The ∆J, µA mm-2 for Diamox (50 mg/kg) i.p. administrations are 2.78 ± 0.37 ∆J, µA mm-2 
(n= 8, 3 animals) for Pt-MMA electrodes and 1.37 ± 0.32 ∆J, µA mm-2 (n=5) for CPEs 
(Bolger & Lowry, 2005). The current changes (∆I) in terms of current densities (∆J, µA 
mm
-2
) for Pt-MMA electrodes and CPEs for an i.p Diamox (50 mg/kg) injection are plotted 
in Figure 5.11. 
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Figure 5.11:  Comparison graph of calculated current density ∆J, µA mm-2 values for an i.p. 
administration of Diamox (50 mg/kg), monitored using Pt-MMA and CPEs implanted in the striatum 
of freely-moving rats. 
 
From these results it can be seen that the Pt-MMA electrodes exhibit a greater change in O2 
current in terms of current density compared to CPEs when monitoring an i.p. 
administration of Diamox (50 mg/kg) in the striatum of freely-moving rats. 
5.3.7.5 Chloral Hydrate 
The ∆J, µA mm-2 for chloral hydrate (350 mg/kg) i.p. administrations are 3.21 ± 0.50 ∆J, 
µA mm
-2 
(n= 12, 4 animals) for Pt-MMA electrodes and 0.60 ± 0.10 ∆J, µA mm-2 (n=10) 
for CPEs (Bolger & Lowry, 2005). The current changes (∆I) in terms of current densities 
(∆J, µA mm-2) for Pt-MMA electrodes and CPEs for an i.p. chloral hydrate (350 mg/kg) 
injection are plotted in Figure 5.12. 
Chapter 5: In Vivo Oxygen 
157 
Chloral Hydrate (350 mg/kg) i.p.
0
1
2
3
4 Pt-MMA
CPE

J
, 
µ
A
 m
m
-2

M
-1
 
Figure 5.12: Comparison graph of calculated current density ∆J, µA mm-2 values for an i.p. 
administration of chloral hydrate (350 mg/kg), monitored using Pt-MMA and CPEs implanted in the 
striatum of freely-moving rats. 
 
From these results it can be seen that the Pt-MMA electrodes exhibit a greater change in O2 
current in terms of current density compared to CPEs when monitoring an i.p. 
administration of chloral hydrate (350 mg/kg) in the striatum of freely-moving rats. 
5.4 Conclusions 
Pt-based electrodes have been shown by characterisation in vitro to be a potential 
alternative to CPEs to monitor brain tissue O2 (Bolger et al., 2011a).  Carbon paste 
electrodes have been previously characterised in vivo by our group (Bolger & Lowry, 
2005).  In this chapter the in vivo characterisation of Pt-MMA electrodes was investigated 
using similar protocols to that of the CPE characterisation (Bolger & Lowry, 2005). 
Results presented in this chapter demonstrate that Pt-MMA electrodes have the ability to 
monitor changes in striatal O2, evidenced by response of the sensors to the administration of 
O2 and N2 gases to the snout of the animals.  The changes in tissue O2 following neuronal 
activation in the form of a tail pinch and the administrations of saline, DMSO, 
acetazolamide and chloral hydrate have also been demonstrated.  The Pt-MMA electrodes 
were directly compared to CPEs (Section 5.3.7) using previously published data (Bolger & 
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Lowry, 2005) and from these results it can be said that Pt-MMA electrodes exhibit a greater 
change in O2 current in terms of current density compared to CPEs when implanted in the 
striatum of freely-moving rats. It can therefore be concluded that Pt-MMA electrodes 
provide a viable alternative to CPEs to monitor tissue O2 in the brain.  This is advantageous 
due to the smaller probe size of Pt-MMA electrodes (125 µm) less than 160 µm the 
maximum recommended diameter for brain tissue damage,  resulting in uric acid 
production (Duff & O'Neill, 1994).  However Pt-MMA electrodes are only suitable for 
short-term monitoring, established in Chapter 4 (Section 4.3.3.4) as there is a large 
reduction in sensitivity after 19 ± 3 days.  The degradation of the signal over a period of 
time is apparent upon examination of the raw data trace.   Even though CPEs are above the 
threshold for tissue damage they are stable over a 12 week period (Bolger et al., 2011b) 
making them the sensor of choice for long-term chronic monitoring of brain tissue O2. 
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6.1 Introduction 
The hemodynamic response refers to changes in cerebral blood flow, blood volume and 
blood oxygenation, a result of increases in neuronal activity.  The imaging technique blood 
oxygenation dependent (BOLD) functional magnetic imaging (fMRI) is founded on this 
hemodynamic response (Ogawa et al., 1990; Bandettini et al., 1992; Ogawa et al., 1992).  
The MRI signal intensity is sensitive to the amount of oxygen (O2) carried by hemoglobin 
in the blood as this changes the degree to which hemoglobin disturbs the magnetic field.  
An increase in the O2 hemoglobin oxygenation results in an increase in the BOLD signal 
and vice versa.  BOLD fMRI is a valuable, non-invasive way of mapping the regional 
activity of the brain during sensory, motor and cognitive tasks. fMRI imaging has been 
employed to map rodent brains (Houston et al., 2001; Preece et al., 2001).  Both these and 
the majority of such studies use anesthetics to prevent motion of the animals which is 
common practice in most experiments; however the use of these anesthetics can alter brain 
metabolism. 
Metal-free electrodes based on a carbon transducer have been utilised in conjunction with 
fMRI imaging studies, simultaneously obtaining BOLD fMRI and amperometric tissue O2 
data from a rat cerebral cortex (Lowry et al., 2010).  This study verifies that real-time 
metabolic information can be acquired during fMRI investigations and that the changes in 
the magnitude of the BOLD response can be directly correlated to changes in tissue O2 
concentrations.  This technique provides an alternative to fMRI experiments as these O2 
sensors can be used in freely-moving animals eliminating the disadvantages of anaesthesia. 
The sensors used in this study were carbon fibre bundle electrodes.  Carbon fibre was 
selected as it has very weak paramagnetic properties compared to metal electrodes which 
can produce artifacts.  Previously carbon fibre electrodes (CFEs) were manufactured as a 
method for direct cortical stimulation in the rat (Austin et al., 2003).  In this study the 
electrodes were used to stimulate neuronal firing, therefore the CFEs were not standardised 
in terms of manufacture.  There were variations in both the amount of carbon fibre strands 
that were used in each electrode and also the length of the carbon fibres.  Due to the 
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varying dimensions of the carbon fibre bundle, reproducibility was difficult to obtain 
therefore hindering the characterisation of these sensors.   
The aim of this chapter was to fabricate a stable and reproducible sensor that can be 
characterised in vitro and in vivo. 
The first part of this chapter (Section 6.3.1) explores the standardisation of the CFEs whilst 
the latter sections explore the use of a carbon (graphite) based composite electrode. 
6.2 Experimental 
The instrumentation and software used are detailed in Section 3.2 and all chemicals and 
solutions are detailed in Section 3.3. 
Silver based carbon composite electrodes were constructed as described in Section 3.4.2, 
Carbon Rhoplex
®
 composite electrodes - fMRI design (CRCEs) are described in Section 
3.4.3, Carbon Rhoplex
®
 composite electrodes - in vivo freely-moving design (CRCEs) are 
described in Section 3.4.4.  
Electrochemical experiments are detailed in Section 3.6 and electrode treatments in Section 
3.5.4. 
Data is represented as the mean ± SEM where n = number of electrodes used, unless 
otherwise stated.  The slope, nA/µM was obtained from calibration plots using linear 
regression analysis and is used to represent the sensitivity.  Goodness of fit is denoted by 
the R
2
 value.  Sensitivities were compared using unpaired t-tests and ANOVA.  To compare 
the different electrodes due to varying physical dimensions current values were converted 
to current densities (Section 2.8.3). 
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6.3 Results and discussion 
6.3.1 Carbon fibre electrodes 
CFEs to monitor O2 for use in an MRI scanner have been recently described by (Lowry et 
al., 2010).  This electrode, based on the design by Austin (2003) and co-workers, can 
reliably measure tissue O2 but the reproducibility of the sensor is an issue due to variations 
in both the amount of carbon fibre strands that were used in each electrode and also the 
length of the carbon fibres.  Therefore the standardisation of the CFEs in terms of 
manufacture was investigated. 
6.3.1.1 Preliminary investigations: Carbon fibre wire (30 µm) 
The optimal reduction potential of O2 at the surface of CFEs has previously been 
determined using cyclic voltammetry (Lowry et al., 2010).  The chosen reduction potential 
was -900 mV and subsequent constant potential amperometry (CPA) experiments were 
carried out at this potential.  
CF wire with a diameter of 30 µm was used for the preliminary experiments in this section.  
Varying CF lengths were used to give an estimation of the currents expected with the 
different lengths with the view to standardising the electrodes. 
O2 calibrations were performed on CFEs as described in Section 3.6.1.4. 
Results obtained for O2 calibrations performed in PBS on CFEs (30 µm x 4) are presented 
below in Table 6.1 and plotted in Figure 6.1.  The mean background current of -1937.6 ± 
315.6 nA (n=3) was subtracted.  Current in nA was converted to current densities (J, µA 
mm
-2)
 to allow for the comparison of the electrodes due to their varying geometries.  
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 CF 30µm x 4 (n=3) 
[O2], µM Mean J, µA mm
-2
 SEM 
0 0 0 
240 -760.8 88.3 
1200 -2950.9 441.1 
Table 6.1:  Table of results for O2 calibrations (0-1200 µM) for CFEs.  CPA performed at -900 mV vs. 
SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted.  
 
250 500 750 1000 1250 1500
-4000
-3000
-2000
-1000
0
CF 30m x 4
[O2], M
J
, 
µ
A
 m
m
-2
 
Figure 6.1: O2 calibration data (0-1200 µM) for CFEs (n=3).  CPA performed at -900 mV vs. SCE in 
PBS (pH 7.4) at 21˚C.   
 
Results obtained for O2 calibrations performed in PBS on CFEs (30µm x 4, 2mm cylinders) 
and (30µm x 4, 3mm cylinders) are presented below in Table 6.2 and plotted in Figure 6.2. 
 CF 30µm x 4, 2mm cylinders (n=1) CF 30µm x 4 3mm cylinders (n=1) 
[O2], µM J, µA mm
-2
 J, µA mm
-2
 
0 0 0 
240 -1.4 -3.8 
1200 -5.3 -10.6 
Table 6.2:  Table of results for O2 calibrations (0-1200 µM) for CFEs.  CPA performed at -900 mV vs. 
SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted.  
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Figure 6.2:  O2 calibration data (0-1200 µM) for CF 30µm x 4, 2mm cylinders (n=1) and CF 30µm x 4 
3mm cylinders (n=1).  CPA performed at -900 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
Linear regression analysis was performed on electrodes to compare sensitivities in terms of 
current density of CFEs calibrated in PBS solutions, presented in Table 6.3 and plotted in 
Figure 6.3.  All further data will be presented in a similar format: O2 calibrations data 
presented via a table and graph, followed by linear regression analysis comparing electrode 
sensitivities presented via a table and graph.  
 Sensitivity (µAmm
-2
µM
-1
) R
2
 n 
CF 30 µm x 4 -2.4080 ± 0.1465 0.9963 3 
CF 30 µm x 4, 2mm cylinders -0.0044 ± 0.0002 0.9969 1 
CF 30 µm x 4, 3mm cylinders -0.0083 ± 0.0014 0.9718 1 
Table 6.3:  Calculated sensitivity values of O2 calibrations (0-1200 µM) for CFEs. 
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Figure 6.3: Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for CF 
30µm x 4 (n=3), CF 30µm x 4, 2mm cylinders (n=1) and CF 30µm x 4 3mm cylinders (n=1). 
 
From the results presented it can be seen from the preliminary investigations that the 
sensitivity values are variable.  The CF 30 µm x 4 CFE has a much higher sensitivity 
although it was a disk shape.  This is thought to be due to the electrode design.  The space 
between the carbon fibres and the silica tubing are easily sealed with epoxy with the 
cylindrical geometries however this was not possible for the disk electrodes.  It is thought 
that the active surface was not just the disk shape and that the electrolyte (PBS) was able to 
migrate past the silica tubing causing a much larger surface area to be present.  The 
standardisation of the electrodes was the main focus of this section.  Four cylindrical 
electrodes combined as one electrode could not be standardised easily therefore it was 
decided to move away from single carbon fibres and to investigate a carbon fibre coated 
bundle with a known diameter. 
6.3.1.2 Polyamide coated CF (1mm) 
6.3.1.2.1 Cyclic Voltammetry 
CV was initially performed on the polyamide coated CF (1mm) to determine the diffusion 
limited reduction potential of O2 at the surface of these electrodes.  This was performed as 
Chapter 6: In Vitro fMRI Oxygen 
170 
described in Section 3.6.1.2.  The results obtained are presented graphically below in 
Figure 6.4. 
-1.0 -0.8 -0.6 -0.4 -0.2 -0.0
-80000
-60000
-40000
-20000
0
E/V (SCE)
I, n
A
 
Figure 6.4: Cyclic voltammogram from -1 to 0 V vs. SCE at 100 mVs
-1
 performed in O2 saturated PBS 
(pH 7.4, 21˚C) buffer solution, illustrating the reduction of O2 at a polyamide coated CFE. 
 
For the polyamide coated CFEs an O2 reduction peak was observed at ca. -500 mV with the 
foot of the wave occurring at ca. -350 mV.  The chosen reduction potential was -650 mV 
which allows for comparisons with CPEs and subsequent constant potential amperometry 
(CPA) experiments were carried out at this potential.  
6.3.2 Silver based carbon composite electrodes 
Carbon composite electrodes have been previously utilised to detect brain tissue O2 (Bazzu 
et al., 2009).  The use of Carbon Polyvinyl Acetate (PVA) and Rhoplex
®
 combined with 
varying amounts of carbon (graphite) powder was preliminarily investigated as a means of 
standardising the surface area of the sensors.  The PVA or Rhoplex
®
 and carbon were 
uniformly mixed and then packed into the cavity of a silver wire (200 µm) as described in 
Section 3.4.2, in a similar way to the construction of carbon paste electrodes (CPE).  This 
method was employed as a simpler way of determining the viability of the mixture for use 
in conjunction with the carbon fibres. 
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6.3.2.1 PVA silver composite electrodes 
The results obtained for O2 calibrations (0-1200 µM) on PVA silver composite electrodes 
containing: 
 PVA (0.05g)/ Carbon (0.01g) 
 PVA (0.05g)/ Carbon (0.02g) 
 PVA (0.05g)/ Carbon (0.03g) 
 are presented below in Table 6.4 and plotted in Figure 6.5. 
  
 PVA (0.05g)/ Carbon (0.01g) 
(n=4) 
 PVA (0.05g)/ Carbon (0.02g) 
(n=5) 
 PVA (0.05g)/ Carbon (0.03g) 
(n=4) 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 
240 -1010.1 125.7 -1055.1 107.2 -571.1 175.2 
1200 -2965.2 283.8 -3195.1 318.1 -1837.2 479.2 
Table 6.4:  Table of results for O2 calibrations (0-1200 µM) for PVA silver composite electrodes.  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21°C.  Mean background subtracted.  
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Figure 6.5:  O2 calibration data (0-1200 µM) for PVA silver composite electrodes.  CPA performed at -
650 mV vs. SCE in PBS (7.4) at 21˚C. 
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 Sensitivity (nA/µM) R
2
 n 
PVA (0.05g)/ Carbon (0.01g) -2.347 ± 0.358 0.9772 4 
PVA (0.05g)/ Carbon (0.02g) -2.539 ± 0.358 0.9806 5 
PVA (0.05g)/ Carbon (0.03g) -1.470 ± 0.175 0.9860 4 
Table 6.5: Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for PVA silver 
composite electrodes.  
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Figure 6.6:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) PVA 
silver composite electrodes.  PVA (0.05g)/ Carbon (0.01g) (n=4), PVA (0.05g)/ Carbon (0.02g) (n=5) and 
PVA (0.05g)/ Carbon (0.03g) (n=4).   
 
Although there was no statistically significant difference between PVA (0.05g)/Carbon 
(0.01g) and PVA (0.05g)/Carbon (0.02g) composites (P= 0.7176) the PVA (0.05g)/Carbon 
(0.02g) had the highest sensitivity of -2.539 ± 0.358 nA/µM.  
6.3.2.2 Rhoplex® silver composite electrodes 
The results obtained for O2 calibrations (0-1200 µM) on Rhoplex
®
 silver composite 
electrodes containing: 
 Rhoplex® (0.05g)/ Carbon (0.01g) 
 Rhoplex® (0.05g)/ Carbon (0.02g) 
 Rhoplex® (0.05g)/ Carbon (0.03g) 
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are presented below in Table 6.6 and plotted in Figure 6.7. 
  
Rhoplex
®
 (0.05g)/ Carbon 
(0.01g) (n=3) 
Rhoplex
®
 (0.05g)/ Carbon 
(0.02g) (n=4) 
Rhoplex
®
 (0.05g)/ Carbon 
(0.03g) (n=4) 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 
240 -150.4 61.3 -733.7 85.8 -529.2 111.0 
1200 -676.0 115.4 -2015.6 328.0 -1454.2 245.3 
Table 6.6:  Table of results for O2 calibrations (0-1200 µM) for Rhoplex
®
 silver composite electrodes.  
CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21°C.  Mean background subtracted.  
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Figure 6.7:  O2 calibration data (0-1200 µM) for Rhoplex
®
 silver composite electrodes.  CPA performed 
at -650 mV vs. SCE in PBS (7.4) at 21˚C. 
 
 Sensitivity (nA/µM) R
2
 n 
Rhoplex
®
 (0.05g)/ Carbon (0.01g) -0.559 ± 0.013 0.9995 3 
Rhoplex
®
 (0.05g)/ Carbon (0.02g) -1.581 ± 0.284 0.9687 4 
Rhoplex
®
 (0.05g)/ Carbon (0.03g) -1.141 ± 0.205 0.9688 4 
Table 6.7:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for Rhoplex
®
 silver 
composite electrodes.  
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Figure 6.8:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for 
Rhoplex
®
 silver composite electrodes.  Rhoplex
®
 (0.05g)/ Carbon (0.01g) (n=3), Rhoplex
®
 (0.05g)/ 
Carbon (0.02g) (n=4) and Rhoplex
®
 (0.05g)/ Carbon (0.03g) (n=4).   
 
From these results it can be seen that the Rhoplex
®
 (0.05g)/Carbon (0.02g) composite has 
the highest sensitivity of -1.581 ± 0.284 nA/µM. 
6.3.3 Carbon Fibre based composite electrodes 
From the results presented in Section 6.3.2 both silver PVA and Rhoplex
®
 composite 
electrodes can detect O2 in vitro.  The sensitivity of the sensor, although important, is not 
the only determining factor as ease of construction plays an important role in sensor design 
and development.  The ease at which the electrodes are packed is a crucial factor in the 
construction.  The higher the carbon content of the composite the easier the sensor is to 
construct so the following composites were used to construct the carbon fibre based O2 
fMRI compatible sensor: 
 PVA (0.05g)/Carbon (0.03g) 
 Rhoplex® (0.05g)/Carbon (0.02g) 
 Rhoplex® (0.05g)/Carbon (0.03g) 
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Although the PVA (0.05g)/Carbon (0.02g) silver composite electrodes had the highest 
sensitivity (Table 6.5), construction of the carbon fibre based sensors were attempted but 
due to the difficulty in packing the tip of the electrode the sensors were not suitable for 
calibration.  The difficulty in the construction of these sensors arises from the inability to 
plunge the composite with bare silver wire like the CPEs.  This method ensures good 
packing at the tip of the electrode producing good reproducibility. 
6.3.3.1 CF PVA composite electrodes 
6.3.3.1.1 CV 
CV was initially performed on the CF PVA (0.05g)/Carbon (0.03g) composite electrodes to 
determine the diffusion limited reduction potential of O2 at the surface of these electrodes.  
This was performed as described in Section 3.6.1.2.  The results obtained are presented 
graphically below in Figure 6.9.  
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Figure 6.9:  Cyclic voltammogram from -1 to 0 V vs. SCE at 100 mVs
-1
 performed in O2 saturated PBS 
(pH 7.4, 21˚C) buffer solution, illustrating the reduction of O2 at a CF PVA (0.05g)/Carbon (0.03g) 
composite electrodes. 
 
For the CF PVA (0.05g)/Carbon (0.03g) composite electrodes there was no observable O2 
reduction peak. The chosen reduction potential was -650 mV for comparative purposes 
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with other O2 electrodes and subsequent constant potential amperometry (CPA) 
experiments were carried out at this potential.  
6.3.3.1.2 Oxygen calibrations 
O2 calibrations were performed on CF PVA (0.05g)/Carbon (0.03g) composite electrodes 
as described in Section 3.6.1.4.   
 
CF PVA (0.05g)/Carbon (0.03g) (n=11) 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -231.5 102.9 
1200 -1544.2 244.0 
Table 6.8:  Table of results for O2 calibrations (0-1200 µM) for CF PVA (0.05g)/Carbon (0.03g) 
composite electrodes (n=11).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean 
background subtracted. 
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Figure 6.10:  O2 calibration data (0-1200 µM) for CF PVA (0.05g)/Carbon (0.03g) composite electrodes 
(n=11).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
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Sensitivity (nA/µM) R
2
 n 
CF PVA (0.05g)/Carbon (0.03g) -1.310 ± 0.066 0.9974 11 
Ag PVA (0.05g)/Carbon (0.03g) -1.470 ± 0.175 0.9860 4 
Table 6.9:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CF PVA 
(0.05g)/Carbon (0.03g) and Silver PVA (0.05g)/Carbon (0.03g) composite electrodes. 
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Figure 6.11:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for CF 
PVA (0.05g)/Carbon (0.03g) composite electrodes (n=11) and Silver PVA (0.05g)/Carbon (0.03g) 
composite electrodes (n=4). 
 
From the results presented in Table 6.9 it can be seen that the CF PVA (0.05g)/Carbon 
(0.03g) composite electrodes have a similar high sensitivities.  However the packing of 
theses electrodes using the CF transducer proved to be taxing as the composite dried too 
quickly to pack more than one electrode at a time and a new composite had to be made for 
each electrode which was overly time consuming. 
6.3.4 CF Rhoplex® composite electrodes 
6.3.4.1 CV 
CV was initially performed on the CF Rhoplex
®
 (0.05g)/Carbon (0.03g) composite 
electrodes to determine the diffusion limited reduction potential of O2 at the surface of these 
electrodes.  This was performed as described in Section 3.6.1.2.  The results obtained are 
presented graphically below in Figure 6.12. 
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Figure 6.12:  Cyclic voltammogram from -1 to 0 V vs. SCE at 100 mVs
-1
 performed in O2 saturated PBS 
(pH 7.4, 21˚C) buffer solution, illustrating the reduction of O2 at a CF Rhoplex
®
 (0.05g)/Carbon (0.03g) 
composite electrodes. 
 
For the CF Rhoplex
®
 (0.05g)/Carbon (0.03g) electrodes an O2 reduction peak was observed 
at ca. -450 mV. The chosen reduction potential was -650 mV and subsequent constant 
potential amperometry (CPA) experiments were carried out at this potential.  
6.3.4.2 Oxygen calibrations 
 
Figure 6.13:  An example of typical raw data for an O2 calibration in PBS using a CRCE (Rhoplex
®
 
(0.05g)/Carbon (0.03g).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
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O2 calibrations were performed on CF Rhoplex
®
 (0.05g)/Carbon (0.03g) and CF Rhoplex
®
 
(0.05g)/Carbon (0.02g) composite electrodes as described in Section 3.6.1.4. 
 
CF Rhoplex
®
 (0.05g)/ Carbon (0.02g) (n=8) Rhoplex
®
 (0.05g)/ Carbon (0.03g) (n=4) 
[O2], µM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 
240 -205.1 29.6 -323.1 30.1 
1200 -849.9 102.0 -1175.3 94.3 
Table 6.10:  Table of results for O2 calibrations (0-1200 µM) for CF Rhoplex
®
 (0.05g)/Carbon (0.02g) 
and CF Rhoplex
®
 (0.05g)/Carbon (0.03g) composite electrodes.  CPA performed at -650 mV vs. SCE in 
PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 6.14:  O2 calibration data (0-1200 µM) for CF Rhoplex
®
 (0.05g)/Carbon (0.02g) (n=8) and CF 
Rhoplex
®
 (0.05g)/Carbon (0.03g) (n=4) composite electrodes (n=11).  CPA performed at -650 mV vs. 
SCE in PBS (pH 7.4) at 21˚C.   
 
 
Sensitivity (nA/µM) R
2
 n 
CF Rhoplex
®
 (0.05g)/ Carbon (0.02g) -0.698 ± 0.030 0.9981 8 
Ag Rhoplex
®
 (0.05g)/ Carbon (0.02g) -1.581 ± 0.284 0.9687 4 
CF Rhoplex
®
 (0.05g)/ Carbon (0.03g) -0.953 ± 0.076 0.9937 4 
Ag Rhoplex
®
 (0.05g)/ Carbon (0.03g) -1.141 ± 0.205 0.9688 4 
Table 6.11: Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CF Rhoplex
®
 
(0.05g)/Carbon (0.02g), silver Rhoplex
®
 (0.05g)/Carbon (0.02g), CF Rhoplex (0.05g)/Carbon (0.03g) and 
silver Rhoplex
®
 (0.05g)/Carbon (0.03g)  composite electrodes. 
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Figure 6.15:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for CF 
Rhoplex
®
 (0.05g)/Carbon (0.02g) (n=8), silver Rhoplex
®
 (0.05g)/Carbon (0.02g) (n=4), CF Rhoplex
®
 
(0.05g)/Carbon (0.03g) (n=4) and silver Rhoplex
®
 (0.05g)/Carbon (0.03g) (n=4) composite electrodes. 
 
From these results presented in Table 6.11, it can be seen that the CF Rhoplex
®
 (0.05g)/ 
Carbon (0.03g) composite electrode had the highest sensitivity of the two CF composite 
electrodes.   
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities of CF Rhoplex
®
 (0.05g)/Carbon (0.03g) and silver Rhoplex
®
 
(0.05g)/Carbon (0.03g) composite electrodes with P= 0.4531. 
The CF Rhoplex
®
 (0.05g)/Carbon (0.03g) composite electrode (CRCE) was chosen as the 
final design due to it having the highest sensitivity for O2 in vitro and was the easiest sensor 
to construct with good reproducibility. 
6.3.4.3 CRCE Heat treatment 
To attempt to reduce the construction time ca. 2 days and increase the sensitivity of the 
CRCEs the electrodes were dried in an oven at 50˚C for 1 hour.  The active surface of the 
electrodes were very dry shortly after packing the tip of the electrodes but whether the 
composite was fully dry within the cavity was unclear. 
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CRCE full MRI design, heated at 50°C for 1 hr (n=7) CRCE full MRI design (n=4) 
[O2], µM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 
240 -226.5 34.0 -323.1 30.1 
1200 -1009.9 99.1 -1175.3 94.3 
Table 6.12:  Table of results for O2 calibrations (0-1200 µM) for CRCE full MRI design, heated at 50°C 
for 1 hr and CRCE full MRI design.  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  
Mean background subtracted. 
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Figure 6.16:  O2 calibration data (0-1200 µM) for CRCE full MRI design, heated at 50°C for 1 hr (n=7) 
and CRCE full MRI design (n=4).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
 
Sensitivity (nA/µM) R
2
 n 
CRCE full MRI design heated at 50°C for 1 hr -0.834 ± 0.021 0.9994 7 
CRCE full MRI design -0.953 ± 0.076 0.9937 4 
Table 6.13: Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCE full MRI 
design, heated at 50°C for 1 hr and CRCE full MRI design. 
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Figure 6.17:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for 
CRCE full MRI design, heated at 50°C for 1 hr (n=7) and CRCE full MRI design (n=4).   
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities of air dried CRCEs and CRCEs dried at 50°C for 1 hr with a 
P value of 0.2284.  As heat treating the electrodes gave no increase on the sensitivity of the 
CRCEs the original non-heat treated design was retained for further experiments. 
6.3.4.4 CRCE In Vivo freely-moving design 
As the construction of the CRCEs is very time consuming and for freely-moving in vivo 
experiments the length of the electrode (ca. 38 cm) is not feasible for implantation, the 
removal of the PVA coated carbon fibre bundle and shortening of the electrode length (ca. 
7 cm) was investigated.  The Teflon
®
 coated carbon fibre was directly connected to the 
copper wire and the electrodes were calibrated to determine if there is a significant 
difference between the two designs. 
 
CRCE in vivo design (n=19) 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -326.3 47.9 
1200 -1278.4 148.5 
Table 6.14:  Table of results for O2 calibrations (0-1200 µM) for CRCE in vivo design (n=19).  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 6.18:  O2 calibration data (0-1200 µM) for CRCE in vivo design (n=19).  CPA performed at -650 
mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
 
Sensitivity (nA/µM) R
2
 n 
CRCE in vivo design -1.044 ± 0.061 0.9966 19 
CRCE full MRI design -0.953 ± 0.076 0.9937 4 
Table 6.15:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCE in vivo 
design and CRCE full MRI design. 
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Figure 6.19:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for 
CRCE in vivo design (n=19) and CRCE full MRI design (n=4).   
 
Chapter 6: In Vitro fMRI Oxygen 
184 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
difference in the sensitivities of CRCEs in vivo and full MRI designs with a P value of 
0.3803. 
6.3.4.5 Disk shaped active surface 
It was observed that when the carbon Rhoplex
®
 composite was left to dry that many of the 
electrodes had an active surface that was no longer disk shaped.  The composite appeared to 
have expanded when drying causing the composite to push out so a cylindrical shape is 
observed at the active surface of the electrode.  In order to eliminate the cylindrical shape 
the electrodes were left to dry overnight against a hard, flat surface.   
 
CRCE, dried on flat surface (n=4) 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -293.7 17.4 
1200 -1200.6 82.5 
Table 6.16:  Table of results for O2 calibrations (0-1200 µM) for CRCE dried on a flat surface (n=4).  
CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 6.20:  O2 calibration data (0-1200 µM) for CRCE dried on a flat surface (n=4).  CPA performed 
at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
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Linear regression analysis shows that the electrodes have a sensitivity of -0.985 ± 0.046 
nA/µM (n=4).  The response was linear over the range with an R
2
 value of 0.9978 (n=4). 
 
Figure 6.21:  Images of the active surface of CRCEs (A,B,D) and (C) CRCE without silica tubing 
demonstrating packing at the active surface of the electrode. 
6.3.4.6 Biocompatibility 
In this section the effects of proteins, lipids and brain tissue on the sensitivity of CRCEs 
was investigated, based on previous work (Ormonde & O'Neill, 1989, 1990) to determine if 
there is a significant reduction in the electrodes ability to remain sensitive to O2 in vivo.  
6.3.4.6.1 Protein (BSA) treated CRCEs 
The effect of exposure to the protein BSA (Section 3.5.4.1) on CRCEs with respect to time 
was investigated.  Untreated CRCEs (0 days) were calibrated and subsequently exposed to 
BSA for 24 hours, 3 days, 7 days and 14 days.  
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BSA (0 days) n=6 BSA (12 hrs) n=6 BSA (3 days) n=6 BSA (7 days) n=5 BSA (14 days) n=6 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 0 0 
240 -176.6 100.0 -229.5 58.8 -183.1 55.6 -173.5 30.2 -150.5 44.5 
1200 -712.7 143.5 -742.9 110.5 -782.5 78.1 -724.1 104.5 -663.2 145.0 
Table 6.17:  Table of results for O2 calibrations (0-1200 µM) for CRCEs exposed to BSA.  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 6.22:  O2 calibration data (0-1200 µM) for CRCEs untreated (0 days) and treated with BSA (12 
hrs, 3 days, 7 days and 14 days).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
BT treatment Sensitivity (nA/µM) R
2
 n 
0 days -0.760 ± 0.165 0.9629 4 
24 hrs -0.683 ± 0.005 1.0000 3 
3 days ˗0.814 ± 0.094 0.9868 3 
7 days ˗0.733 ± 0.105 0.9799 3 
14 days ˗0.948 ± 0.060 0.9961 3 
Table 6.18:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCEs exposed to 
BSA. 
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Figure 6.23:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for 
CRCEs exposed to BSA.   
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
different in the sensitivities with P values greater than 0.05 between untreated (0 days 
exposure) and BSA treated electrodes with P values of 0.8868 (12 hrs), 0.1382 (3 days), 
0.7790 (7days) and 0.3056 (14 days). 
One-way Analysis of Variance (ANOVA) was performed on CRCEs only exposed to BSA 
with a P value of 0.4179, showing no significant difference in the sensitivities between the 
electrodes once exposed to BSA over a period of 14 days.  From these results it can be seen 
that there is a small but non-significant reduction in the sensitivity of CRCEs following 
exposure to BSA over a period of 14 days.  
6.3.4.6.2 Lipid (PEA) treated CRCEs 
The effect of exposure to the protein PEA (Section 3.5.4.2) on CRCEs with respect to time 
was investigated.  Untreated CRCEs (0 days) were calibrated and subsequently exposed to 
PEA for 24 hours, 3 days and 14 days.   
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PEA (0 days) n=8 PEA (12 hrs) n=8 PEA (3 days) n=7 PEA (7 days) n=6 PEA (14 days) n=7 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 0 0 
240 -282.8 56.6 -191.1 89.1 -281.7 122.7 -325.3 68.9 -307.7 82.0 
1200 -948.5 134.0 -900.2 189.6 -942.7 204.8 -876.0 123.6 -904.1 197.9 
Table 6.19:  Table of results for O2 calibrations (0-1200 µM) for CRCEs exposed to PEA.  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 6.24: O2 calibration data (0-1200 µM) for CRCEs untreated (0 days) and treated with PEA (12 
hrs, 3 days, 7 days and 14 days).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
PEA treatment Sensitivity (nA/µM) R
2
 n 
0 days -0.763 ± 0.080 0.9891 8 
24 hrs -0.747 ± 0.009 0.9998 8 
3 days ˗0.758 ± 0.080 0.9890 7 
7 days ˗0.685 ± 0.129 0.9658 6 
14 days ˗0.716 ± 0.109 0.9773 7 
Table 6.20: Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCEs exposed to 
PEA. 
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Figure 6.25:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for 
CRCEs exposed to PEA.   
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
different in the sensitivities with P values greater than 0.05 between untreated (0 days 
exposure) and PEA treated electrodes with P values of 0.8500 (12 hrs), 0.9669 (3 days), 
0.6239 (7days) and 0.7347 (14 days). 
One-way Analysis of Variance (ANOVA) was performed on CRCEs only exposed to PEA 
with a P value of 0.9396, showing no significant difference in the sensitivities between the 
electrodes once exposed to PEA over a period of 14 days.  From these results it can be seen 
that there is small but non-significant reduction in the sensitivity of CRCEs following 
exposure to PEA over a period of 14 days.  
6.3.4.6.3 Brain tissue (BT) treated CRCEs 
The effect of exposure to a sample of ex-vivo BT (Section 3.5.4.3) on CRCEs with respect 
to time was investigated.  Untreated CRCEs (0 days) were calibrated and subsequently 
exposed to BT for 24 hours, 3 days and 14 days. 
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BT (0 days) n=4 BT (12 hrs) n=3 BT (3 days) n=3 BT (7 days) n=3 BT (14 days) n=3 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 0 0 
240 -395.3 68.0 -161.2 24.4 -312.8 94.3 -306.7 69.9 -301.8 54.7 
1200 -1045.1 209.2 -815.3 93.6 -1016.4 191.0 -922.7 116.1 -1162.0 143.5 
Table 6.21:  Table of results for O2 calibrations (0-1200 µM) for CRCEs exposed to BT.  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 6.26:  O2 calibration data (0-1200 µM) for CRCEs untreated (0 days) and treated with BT (24 
hrs, 3 days, 7 days and 14 days).  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
BT treatment Sensitivity (nA/µM) R
2
 n 
0 days -0.760 ± 0.165 0.9629 4 
24 hrs -0.683 ± 0.005 1.0000 3 
3 days ˗0.814 ± 0.094 0.9868 3 
7 days ˗0.733 ± 0.105 0.9799 3 
14 days ˗0.948 ± 0.060 0.9961 3 
Table 6.22:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCEs exposed to 
BT. 
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Figure 6.27:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for 
CRCEs exposed to BT.   
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant 
different in the sensitivities with P values greater than 0.05 between untreated (0 days 
exposure) and BT treated electrodes with P values of 0.6717 (12 hrs), 0.7895 (3 days) 
0.8947 (7 days) and 0.3640 (14 days). 
One-way Analysis of Variance (ANOVA) was performed on Pt-MMA electrodes only 
exposed to BT with a P value of 0.1555 showing no significant difference in the 
sensitivities between the electrodes once exposed to BT over a period of 14 days.  From 
these results it can be seen that there is small but non-significant reduction in the sensitivity 
of CRCEs following exposure to BT over a period of 14 days.  
6.3.4.7 CRCE heat damage 
Construction of the CRCEs involves the use of a considerable amount of heat-shrink and 
therefore exposure to large amounts of heat.  As can be seen in Section 6.3.4.5 it was 
observed for non-treated electrodes that there was a substantial reduction in the sensitivity 
((BSA 0 days: -0.584 ± 0.029 nA/µM, n=6), (PEA 0 days: -0.763 ± 0.080 nA/µM, n=8), 
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(BT 0 days: -0.760 ± 0.165 nA/µM, n=4)) and also for CRCEs, full MRI design with a 
sensitivity of -0.672 ± 0.086 nA/µM, n=11. 
This issue of reduced sensitivity was investigated.  The following steps were taken to 
minimise that heat damage to the CRCEs:  
• Heat-shrink use was minimised to use over the silver epoxy connections and the Teflon® 
containing the carbon fibres was protected with the PVA coating to ensure that the Teflon
® 
did not come into contact with heat.   
• The copper wire was soldered into a gold clip before sensor construction. 
• The electrodes were packed at the final point instead of at the beginning of the sensor 
construction, as it was observed by eye that when the heat shrink was being heated the 
composite at the tip of the electrode would push out away from the Teflon
®
 altering the 
active surface of the electrodes. 
These precautions were taken for construction of the CRCEs full MRI and in vivo designs.   
  CRCE full MRI design (n=11) CRCE full MRI design, no heat  (n=2) CRCE in vivo design, no heat (n=4) 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 
240 -268.5 21.4 -428.2 19.4 -316.9 60.7 
1200 -842.6 87.0 -1410.7 65.7 -1309.4 81.7 
Table 6.23: Table of results for O2 calibrations (0-1200 µM) for CRCE full MRI design, CRCE full 
MRI design, no heat and CRCE in vivo design, no heat.  CPA performed at -650 mV vs. SCE in PBS 
(pH 7.4) at 21˚C.  Mean background subtracted. 
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Figure 6.28:  O2 calibration data (0-1200 µM) for CRCE full MRI design (n=11), CRCE full MRI 
design, no heat (n=2) and CRCE in vivo design, no heat (n=4). CPA performed at -650 mV vs. SCE in 
PBS (pH 7.4) at 21˚C.   
 
 
Sensitivity (nA/µM) R
2
 n 
CRCE full MRI design -0.672 ± 0.086 0.9839 11 
CRCE full MRI design, no heat -1.132 ± 0.126 0.9879 2 
CRCE in vivo design, no heat -1.075 ± 0.047 0.9981 4 
Table 6.24: Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCE full MRI 
design, CRCE full MRI design, no heat and CRCE in vivo design, no heat.   
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Figure 6.29:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for 
CRCE full MRI design (n=11), CRCE full MRI design, no heat (n=2) and CRCE in vivo design, no heat 
(n=4). 
 
It can be seen in Figure 6.29 that these modifications to the construction of the sensors were 
effective.  The heat has an effect on the sensitivity so the no heat method was used 
following on from this.  Experiments from this point onwards were performed using the 
CRCE in vivo no heat design unless otherwise stated. 
6.3.4.8  Effect of temperature 
Membrane covered O2 sensors tend to have significant temperature dependence primarily 
due to the effects of temperature on the diffusion coefficient and the solubility of the gas in 
the membrane with temperature.  The signal typically increasing by 1-6% for a rise of 1˚C 
(Hitchman, 1978; Jeroschewski & Zur Linden, 1997).  In vitro experiments are routinely 
performed at a room temperature of ca. 21˚C.  The effect of an increase in the temperature 
of the PBS on the CRCEs O2 sensitivity at the physiological temperate of 37˚C was 
investigated. The concentration of dissolved O2 was calculated to be 214 µM for air 
saturated PBS and 1020 µM for O2 saturated PBS at 37°C detailed in Section 2.8.4. 
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  PBS 37°C 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -798.4 138.3 
1200 -2640.7 187.9 
 
 
PBS 21°C 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -316.9 60.7 
1200 -1309.4 81.7 
Table 6.25:  Tables of results for O2 calibrations (0-1200 µM) for CRCEs.  CPA performed at -650 mV 
vs. SCE in PBS (pH 7.4) at 37˚C (0-1020 µM) (n=4) and 21˚C (0-1200 µM) (n=4).  Mean background 
subtracted.  
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Figure 6.30:  O2 calibration data (0-1200 µM) for CRCEs.  CPA performed at -650 mV vs. SCE in PBS 
(7.4) at 37˚C (0-1020 µM) & 21˚C (0-1200 µM). 
 
  Sensitivity (nA/µM) R
2
 n 
PBS 37°C -2.506 ± 0.249 0.9902 4 
PBS 21°C -1.075 ± 0.047 0.9981 4 
Table 6.26:  Comparison of calculated sensitivity values of O2 calibrations for CRCEs calibrated in PBS 
solutions of 37˚and 21˚C. 
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Figure 6.31:  Comparison graph of calculated sensitivity values for O2 calibrations for CRCEs 
calibrated in PBS at 37˚C (n=4) & 21˚C (n=4). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is a significant 
difference in the sensitivities of CRCEs calibrated at 37˚C and 21˚C with a P value of 
0.0216.  From the results obtained for CRCEs it can be seen that the sensitivity increases by 
133.12 ± 23.14 % corresponding to a 3.60 ± 0.63 % for every 1˚C increase indicating that 
CRCEs do exhibit significant temperature dependence at the physiological temperature. 
6.3.4.9 Effect of pH 
Changes in pH may occur during physiological experiments in vivo (Zimmerman & 
Wightman, 1991) these changes in pH could also affect the cathodic reduction of O2 at the 
electrode surface involving proton transfer.  Previous reports for carbon-based electrodes 
found that for pH 12-14 the reduction of O2 seems to be independent of pH, but as pH 
decreases the reduction becomes pH dependent (Taylor & Humffray, 1975; Yang & 
McCreery, 2000).  The effect of changes in pH on CRCEs was investigated. 
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PBS pH 6.5 PBS pH 7.4 PBS pH 8 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 
240 -352.2 49.1 -316.9 60.7 -302.1 39.1 
1200 -1616.7 145.6 -1309.4 81.7 -1636.9 78.6 
Table 6.27:  Table of results for O2 calibrations (0-1200 µM) for CRCEs.  CPA performed at -650 mV 
vs. SCE in PBS: pH 6.5 (n=4), 7.4 (n=4) & 8 (n=4) at 21˚C.  Mean background subtracted.  
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Figure 6.32:  O2 calibration data (0-1200 µM) for CRCEs.  CPA performed at -650 mV vs. SCE in PBS 
(pH 6.5, 7.4 & 8) at 21˚C.   
 
 
Sensitivity (nA/µM) R
2
 n 
PBS pH 6.5 -1.339 ± 0.025 0.9997 4 
PBS pH 7.4 -1.075 ± 0.047 0.9981 4 
PBS pH 8 -1.372 ± 0.022 0.9997 4 
Table 6.28:  Comparison of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCEs 
calibrated in PBS 6.5, 7.4 & 8. 
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Figure 6.33:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for 
CRCEs electrodes calibrated in PBS pH 6.5 (n=4), 7.4 (n=4) and 8 (n=4). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is a significant 
difference in the sensitivities of CRCEs calibrated in PBS pH 6.5 and 7.4 with a P value of 
0.0078.  There is a significant difference in the sensitivities between electrodes calibrated in 
PBS pH 8 and 7.4 with a P value of 0.0047. 
6.3.4.10 Effect of ion changes 
Changes in ion concentrations are of interest in vivo as previously discussed in Section 0.  
The effect of ion changes on the sensitivities of CRCEs was investigated.  
 
aCSF (n=7) aCSF no Ca2+ (n=4) aCSF no Mg2+ (n=8) aCSF no Ca2+or Mg2+(n=8) 
[O2], µM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 
240 -211.7 59.4 -358.9 77.2 -483.7 60.5 -536.8 57.3 
1200 -1224.1 103.0 -1428.9 28.1 -1460.6 101.6 -1677.3 133.8 
Table 6.29:  Table of results for O2 calibrations (0-1200 µM) for CRCEs.  CPA performed at -650 mV 
vs. SCE in aCSF (n=7), aCSF no Ca
2+
 (n=4), aCSF no Mg
2
+ (n=8) and aCSF no
 
Ca
2+ 
or Mg
2+ 
(n=8) at 
21˚C.  Mean background subtracted. 
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Figure 6.34:  O2 calibration data (0-1200 µM) for CRCEs.  CPA performed at -650 mV vs. SCE in 
aCSF, aCSF no Ca
2+
, aCSF no Mg
2 
and aCSF no
 
Ca
2+ 
or Mg
2+ at 21˚C. 
 
 
Sensitivity (nA/µM) R
2
 n 
aCSF -1.030 ± 0.028 0.9992 7 
aCSF no Ca
2+
 -1.169 ± 0.063 0.9971 4 
aCSF no Mg
2+
 ˗1.160 ± 0.165 0.9803 8 
aCSF no Ca
2+
or Mg
2+
 ˗1.338 ± 0.173 0.9835 8 
Table 6.30:  Comparison of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCEs 
calibrated in aCSF, aCSF no Ca
2+
, aCSF no Mg
2+
, aCSF no Ca
2+
or Mg
2+
 at 21˚C. 
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Figure 6.35:  Comparison graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for Pt-
MMA electrodes calibrated in aCSF (n=7), aCSF no Ca
2+
 (n=4), aCSF no Mg
2
+ (n=8) and aCSF no 
Ca
2+
or Mg
2+
 (n=8). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is no significant  
difference in the sensitivities of CRCEs calibrated in aCSF and aCSF with no with Ca
2+
, 
Mg
2+
 and Ca
2+
or Mg
2+
 with P values of 0.1141 (aCSF no Ca
2+
), 0.4619 (aCSF no Mg
2+
) 
and  0.1224 (aCSF no Ca
2+
or Mg
2+
).  There is a decrease in the sensitivity for CRCEs 
calibrated in aCSF (-1.030 ± 0.028 nA/µM) compared to PBS (-1.075 ± 0.047 nA/µM) 
although the difference is not significant P = 0.4482. 
6.3.4.11 Post-implantation calibrations 
The effect of proteins, lipids and brain tissue on the sensitivity of CRCEs in vitro was 
investigated (Section 6.3.4.5).  Although this gives an indication as to the effect that 
proteins, lipids and ex-vivo brain tissue has on the sensitivity of the electrodes the effect of 
the living brain with endogenous species present was investigated by performing post 
implantation calibrations where possible on the CRCEs (implanted for 9 ± 2 days (n=3)) 
once removed from the brain. These calibrations are described in Section 3.6.1.8. 
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CRCE (pre-implantation) CRCE (post-implantation) 
[O2], µM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 
240 -432.0 58.5 -93.1 125.7 
1200 -1727.4 137.4 -596.7 122.6 
Table 6.31:  Table of results for O2 calibrations (0-1200 µM) for CRCEs pre-implantation and post-
implantation (n=8) for a standard O2 calibration.  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) 
at 21˚C.  Mean background subtracted.  
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Figure 6.36: O2 calibration data (0-1200 µM) for CRCEs pre-implantation and post-implantation (n=8).  
CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C. 
 
 
Sensitivity (nA/µM) R
2
 n 
Pre-implantation ˗1.414 ± 0.074 0.9972 8 
Post-implantation ˗0.505 ± 0.023 0.9989 8 
Table 6.32:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for CRCEs pre-
implantation and post-implantation. 
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Figure 6.37:  Graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for CRCEs pre-
implantation and post-implantation (n=8). 
 
Unpaired t-test statistical analysis was performed and it can be seen there is an extremely 
significant difference in the sensitivities between CRCEs calibrated pre and post-
implantation with a P value < 0.0001.   
From the results presented in it can be seen that the brain has detrimental effect on the 
sensitivity of the CRCEs to O2.  This decrease in sensitivity of 64.29 ± 1.60 % of the 
electrodes post-implantation compared to pre-implantation.  This decrease is thought to be 
due to fouling at the electrode surface preventing O2 from reaching the active surface of the 
electrode and example of which can be seen in Figure 6.38 . 
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Figure 6.38:  Image of a CRCE post-implantation demonstrating accumulation of tissue at active 
surface of the electrode.  
6.3.4.12 Preliminary fMRI calibrations 
Preliminary, acute in vivo experiments using the full fMRI CRCE were performed (see 
Section 7.3.6).  During these experiments it was found that there was an issue with the 
background settling time.  The permitted duration of these experiments were 2-3 hours and 
it was found that the background current was not sufficiently settled to accurately monitor 
changes in brain tissue O2 (see Section 7.3.6).  The settling time was not an issue for 
chronic in vivo experiments as the animals were allowed to recover overnight once 
connected to the recording equipment enabling the baseline to reach a steady-state.  To 
allow for these acute in vivo experiments, alterations in the electrode’s composition were 
investigated. 
6.3.5 fMRI compatible acute design 
To reduce the background current and minimise the settling time of the CRCEs, variations 
in the composite quantities were investigated.  It was decided to increase the amount of 
carbon present and decrease the amount of Rhoplex
®
 in the hope that a lesser amount of 
polymer present would increase the settling time and reduce any insulating effect that the 
polymer might have. 
Chapter 6: In Vitro fMRI Oxygen 
204 
6.3.5.1 Silver based CRCEs acute designs 
6.3.5.1.1 1:5 ratio of Rhoplex®:Carbon 
Silver based CRCEs incorporating a 1:5 ratio of Rhoplex
®
:Carbon using 0.01g 
Rhoplex
®
/0.05g Carbon or 0.005g Rhoplex
®
/0.0125g Carbon were constructed as described 
in Section 3.4.2. The quantities were halved to ensure more accurate mixing of the 
composite.  This method using silver wire was employed as discussed previously as a 
simpler way of determining the viability of the mixture for use in conjunction with the 
carbon fibre transducer. As there is a high carbon content and a small amount of binder, the 
use of a membrane in the form of nitrocellulose was investigated as a means of securing the 
composite in place.  Nitrocellulose has been previously utilised with O2 sensors (Dittmar et 
al., 1997) as it is hydrophobic and allows for small charged ions and O2 to permeate the 
membrane, acting as a barrier for larger organic molecules such as proteins.  This barrier 
reduces the poisoning of the active surface of the electrode.  O2 calibrations on silver 
CRCEs were investigated.  The mean background currents presented in Table 6.33 were 
subtracted. 
 
Mean Background I, nA (0 µM O2) SEM n 
Silver Rhoplex® (0.01g)/Carbon (0.05g) -70.6 5.7 4 
Silver Rhoplex® (0.005g)/Carbon (0.0125g) -20.0 8.5 6 
Silver Rhoplex® (0.005g)/Carbon (0.0125g), Nitrocellulose -27.5 6.5 4 
Silver Rhoplex® (0.005g)/Carbon (0.0125g), 10% Nitrocellulose -19.7 4.1 4 
Table 6.33:  Table of results for mean background currents at 0 µM O2 for Rhoplex
®
/Carbon silver 
composite electrodes with and without nitrocellulose.  CPA performed at -650 mV vs. SCE in PBS (pH 
7.4) at 21°C.   
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Silver Rhoplex
®
 
(0.01g)/Carbon 
(0.05g) (n=4) 
Silver Rhoplex
®
 
(0.005g)/Carbon 
(0.0125g) (n=6) 
Silver Rhoplex
®
 
(0.005g)/Carbon (0.0125g), 
Nitrocellulose (n=4) 
Silver Rhoplex
®
 
(0.005g)/Carbon (0.0125g), 
10% Nitrocellulose (n=4) 
[O2], µM 
Mean I, 
nA 
SEM 
Mean I, 
nA 
SEM Mean I, nA SEM Mean I, nA SEM 
0 0 0 0 0 0 0 0 0 
240 -910.7 38.0 -868.4 65.5 -582.0 48.3 -849.0 62.3 
1200 -2962.0 119.6 -3193.0 180.1 -1885.8 150.8 -2955.6 179.5 
Table 6.34: Table of results for O2 calibrations (0-1200 µM) for Rhoplex
®
/Carbon silver composite 
electrodes with and without nitrocellulose.  CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 
21°C.  Mean background subtracted.  
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Figure 6.39:  O2 calibration data (0-1200 µM) for Silver Rhoplex
®
 (0.01g)/Carbon (0.05g) (n=4), Silver 
Rhoplex
®
 (0.005g)/Carbon (0.0125g) (n=6), Silver Rhoplex
®
 (0.005g)/Carbon (0.0125g), Nitrocellulose 
(n=4), Silver Rhoplex
®
 (0.005g)/Carbon (0.0125g), 10% Nitrocellulose (n=4). CPA performed at -650 
mV vs. SCE in PBS (pH 7.4) at 21˚C. 
 
 
Sensitivity (nA/µM) R
2
 n 
Silver Rhoplex® (0.01g)/Carbon (0.05g) -2.374 ± 0.273 0.9869 4 
Silver Rhoplex® (0.005g)/Carbon (0.0125g) -2.592 ± 0.198 0.9942 6 
Silver Rhoplex® (0.005g)/Carbon (0.0125g), Nitrocellulose ˗1.511 ± 0.176 0.9866 4 
Silver Rhoplex® (0.005g)/Carbon (0.0125g), 10% Nitrocellulose ˗2.386 ± 0.222 0.9915 4 
Table 6.35:  Table of calculated sensitivity values of O2 calibrations (0-1200 µM) for Rhoplex
®
/Carbon 
silver composite electrodes with and without nitrocellulose. 
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Figure 6.40:  Graph of calculated sensitivity values for O2 calibrations (0-1200 µM) for Silver Rhoplex
®
 
(0.01g)/Carbon (0.05g) (n=4), Silver Rhoplex
®
 (0.005g)/Carbon (0.0125g) (n=6), Silver Rhoplex
®
 
(0.005g)/Carbon (0.0125g), Nitrocellulose (n=4), Silver Rhoplex
®
 (0.005g)/Carbon (0.0125g), 10% 
Nitrocellulose (n=4). 
 
It can be seen that there is improvement in sensitivity of the electrodes, presumably due to 
the higher carbon ratio of the composite.  There is also a lower background current but this 
could be due to the silver wire as a transducer instead of carbon fibres.  When the 
composites were constructed in combination with the fMRI design (CF transducer) the 
assembly of these electrodes was not achievable as the packing of the electrodes was not 
possible.  The silver Rhoplex® (0.005g)/Carbon (0.0125g), nitrocellulose dipped electrodes 
had a lower sensitivity compared to the other designs (Table 6.35) this was due to the 
electrode being immersed in nitrocellulose which created a thick visible membrane on the 
electrode surface which had a negative effect  on the sensitivity of the electrodes. 
6.3.5.1.2 Rhoplex® (0.05g)/Carbon (0.03g) and Carbon paste composite electrodes 
(CRC/CPEs) 
As the packing of the active surface of the electrode was an issue with a higher proportion 
of carbon, reported in Section 6.3.5.1.1, the original CRCE mixture (Rhoplex
®
 
(0.05g)/Carbon (0.03g)) was reassessed. The CF based electrode needs a glue-like mixture 
to ensure a good contact with the active surface as it cannot be packed with a silver wire 
traditionally used in CPEs. The composite was packed into the majority of the cavity of the 
Chapter 6: In Vitro fMRI Oxygen 
207 
electrode and the end of the cavity (active surface) was packed using carbon paste.  O2 
calibrations on silver CRC/CPEs were investigated.  The mean background of -161.21 ± 
98.12 nA (n=5) was subtracted. 
 
Silver CRC/CPEs  (n=5) 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -343.8 38.8 
1200 -1460.1 154.6 
Table 6.36:  Table of results for O2 calibrations (0-1200 µM) for CRC/CP silver composite electrodes.  
CPA performed at -650 mV vs. SCE in PBS (pH 7.4) at 21°C.  Mean background subtracted.  
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Figure 6.41:  O2 calibration data (0-1200 µM) for Silver CRC/CPEs (n=5). CPA performed at -650 mV 
vs. SCE in PBS (pH 7.4) at 21˚C. 
 
Linear regression analysis shows that the electrodes have a sensitivity of -1.201 ± 0.045 
nA/µM (n=5).  The response was linear over the range with an R
2
 value of 0.9986 (n=5).   
As with the electrodes in Section 6.3.5.1.1 when the design was translated to the CF 
transducer the construction was not viable due to issues with the packing of the cavity of 
the electrode. 
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6.3.5.2 Liquid CPEs 
As the attempts at constructing a reproducible fMRI compatible sensor with a rapid settling 
time were not successful using the composite mixtures previously employed in Section 
6.3.4, a conductive, liquid carbon paste (SPI Supplies
®
) based electrode was investigated.  
The liquid carbon paste was utilised in conjunction with the full fMRI design to compare 
the sensitivities and background currents to the full fMRI CRCEs. 
6.3.5.2.1 O2 calibrations liquid CP full fMRI design 
 
Liquid carbon paste composite electrode (n=12) 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -402.5 29.8 
1200 -1990.3 203.8 
Table 6.37:  Table of results for O2 calibrations (0-1200 µM) for liquid CPEs full fMRI design.  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21°C.  Mean background subtracted.  
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Figure 6.42:  O2 calibration data (0-1200 µM) for liquid CPEs full fMRI design (n=12). CPA performed 
at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C. 
 
Linear regression analysis shows that the electrodes have a sensitivity of -1.657 ± 0.004 
nA/µM (n=12).  The response was linear over the range with an R
2
 value of 1.000 (n=12).    
From these results it can be concluded that the liquid CPEs can detect O2 in vitro and that 
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the sensitivity was improved in comparison to the CRCEs full fMRI design (-0.953 ± 0.07 
nA/µM (n=4)). The settling time for the background current was subsequently investigated. 
6.3.5.2.2 CRCEs and liquid CPEs background settling time comparison 
The background currents for CRCEs and liquid CPEs (full fMRI designs) were compared.  
The current (nA) was averaged for each electrode type settling in N2 every 10 min for a 
duration of 50 min.   
 
CRCE full fMRI design (n=16) Liquid carbon paste full fMRI (n=12) 
Time (mins) Mean I, nA SEM Mean I, nA SEM 
0 -230.6 46.4 -327.1 59.2 
10 -205.2 31.2 -285.6 43.7 
20 -185.9 22.5 -933.4 80.1 
30 -188.9 30.7 -688.1 55.8 
40 -189.6 24.0 -2317.9 224.3 
50 -199.5 23.7 -2426.2 203.5 
Table 6.38:  Table of results for mean background currents at 0 µM O2 at 10 min intervals for 50 min 
for CRCEs full fMRI design and liquid CPEs full fMRI design.  CPA performed at -650 mV vs. SCE in 
PBS (pH 7.4) at 21°C.   
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Figure 6.43:  Mean background current data at 0 µM O2 at 10 min intervals for a period of 50 min for 
CRCEs full fMRI design (n=16) and liquid CPEs full fMRI design (n=12). 
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It can be seen that the liquid CPEs background current increases instead of stabilising over 
50 min.  The CRCEs current decreases by -31.1 ± 22.7 nA over 50 min.  From these results 
it was determined that the liquid CP was unsuitable for use in acute fMRI studies due to the 
background current being unstable.  
6.4 Conclusions 
This chapter examines the standardisation and use of metal free O2 sensors based on a 
previous designs (Austin et al., 2003; Lowry et al., 2010) for use in conjunction with fMRI 
studies.  The final design incorporating a carbon composite containing Rhoplex
®
 (Section 
6.3.4) was characterised in vitro to determine the sensitivity of the CRCEs to O2 and the 
effects on the sensitivity following exposure to proteins, lipids and brain tissue (Section 
6.3.4.5)  The effects of temperature, pH, ions, and implantation were also examined.  Due 
to issues with the background current settling times in preliminary acute experiments an 
alternative design for acute studies was investigated (Section 6.3.5). 
From the results presented in this chapter it can be concluded that single carbon fibre 
bundles are not suitable for designing a reproducible sensor.  With CRCEs it was found that 
the active surface requires drying against a flat surface and sensor construction with 
minimal heat exposure improved the sensitivity of the electrodes.  It was found that the 
length of the electrode could be reduced approximately 5 times its original length and there 
was no significant reduction in the sensitivity.  The CRCEs were found to be biocompatible 
with no significant reduction in the sensitivity following exposure to proteins, lipids and 
brain tissue.  The physiological temperature (37°C) affects the CRCEs (Section 6.3.4.8) 
causing a large increase in sensitivity.  Changes in pH did have an effect on the sensitivity, 
however changes in ions showed no significant effect.  The effect of implantation of the 
sensors into the living brain indicated that implantation has a detrimental effect on the 
sensitivity of the CRCEs which is thought to be due to fouling of the active surface of the 
electrodes (Section 6.3.4.11).  During preliminary acute in vivo experiments using the 
CRCE full fMRI design it was found that the electrodes background current did not reach a 
steady state quickly enough for experiments to take place.  An fMRI compatible acute 
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design was explored with an attempt at minimising the settling time which was 
unsuccessful.  The original CRCE design was found to be the superior design.  It has 
previously been reported that the number of carbon fibre in a bundle has an effect on the 
resistance (Coeuret et al., 2002) of the electrode.  Future work for the acute fMRI sensor 
will involve elimination of the majority of the CF wire and pre-conditioning the sensors 
before the acute in vivo experiments by applying a potential to the electrodes overnight 
prior to the acute implantation.  CRCEs can therefore be deemed suitable for use in chronic 
in vivo fMRI experiments for the detection of brain tissue O2. 
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7.1 Introduction 
Carbon based composite electrodes have previously been used to detect brain tissue O2 in 
freely-moving animals (Bazzu et al., 2009).  A metal free composite electrode containing 
Rhoplex
®
 and graphite powder (CRCR) with a carbon fibre transducer, suitable for use in 
fMRI imaging studies was fabricated and characterised in vitro and presented in Chapter 6.  
It has been shown that BOLD fMRI and amperometric tissue O2 data from  rat cerebral 
cortex can be measured simultaneously using carbon fibre electrodes (Lowry et al., 2010) 
verifying that real-time metabolic information can be acquired during fMRI investigations 
and that the changes in the magnitude of the BOLD response can be directly correlated to 
changes in tissue O2 concentrations. This technique offers an alternative to fMRI 
experiments as the O2 sensors can be used in freely-moving animals. 
This chapter investigates and characterises the use of CRCEs for the detection of brain 
tissue O2 in the striatum following on from the in vitro characterisation (Chapter 6) with the 
intention for use in conjunction with in vivo fMRI studies. 
7.2 Experimental In Vivo 
The instrumentation and software used are detailed in Section 3.2 and all chemicals and 
solutions are detailed in Section 3.3. 
CRCEs (200 µm bare diameter) were constructed as described in Section 3.4.4.  A potential 
of -650 mV vs. SCE was applied to the working electrodes and all experiments were 
performed on freely-moving Wistar rats.  Full fMRI CRCEs were constructed as described 
in Section 3.4.3 and used for preliminary acute (non recoverable) experiments.  A potential 
of -650 mV vs. SCE was applied to the working electrode implanted in the cortex and 
experiments were performed on an anesthetised Sprague Dawly rat.  
In vivo procedures are detailed in Section 3.7.  CRCEs were implanted in the striatum.  The 
initial surgery contained bilateral CRCEs and a unilateral CPE in the left striatum for 
confirmation of the O2 signal (results not presented). 
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Data is represented via the mean ± SEM where n = number of administrations, unless 
otherwise stated.  Significant differences were calculated using two-tailed unpaired t-tests 
unless otherwise stated. 
7.3 Results and Discussion  
7.3.1 Characterisation of CRCEs In Vivo 
7.3.2 Gaseous Administrations 
7.3.2.1 Hyperoxia 
Mild hyperoxia was achieved by administration of O2 gas to the snout of the animal.  The 
flow was maintained at a slow steady rate similar to the method used previously (Lowry et 
al., 1998) and as described in Section 3.7.4.   The inhalation of the O2 gas for 3 minutes 
resulted in a change from baseline levels for the O2 signals, monitored using CRCEs as can 
be seen in Figure 7.1 below. 
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Figure 7.1:  A typical example of a 3-min period of mild hyperoxia (administration of O2 gas) monitored in vivo 
using a CRCE implanted in the striatum of a freely-moving rat.  The bar indicates the period of gaseous 
administration. 
 
A 3-min period of mild hyperoxia shows an average immediate increase in current from the 
baseline level of -72.20 ± 5.48 nA (n=23, 2 animals) to -107.96 ± 13.38 nA (n=23, 2 
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animals).  This increase was found to be significant (P= 0.0195).  The percentage increase 
was found to be 46.57 ± 11.88 % (n=23, 2 animals). Changes were immediate and on 
cessation of inhalation the signals quickly returned to baseline levels of -74.64 ± 5.83 nA 
after 8.13 ± 1.81 min (n =23, 2 animals) (P= 0.7619), indicating a rapid return to normoxic 
conditions. A summary of these results can be seen in Table 7.1. 
Hyperoxia 
Baseline (nA) -72.20 ± 5.48 
Max Increase (nA) -107.96 ± 13.38 
% Increase 46.57 ± 11.88 
Post-baseline (nA) -74.64 ± 5.83 
t to post-baseline (min) 8.13 ± 1.81 
 
Table 7.1:  Summary of results for a 3-min period of mild hyperoxia monitored in vivo using CRCEs (n 
= 23, 2 animals), implanted in the striatum of freely-moving rats. 
 
From these results it can be seen that there is a significant increase in striatal tissue O2 upon 
administration of O2 gas to the animal’s snout and this change can be reliably monitored 
using CRCEs. 
7.3.2.2 Hypoxia 
Mild hypoxia was achieved by administration of N2 gas to the snout of the animal.  The 
flow was maintained at a slow steady rate similar to the method used previously (Lowry et 
al., 1998) and as described in Section 3.7.4.   The inhalation of the N2 gas for 3 minutes 
resulted in a change from baseline levels for the O2 signals, monitored using CRCEs as can 
be seen in Figure 7.2 below. 
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Figure 7.2:  A typical example of a 3-min period of mild hypoxia (administration of N2 gas) monitored 
in vivo using a CRCE implanted in the striatum of a freely-moving rat.  The bar indicates the period of 
gaseous administration. 
 
A 3-min period of mild hypoxia shows an average immediate decrease in current from the 
baseline level of -75.37 ± 6.22 nA (n=11, 2 animals) to -54.79 ± 4.98 nA (n=11, 2 animals).  
This decrease was found to be significant (P =0.0182).  The percentage decrease was found 
to be 27.24 ± 3.19 % (n=11, 2 animals). Changes were immediate and on cessation of 
inhalation the signals quickly returned to baseline levels of -73.30 ± 5.88 nA after 4.86 ± 
0.70 min (n=11, 2 animals) (P= 0.8115), indicating a rapid return to normoxic conditions. 
A summary of these results can be seen in Table 7.2. 
Hypoxia 
Baseline (nA) -75.37 ± 6.22 
Max Decrease (nA) -54.79 ± 4.98 
% Decrease 27.24 ± 3.19 
Post-baseline (nA) -73.30 ± 5.88 
t to post-baseline (min) 4.86 ± 0.70 
Table 7.2:  Summary of results for a 3-min period of mild hypoxia monitored in vivo using CRCEs (n = 
14, 2 animals), implanted in the striatum of freely-moving rats. 
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From these results it can be seen that there is a significant decrease in striatal tissue O2 
upon administration of N2 gas to the animal’s snout and this change can be reliably 
monitored using CRCEs. 
7.3.3 Neuronal Activation 
7.3.3.1 Tail pinch 
Neuronal activation was stimulated physiologically by means of a tail pinch.  A tail pinch 
induces a well characterised behaviour pattern consisting of gnawing, licking, eating and a 
general increase in the level of motor activity (Antelman et al., 1975).  The tail pinch was 
performed for a duration of 5 minutes similar to methods used previously (Bolger & 
Lowry, 2005) and as described in Section 3.7.5.1.  Induced neuronal activation for 5 
minutes resulted in a change from baseline levels for the O2 signals, monitored using 
CRCEs as can be seen in Figure 7.3. 
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Figure 7.3:  A typical example of a 5-min tail pinch (neuronal activation) monitored in vivo using a 
CRCE implanted in the striatum of a freely-moving rat. .  The bar indicates the duration of the tail 
pinch. 
 
A 5-min period of neuronal activation shows an average increase in current from a baseline 
level of -67.32 ± 10.80 nA (n=4, 2 animals) to -80.25 ± 10.38 nA (n=4, 2 animals) after 
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1.87 ± 0.93 min (P=0.4275).  The percentage increase was found to be 21.79 ± 9.65 % 
(n=4, 2 animals). Upon cessation of the tail pinch, the current increased to -81.63 ± 10.01 
nA (n=4, 2 animals) corresponding to a mean percentage increase of 24.62 ± 11.79 % 
(n=4, 2 animals) from baseline levels (P=0.3758). The post-tail pinch current returned to 
baseline levels of -77.87 ± 9.83 nA (n=4, 2 animals) after 15.59 ± 5.50 min. A summary of 
these results can be seen in Table 7.3. 
Tail pinch 
Baseline (nA) -67.32 ± 10.80 
Max Increase (nA) -80.25 ± 10.38 
% Increase 21.79 ± 9.65 
Post-baseline (nA) -77.87 ± 9.83 
t to post-baseline (min) 15.59 ± 5.50 
Table 7.3:  Summary of results for a 5-min tail pinch monitored in vivo using CRCEs (n = 4, 2 animals), 
implanted in the striatum of freely-moving rats. 
 
From these results it can be seen that there is a non significant increase in striatal tissue O2 
with the tail pinch experiment.  This is thought to be due to variations in the stress score 
between experiments and habituation of the animal to the tail pinch.  Due to the lack of 
response from the tail pinch a restraint test was performed. 
7.3.3.2 Restraint test 
Neuronal activation was stimulated physiologically by means of a restraint test (Cloutier et 
al., 2009).  The animal was physically immobilised and the stress associated with freeing 
itself are associated with an increase in neuronal activation with an associated increase in 
blood flow. The restraint test was performed for a duration of 5 minutes as described in 
Section 3.7.5.2.  Induced neuronal activation for 5 minutes resulted in a change from 
baseline levels for the O2 signals, monitored using CRCEs as can be seen in Figure 7.4. 
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Figure 7.4:  A typical example of a 5-min restraint test (neuronal activation) monitored in vivo using a 
CRCE implanted in the striatum of a freely-moving rat.  The bar indicates the duration of the tail 
pinch. 
 
A 5-min period of restraint shows an average increase in current from baseline level of -
67.59 ± 7.48 nA (n=12, 2 animals) to -75.69 ± 8.35 nA (n=12, 2 animals) after 2.58 ± 0.49 
min, representing a significant increase of 13.05 ± 4.63 % (n=12, 2 animals) compared to 
baseline levels (P=0.0015(paired t-test)). The current returned to baseline levels of -67.87 ± 
7.44 nA (n=12, 2 animals) (P=0.9791) after 14.69 ± 3.60 min.   The period following the 
cessation of the restraint shows a delay in returning to baseline levels.  This sustained 
increase can be attributed to the animal grooming and to post-restraint stress/activation. A 
summary of these results can be seen in Table 7.4. 
Restraint test 
Baseline (nA) -67.59 ± 7.48 
Max Increase (nA) -75.69 ± 8.35 
% Increase 13.05 ± 4.63 
Post-baseline (nA) -67.87 ± 7.44 
t to post-baseline (min) 14.69 ± 3.60 
Table 7.4: :  Summary of results for a 5-min restraint test monitored in vivo using CRCEs (n = 12, 2 
animals), implanted in the striatum of freely-moving rats. 
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From these results it can be seen that there is a non significant increase in striatal tissue O2 
with the tail pinch experiment.  This may be due to variations in the stress score between 
experiments (animals chewed for 2 mins on average) and habituation of the animal to the 
tail pinch.  Due to the lack of response from the tail pinch a restraint test was performed.  
7.3.4 Drug Administration 
7.3.4.1 Effect of Acetazolamide 
Acetazolamide (Diamox) is a carbonic anhydrase inhibitor and when administered 
systematically has been shown to increase brain tissue oxygen concentrations (Clark Jr & 
Lyons, 1965; Dixon et al., 2002; Bolger & Lowry, 2005).  Acetazolamide acts by inhibiting 
the carbonic anhydrase enzymes whose function is to catalyse the conversion of CO2 and 
H2O2 to bicarbonate (HCO3
-
).  This increase in CO2 and a subsequent decrease in pH 
results in vasodilatation and an increase in tissue O2.  The vehicle used to administer 
Diamox intraperitoneally was DMSO which has been previously shown to have no long 
lasting effect on brain tissue O2 (Section 5.3.4.2).  The effect of acetazolamide on the O2 
signal, monitored with CRCEs can be seen in Figure 7.5 below. 
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Figure 7.5:  A typical example of an i.p. administration of Diamox (50 mg/kg) monitored in vivo using a 
CRCE implanted in the striatum of a freely-moving rat.  The arrow indicates the point of injection. 
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An i.p. injection of Diamox shows an immediate sharp increase in the O2 signal from 
average baseline levels of -75.36 ± 9.35 nA (n=6, 2 animals) to -90.04 ± 10.44 nA (n=5, 2 
animals) after 48.60 ± 16.10 seconds, this sharp increase in current of 4.50 ± 1.35 % can be 
attributed to injection stress.  The subsequent rapid decrease was followed by a sustained 
maximum increase in the O2 signal to -120.87 ± 12.10 nA (n=5, 2 animals) after 28.98 ± 
14.26 min, representing a significant increase of 41.62 ± 5.89 % (n=5, 2 animals) compared 
to baseline levels (P= 0.0206).  The current returned to post-injection baseline levels of -
78.20 ± 10.27 nA (n=5, 2 animals) (P= 0.8425) after 3.72 ± 0.87 hrs.  A summary of these 
results can be seen in Table 7.5. 
Diamox i.p. 
Baseline (nA) -75.36 ± 9.35 
Max Increase (nA) -120.87 ± 12.10 
t to max increase (min) 28.98 ± 14.26 
% Increase 41.62 ± 5.89 
Post-baseline (nA) -78.20 ± 10.27 
t to post-baseline (hrs) 3.72 ± 0.87 
Table 7.5:  Summary of results for i.p. administrations of Diamox (50mg/kg)) monitored in vivo using 
CRCEs (n = 5, 2 animals), implanted in the striatum of freely-moving rats. 
 
From these results it can be seen that there is a significant increase in striatal tissue O2 upon 
administration of Diamox (50 mg/kg) and this change can be reliably monitored using 
CRCEs. 
7.3.5 Effect of Anesthesia 
7.3.5.1 Chloral Hydrate 
Chloral hydrate was amongst one of the first CNS depressants used in veterinary medicine. 
Chloral hydrate is metabolised by alcohol dehydrogenase to trichloroethanol and 
trichloroacetic acid (Butler, 1948).  Although the precise mechanism is unknown (Sourkes, 
1992), trichloroethanol is the active metabolite (Tao & Auerbach, 1994; Gauillard et al., 
2002) and it’s thought its binding site is at the exogenous γ-aminobutyric acid (GABA) 
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receptor resulting in an influx of chloride ions causing it to potentiate the function of 
GABA in a way similar to that of barbitutes (Lovinger et al., 1993). 
Chloral hydrate has been previously used to increase brain tissue O2 (Lowry & Fillenz, 
2001; Bolger & Lowry, 2005).  This increase in O2 is thought to be due to an increase in 
rCBF.  The vehicle used to administer chloral hydrate intraperitoneally was normal saline 
which has been previously shown to have no long lasting effect on brain tissue O2 (Bolger 
& Lowry, 2005) and Section 5.3.4.1.  The effect of chloral hydrate on the O2 signal, 
monitored with CRCEs can be seen in Figure 7.6 below. 
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Figure 7.6:  A typical example of an i.p. administration of chloral hydrate (350 mg/kg), monitored in 
vivo using a CRCE implanted in the striatum of a freely-moving rat.  The arrow indicates the point of 
injection. 
 
An i.p. injection of chloral hydrate shows an immediate increase in the O2 signal from 
average baseline levels of -77.63 ± 11.27 nA (n=6, 2 animals) to -87.13 ± 8.70 nA (n=4, 2 
animals) after 47.25 ± 12.60 seconds this increase in current of 6.34 ± 1.08 % can be 
attributed to injection stress.  This initial increase rapidly decreases and there is a sustained 
maximum increase in the O2 signal to -121.34 ± 10.68 nA (n=7, 2 animals) after 10.48 ± 
1.01 min, representing a significant increase of 67.30 ± 15.16 % (n=7, 2 animals) compared 
to baseline levels (P=0.0183).  The current returned to post- injection baseline levels of -
77.13 ± 11.22 nA (n=6, 2 animals) (P= 0.9755) after 2.63 ± 0.32 hrs which corresponded to 
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when the animal was almost fully recovered from the anaesthetic. A summary of these 
results can be seen in Table 7.6. 
Chloral Hydrate i.p. 
Baseline (nA) -77.63 ± 11.27 
Max Increase (nA) -121.34 ± 10.68 
t to max increase (min) 10.48 ± 1.01 
% Increase 67.30 ± 15.16 
Post-baseline (nA) -77.13 ± 11.22 
t to post-baseline (hrs) 2.63 ± 0.32 
Table 7.6:  Summary of results for i.p. administrations of chloral hydrate (350mg/kg) monitored in vivo 
using CRCEs, implanted in the striatum of freely-moving rats. 
 
From these results it can be seen that there is a significant increase in striatal tissue O2 upon 
administration of chloral hydrate (350 mg/kg) and this change can be reliably monitored 
using CRCEs.  
7.3.6 Preliminary acute in vivo experiment 
A preliminary, acute (non recovery) in vivo experiment using the full fMRI CRCE was 
performed in an anesthetised rat.  It was found that there was an issue with the background 
settling time, presented in Table 7.7 and plotted in Figure 7.7.  
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Time (min) I, nA 
Baseline 2.09 -579.7 
Gains: potential reapplied 
20% O2/ 80% N2 6.16 -806.3 
100% O2 18.59 -1566.9 
20% O2/ 80% N2 32.37 -1697.2 
30% O2/ 70% N2 36.56 -1838.0 
50% O2/ 50% N2 40.02 -1990.9 
70% O2/ 30% N2 43.05 -2048.0 
100% O2 46.18 -2048.0 
70% O2/ 30% N2 49.25 -2048.0 
50% O2/ 50% N2 52.53 -2204.3 
Gains: potential reapplied 
30% O2/ 70% N2 5.19 -2183.2 
100% N2 5.57 -2183.2 
30% O2/ 70% N2 10.41 -2183.2 
100% N2 11.23 -2219.1 
30% O2/ 70% N2 15.37 -2256.2 
100% N2 16.14 -2266.3 
30% O2/ 70% N2 20.47 -2281.8 
100% O2 21.50 -2310.5 
30% O2/ 70% N2 25.52 -2274.7 
100% O2 26.29 -2254.6 
30% O2/ 70% N2 30.53 -2261.2 
100% O2 31.28 -2211.8 
30% O2/ 70% N2 37.00 -2082.2 
100% O2 45.42 -2080.8 
20% O2/ 80% N2 46.44 -2044.5 
Table 7.7:  Table of results for acute experiments for administration of varying O2/N2 %, monitored 
using CRCEs showing duration of experiment and I, nA. 
 
The permitted duration of these experiments were 2 hours and it was found that the 
background current fluctuated during the experiment as the electrode was not sufficiently 
settled to accurately monitor changes in brain tissue O2. 
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Figure 7.7: Data for an acute experiment performed with a CRCE implanted in the cortex of an 
anesthetised rat.   
 
Future work for the acute application of the fMRI sensor will involve elimination of the 
majority of the CF wire and pre-conditioning the sensors before the acute in vivo 
experiments. By applying a potential to the electrodes overnight prior to the acute 
implantation it is hoped that the electrodes will settle far quicker.  The experimental set-up 
for the acute experiments may also be an issue as the electrodes are not insulated from the 
experimental environment which may have a detrimental effect on the settling time. 
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7.4 Conclusions 
A carbon-based composite electrode (CRCE) suitable for use in conjunction with fMRI 
studies has been characterised in vitro in the previous chapter (Chapter 6).  A design 
intended for use in freely-moving animals (Section 6.3.4.4) was characterised in vivo using 
protocols employed previously by our group (Bolger & Lowry, 2005) and in this thesis 
(Chapter 5).  A preliminary acute experiment using the CRCE full fMRI design was 
performed in an anesthetised animal. 
Results presented in this chapter demonstrate that CRCEs (freely-moving design) have the 
ability to monitor changes in striatal O2, evidenced by response of the sensors to the 
administration of O2 and N2 gases to the snout of the animals.  The changes in tissue O2 
following neuronal activation in the form of a restraint test as well as the administrations of 
acetazolamide and chloral hydrate have also been demonstrated. These results compare 
well to CPE data (Bolger & Lowry, 2005). It can therefore be concluded that CRCEs 
provide a viable alternative to metal electrodes to monitor brain tissue O2 but do not offer 
any advantage in comparison to CPEs in terms of stability or biocompatibility.  CRCEs are 
only suitable for short-term monitoring, established in Chapter 6 (Section 6.3.4.11) as there 
is a large reduction in sensitivity after 9 ± 2 days.  The preliminary acute experiment using 
the CRCE full fMRI design performed in an anesthetised animal was not successful due to 
the background current not stabilising in time.  An alternative design was investigated in 
Chapter 6, however the original CRCE proved to be the best design in terms of settling time 
(Section 6.3.5.2.2) therefore an elimination of the CF wire, pre-conditioning the electrodes 
and alterations to the acute experimental set-up are thought to be the remedy to this 
problem. 
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8.1 Introduction 
The hippocampus has been found to play essential roles in declarative memory (Scoville & 
Milner, 1957; Cohen et al., 1999; Eacott & Easton, 2010), spatial navigation (O'Keefe & 
Nadel, 1978; Morris et al., 1982; D’Hooge & De Deyn, 2001) and has been linked to 
various neurodegenerative/psychiatric disorders (Heckers & Konradi, 2010; Marlatt & 
Lucassen, 2010; Bast, 2011; Dhikav & Anand, 2011; Bonilha et al., 2012). 
Electrochemical sensors and biosensors have been previously utilised to detect brain tissue 
O2 (Lowry et al., 1996; Lowry et al., 1997; Lowry & Fillenz, 2001; Bolger & Lowry, 2005; 
Bolger et al., 2011) and glucose (Lowry et al., 1994; Hu & Wilson, 1997; Fillenz & Lowry, 
1998; Lowry et al., 1998a; Lowry et al., 1998b; Dixon et al., 2002).  Microelectrodes have 
been used to investigate O2 and glucose in the hippocampus (Freund et al., 1989; Hu & 
Wilson, 1997) whilst CPEs have been used to measure hippocampal O2 during various 
behavioural tasks (McHugh et al., 2011) but there have been few studies utilising sensors to 
measure hippocampal glucose as most research groups tend to employ microdialysis.  
There is a need for real-time sensor data to supplement the large amount of microdialysis 
data (McNay et al., 2001; Gold, 2003; De Bundel et al., 2009; López-Pérez et al., 2012), 
electrophysiological data (Bliss & Lømo, 1973; Martin et al., 2000; Morris et al., 2003; 
Colgin & Moser, 2010) and molecular data from tissue samples (Gooney et al., 2002; 
Minichiello, 2009; Barry & Commins, 2011) obtained from work in the hippocampus.  
There has been little work performed using sensors to measure basal levels of O2 and 
glucose in the hippocampus or to determine how basic behavioural and pharmacological 
interventions can alter levels of these particular analytes.  Therefore this chapter 
investigates and characterises the simultaneous measurements of tissue hippocampal O2 
and glucose in freely-moving rats using CPEs and Pt/PPD/GOx electrodes and how a maze 
task can alter the levels of this analytes.   
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8.2 Experimental 
The instrumentation and software used are detailed in Section 3.2 and all chemicals and 
solutions are detailed in Section 3.3. 
8.2.1 In Vitro 
Pt/PPD/GOx disk electrodes (125 µm bare diameter) were constructed as described in 
Section 3.5.3.1.  CPEs (200 µm bare diameter) were constructed as described in Section 
3.4.1. 
In vitro electrochemical experiments are detailed in Section 3.6. 
Data is represented as the mean ± SEM where n = number of electrodes used, unless 
otherwise stated.  The slope, nA/µM was obtained from O2 calibration plots using linear 
regression analysis and is used to represent the sensitivity.  Goodness of fit is denoted by 
the R
2
 value.  For enzymatic experiments calibration plots obeyed Michaelis-Menten Hill-
type kinetics (Section 2.6.1).  The kinetic parameter Vmax was as an indication of sensitivity 
and the Hill coefficient (α) represents deviation from ideal Michaelis-Menten kinetics 
(α=1). 
8.2.2 In Vivo 
In vivo procedures are detailed in Section 3.7.  Electrodes were implanted unilaterally in the 
dorsal hippocampus of Sprague Dawly rats.  This strain of rat was also used for future 
behavioural experiments and to enable comparisons of basal concentrations to be directly 
compared to previous hippocampal data (McNay et al., 2000). 
Experimental data obtained was analysed in a different format to previous in vivo 
characterisation chapters with the focus here on time bins/points.  This was to allow for 
comparisons with future microdialysis maze experiments. Data was either normalised to 
baseline levels for ease of comparison, or area under curve (AUC) analysis was performed 
to quantify any observed changes in the sensor signals for statistical analysis. For multiple 
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comparisons, repeated-measures and mixed-factorial analysis of variance tests (ANOVA) 
with Bonferroni post-hoc analysis were used as appropriate. Paired t-tests were also used 
when comparing results from two different time points. P < 0.05 was considered to be 
significant and all data is presented as the mean ± standard error of the mean (SEM). 
8.3 Results 
8.3.1 In Vitro Pt/PPD/GOx 
A Pt-based glucose biosensor has been previously well characterised in vitro and in vivo 
(Lowry et al., 1994; Fillenz & Lowry, 1998).  The optimum enzyme batch and units of 
enzyme was investigated as over time, due to supplier availability, the batches of enzyme 
and units vary (Section 3.3.3).  Below in Table 8.1 and plotted in Figure 8.1 is an example 
of a glucose calibration (0-100 µM) on Pt/PPD/GOx electrodes constructed using glucose 
oxidase obtained from Genzyme Chemical Co. 
[Gluc], mM Mean I, nA SEM 
0 0 0 
1 0.25 0.02 
5 1.12 0.07 
10 1.98 0.12 
15 2.59 0.16 
20 3.18 0.21 
30 4.27 0.33 
50 5.32 0.49 
80 5.95 0.60 
100 5.93 0.60 
Table 8.1:  Table of results for glucose calibrations (0-100 mM) for Pt/PPD/GOx electrodes (n=4). CPA 
performed at +700 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background (0.102 ± 0.002 nA (n=4)) 
subtracted.  
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Figure 8.1:  Glucose calibration data (0-100 mM) for Pt/PPD/GOx electrodes (n=4).  CPA performed at 
+700 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
 Mean SEM 
Vmax, nA 7.08 0.80 
KM, mM 22.13 5.35 
α 1.21 0.24 
Table 8.2:  Michaelis Menten Hill-Type kinetic parameters for Pt/PPD/GOx electrodes. 
 
It can be seen from the results presented above that the enzyme activity is very low as can 
be seen in the Vmax.  Similar results were observed for Glucose oxidase (Aspergillus 
Niger)-Sigma-Aldrich Co. and Glucose oxidase (G2133 50KU)-Sigma-Aldrich Co.  
However, Glucose oxidase (49180)-Sigma-Aldrich Co. proved to be successful in terms of 
exhibiting normal/expected sensitivity as can be seen from the results presented in Table 
8.3. 
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[Gluc], mM Mean I, nA SEM 
0 0 0 
1 2.07 0.12 
5 9.74 0.57 
10 17.77 0.88 
15 24.80 1.28 
20 31.05 1.66 
30 40.15 2.20 
50 52.00 3.17 
80 57.49 3.37 
100 58.64 3.30 
Table 8.3:  Table of results for glucose calibrations (0-100 mM) for Pt/PPD/GOx electrodes (n=36). 
CPA performed at +700 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background (0.232 ± 0.033 nA 
(n=36)) subtracted.  
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Figure 8.2:  Glucose calibration data (0-100 mM) for Pt/PPD/GOx electrodes (n=36).  CPA performed 
at +700 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
 
Mean SEM 
Vmax, nA 68.80 5.05 
KM, mM 22.76 3.46 
α 1.27 0.16 
 
Table 8.4:  Michaelis Menten Hill-Type kinetic parameters for Pt/PPD/GOx electrodes. 
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It can be seen from the results presented above that the enzyme activity is high 
corresponding well with previously obtained results (Lowry et al., 1994).  The electrodes 
were also calibrated to verify that the PPD layer blocked out in interference caused by 
ascorbic acid (AA) (discussed in Section 2.7.4).  Results for AA calibrations on 
Pt/PPD/GOx electrodes are presented below in Table 8.5 and plotted in Figure 8.3. 
[AA], µM Mean I, nA SEM 
0 0 0 
200 0.32 0.02 
400 0.46 0.03 
600 0.54 0.03 
800 0.50 0.05 
1000 0.51 0.05 
 
Table 8.5:  Table of results for AA calibrations (0-1000 µM) for Pt/PPD/GOx electrodes (n=36). CPA 
performed at +700 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background (0.329 ± 0.031 nA (n=36)) 
subtracted.  
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Figure 8.3:  AA calibration data (0-1000 µM) for Pt/PPD/GOx electrodes (n=36).  CPA performed at 
+700 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
From these results it can be determined that the PPD polymer layer on the electrode causes 
sufficient interference rejection of AA and that the enzyme is sensitive enough for the 
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detection of glucose in vivo.  Therefore the Glucose oxidase (49180)-Sigma-Aldrich Co. 
batch of enzyme was used to construct the Pt/PPD/GOx electrodes used in this study. 
8.3.2 In Vitro CPE 
8.3.2.1 Pre-implantation calibrations 
Average results obtained for O2 calibrations (0-1200 µM) performed in PBS on CPEs 
(n=36) prior to implantation are presented below in Table 8.6 and plotted in Figure 8.4.  
The mean background current was subtracted. 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -287.1 8.1 
1200 -1277.5 40.1 
Table 8.6:  Table of results for pre-implantation O2 calibrations (0-1200 µM) for CPEs (n=35).  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background (-7.65 ± 1.86 nA (n=35)) 
subtracted. 
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Figure 8.4:  O2 calibration data (0-1200 µM) for CPEs (n=35) pre-implantation.  CPA performed at -
650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
Linear regression analysis shows that the electrodes have a sensitivity of -1.055 ± 0.027 
nA/µM (n=35).  The response was linear over the range with an R
2
 value of 0.9993 (n =35). 
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8.3.2.2 Post-implantation calibrations 
Average results obtained for O2 calibrations (0-1200 µM) performed in PBS on CPEs 
(n=17) post-implantation are presented below in Table 8.7 and plotted in Figure 8.5.  The 
mean background current was subtracted. 
[O2], µM Mean I, nA SEM 
0 0 0 
240 -311.4 13.5 
1200 -1304.8 63.8 
Table 8.7:  Table of results for post-implantation O2 calibrations (0-1200 µM) for CPEs (n=17).  CPA 
performed at -650 mV vs. SCE in PBS (pH 7.4) at 21˚C.  Mean background (-36.03 ± 13.85 (n=17)) 
subtracted. 
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Figure 8.5:  O2 calibration data (0-1200 µM) for CPEs (n=17) post-implantation.  CPA performed at -
650 mV vs. SCE in PBS (pH 7.4) at 21˚C.   
 
Linear regression analysis shows that the electrodes have a sensitivity of -1.072 ± 0.043 
nA/µM (n=35).  The response was linear over the range with an R
2
 value of 0.9984 (n=17). 
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8.3.3 In Vivo 
8.3.3.1 Gaseous Administrations 
Mild hyperoxia and hypoxia were achieved by administration of O2 and N2 gas respectively 
to the snout of the animal.  The flow was maintained at a slow steady rate similar to the 
method used previously (Lowry et al., 1998a) (Bolger & Lowry, 2005) and as described in 
Section 3.7.4.  The baseline period was taken as the 3 minutes prior to the beginning of the 
gas administration.  The gaseous administration (O2/N2) was for a duration of 3 minutes 
and the post-baseline period was the 3 minutes following cessation of the gaseous 
administration.  The data was split into 30 s time bins and all data were expressed as a 
percentage of baseline levels. AUC analysis was performed to determine the mean change 
from the baseline signal during each of the gaseous administrations, expressed as nA/min. 
8.3.3.1.1 Hyperoxia 
Administration of O2 gas to the animals’ snouts resulted in mild hyperoxia associated with 
an increase in hippocampal oxygen levels (n = 26, 9 animals) plotted below in Figure 8.6. 
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Figure 8.6: Effect of O2 administration on hippocampal oxygen and glucose showing the mean changes 
in hippocampal oxygen (closed circles) and glucose (open squares) during a 3 min period of mild 
hyperoxia (blue box) with all data normalised to baseline levels. 
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Paired t-tests on the data analysed via AUC showed that hippocampal oxygen significantly 
increased by 67.37 nA.min (t = 4.353; df = 25; P < 0.001; Figure 8.7(A) and that 
hippocampal glucose also significantly increased at a rate of 0.0233 nA.min (t = 2.637; df = 
25; P < 0.05; Figure 8.7(B) during the administration of O2 gas compared to baseline 
levels.  
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Figure 8.7:  Effect of 3 min O2 admin on hippocampal oxygen and glucose, showing the changes in area 
under the curve (AUC; nA.min) for (A) hippocampal oxygen (CPE) and (B) glucose (Pt/PPD/GOx). 
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Both analytes followed a similar time course after the end of the O2 gas administration with 
hippocampal oxygen and glucose returning to baseline levels after 11.10 ± 1.35 min and 
7.01 ± 1.25 min respectively. 
8.3.3.1.2 Hypoxia 
Administration of N2 gas to the animals’ snouts resulted in mild hypoxia associated with a 
decrease in hippocampal oxygen levels (n=23, 9 animals)) plotted below in Figure 8.8. 
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Figure 8.8:  Effect of N2 administration on hippocampal oxygen and glucose showing the mean changes 
in hippocampal oxygen (closed circles) and glucose (open squares) during a 3 min period of mild 
hypoxia (blue box) with all data normalised to baseline levels. 
 
Paired t-tests on the data analysed via AUC showed that hippocampal oxygen significantly 
decreased by 77.20 nA.min (t = 9.628; df = 22; P < 0.001; Figure 8.9(A) but that there was 
no significant change in hippocampal glucose during the N2 gas administration (t = 2.035; 
df = 22; P > 0.05; Figure 8.9(B) compared to baseline levels.  
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Figure 8.9:  Effect of 3 min N2 admin on hippocampal oxygen and glucose, showing the changes in area 
under the curve (AUC; nA.min) for (A) hippocampal oxygen (CPE) and (B) glucose (Pt/PPD/GOx). 
 
Following the end of the N2 gas administration, hippocampal oxygen levels returned to 
baseline levels after 8.09 ± 1.18 min.  These results verify that CPEs respond rapidly to 
changes in hippocampal oxygen in response to different concentrations of inhaled oxygen. 
8.3.3.2 Neuronal Activation 
Neuronal activation was stimulated physiologically by means of a tail pinch (Section 
3.7.5.1).  A tail pinch induces a well characterised behaviour pattern consisting of gnawing, 
licking, eating and a general increase in the level of motor activity (Antelman et al., 1975).  
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The tail pinch was performed for a duration of 5 minutes similar to methods used 
previously (Bolger & Lowry, 2005).  As discussed in Section 7.3.3, the stress-score of the 
tail pinch and habituation to the experiment can have an effect on the response of the 
animal therefore neuronal activation was also stimulated physiologically by means of a 
restraint test (Section 3.7.5.2) (Cloutier et al., 2009).  The animal was physically 
immobilised and the stress associated with freeing itself are associated with an increase in 
neuronal activation with an associated increase in blood flow. The restraint test was 
performed for a duration of 5 minutes.  Both paradigms were split into three time periods. 
The baseline period was taken as the 5 minutes prior to the beginning of the experiment, the 
neuronal activation period covered the 5 minutes of the actual experiment and post-baseline 
period covered the 5 minutes following the end of the experiment.  The data was split into 
30 s time bins and all data were expressed as a percentage of baseline levels for 
comparison. AUC analysis was performed on the raw data to determine the mean change 
from the baseline signal during each of the neuronal activation paradigms expressed as 
nA.min.  
8.3.3.2.1 Tail pinch 
Neuronal activation with an associated increase in rCBF from a tail pinch, resulted in an 
increase in hippocampal oxygen and glucose (n=14, 5 animals) plotted below in Figure 
8.10. 
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Figure 8.10:  Effect of neuronal activation in the form of a tail pinch on hippocampal oxygen and 
glucose, showing the average changes in hippocampal oxygen (closed circles) and glucose (open 
squares) during a 5 min tail pinch (blue box) with all data normalised to baseline levels. 
 
Paired t-tests on the data analysed via AUC showed that hippocampal oxygen significantly 
increased by 28.83 nA.min (t = 2.827; df = 13; P < 0.05;Figure 8.11(A)) and that 
hippocampal glucose also significantly increased at a rate of 0.1145 nA.min (t = 3.023; df = 
13; P < 0.01; Figure 8.11(B)) during the tail pinch compared to baseline levels.  
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Figure 8.11:  Effect of 5 min tail pinch on hippocampal oxygen and glucose, showing the changes in 
area under the curve (AUC; nA.min) for (A) hippocampal oxygen (CPE) and (B) glucose 
(Pt/PPD/GOx). 
 
Both analytes followed a similar time course following the tail pinch with hippocampal 
oxygen and glucose returning to baseline levels after 17.20 ± 2.59 min and 17.98 ± 2.56 
min respectively. 
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8.3.3.2.2 Restraint test 
Neuronal activation with an associated increase in rCBF from a restraint test, resulted in an 
increase in hippocampal oxygen and glucose (n=13, 5 animals) plotted below in Figure 
8.12. 
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Figure 8.12:  Effect of neuronal activation in the form of a restraint test on hippocampal oxygen and 
glucose, showing the average changes in hippocampal oxygen (closed circles) and glucose (open 
squares) during a 5 min restraint test (blue box) with all data normalised to baseline levels. 
 
Paired t-tests on the data analysed via AUC showed that while hippocampal oxygen 
significantly increased at a rate of 32.13 nA.min (t = 2558; df = 12; P < 0.05; Figure 
8.13(A)), the observed change in hippocampal glucose did not reach significance (t = 
1.274; df = 12; P> 0.05; Figure 8.13(B)) during the restraint period compared to baseline 
levels. 
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Figure 8.13:  Effect of 5 min restraint test on hippocampal oxygen and glucose, showing the changes in 
area under the curve (AUC; nA.min) for (A) hippocampal oxygen (CPE) and (B) glucose 
(Pt/PPD/GOx). 
 
Both analytes followed a similar time course after the period of restraint with hippocampal 
oxygen and glucose returning to baseline levels after 13.42 ± 1.97 min and 14.33 ± 2.43 
min respectively. 
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8.3.3.3 Control Administrations 
For control administrations (saline and DMSO) the baseline period was taken as the hour 
prior to the injection and data was collected for 10 hours following the injection. The data 
was split into 10 min time bins and all data were expressed as a percentage of baseline 
levels for visualisation and comparison. 
8.3.3.3.1 Saline 
Saline serves as a vehicle for drug administration so the effects of saline (0.9% NaCl) and 
the i.p. injection on hippocampal oxygen and glucose (n=6, 6 animals) are plotted below in 
Figure 8.14. 
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Figure 8.14:  Effect of i.p. saline (0.9%) administrations on hippocampal oxygen (closed circles) and 
glucose (open squares). Injection is indicated by an arrow at time = 0 hours. All data expressed as a 
percentage of pre-injection baseline levels. 
 
A repeated-measures ANOVA on the normalised data did not reveal any significant effect 
for saline treatment on hippocampal oxygen when compared to baseline (F = 1.153; df = 
10; 50; P > 0.05). Similarly, there was no significant effect for saline treatment on 
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hippocampal glucose (F = 1.371; df = 10; 50; P > 0.05). However, there was a transient 
increase in hippocampal metabolism due to the injection stress.  A paired t-test on the 
AUC-analysed data revealed a significant increase of 20.64 nA,min in hippocampal oxygen 
following the injection compared to baseline levels (t = 3.220; df = 5; P < 0.05) in the first 
5 min post-injection. However, there was no such effect for injection stress on hippocampal 
glucose (t = 1.856; df = 5; P > 0.05). Saline treatment showed no significant long-term 
changes in hippocampal metabolism. It can therefore be concluded that any increase seen 
using saline as a vehicle for drug administrations is a drug effect. 
8.3.3.3.2  DMSO 
Acetazolamide (Diamox) does not dissolve easily in saline therefore a 33% solution of 
DMSO was used as a vehicle. Animals were treated with DMSO (33%) in order to act as a 
control for acetazolamide treatment. The effect of DMSO and the i.p. injection on 
hippocampal oxygen and glucose (n=6, 6 animals) are plotted below in Figure 8.15. 
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Figure 8.15:  Effect of i.p. DMSO (33%) administrations on hippocampal oxygen (closed circles) and 
glucose (open squares). Injection is indicated by an arrow at time = 0 hours. All data expressed as a 
percentage of pre-injection baseline levels. 
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A repeated-measures ANOVA on the normalised data revealed that DMSO treatment had a 
significant effect on hippocampal oxygen (F = 2.124; df = 10; 50; P < 0.05) and on 
hippocampal glucose (F = 5.330; df = 10; 50; P < 0.001) when compared to baseline.  
Analysis on the normalised data suggests that DMSO treatment resulted in a significant 
increase in hippocampal metabolism. The increase in glucose levels began approximately 3 
hours after the injection, the effects of this increase will be discussed in Section 8.3.3.4. 
8.3.3.4 Drug Administration 
8.3.3.4.1 Effect of Acetazolamide 
Acetazolamide (Diamox) is a carbonic anhydrase inhibitor and when administered 
systematically has been shown to increase brain tissue oxygen concentrations (Clark Jr & 
Lyons, 1965; Dixon et al., 2002; Bolger & Lowry, 2005).  Acetazolamide acts by inhibiting 
the carbonic anhydrase enzymes whose function is to catalyse the conversion of CO2 and 
H2O2 to bicarbonate (HCO3
-
).  This increase in CO2 and a subsequent decrease in pH 
results in vasodilatation and an increase in tissue O2.  It has been reported that 
acetazolamide has no effect on striatal glucose (Dixon et al., 2002). The effect of 
acetazolamide on the hippocampal oxygen and glucose (n=6, 6 animals) are plotted below 
in Figure 8.16. 
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Figure 8.16:  Effect of i.p. Diamox (50mg/kg) administrations on hippocampal oxygen (closed circles) 
and glucose (open squares). Injection is indicated by an arrow at time = 0 hours. All data expressed as a 
percentage of pre-injection baseline levels. 
 
A repeated-measures ANOVA on the normalised data revealed that acetazolamide 
treatment had a significant effect on hippocampal oxygen (F = 7.626; df = 10; 50; P < 
0.001) and on hippocampal glucose (F = 4.698; df = 10; 50; P < 0.001) when compared to 
baseline.  We can thus conclude that acetazolamide administration had a significant effect 
on hippocampal metabolism.   
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Figure 8.17:  Effect of drug administrations on hippocampal oxygen (CPE), showing the changes in 
area under the curve (AUC; nA.hour) for hippocampal oxygen following DMSO and acetazolamide 
injections. 
 
Comparing the effects of saline, DMSO and acetazolamide treatment on hippocampal 
oxygen, a 3 x 11 mixed factorial ANOVA with treatment (saline; DMSO; acetazolamide) 
as a between subject variable and time (baseline and hours 1-10 post-injection) as a within 
subject variable on the normalised data showed that there was a significant effect for 
treatment (F = 11.82; df = 2, 15; P < 0.001), time (F = 7.90; df = 10, 150; p < 0.001) as well 
as an interaction effect (F = 3.69; df = 20, 150; P < 0.001).  
Compared to saline injections at the same time points (i.e. 0-3 hours post-injection), a one-
way ANOVA on the AUC-analysed data showed that there was a significant effect for drug 
treatment on hippocampal oxygen (F = 36.46; df = 2, 16; P < 0.001;Figure 8.17). 
Bonferroni post-hoc analysis revealed that while there was no significant difference 
between saline- and DMSO-treated animals (P > 0.05), acetazolamide did have a 
significant effect on hippocampal oxygen. Acetazolamide treatment significantly increased 
hippocampal oxygen by 61.80 nA.hour compared to saline-treated animals (P < 0.001) and 
by 54.71 nA.hour compared to DMSO-treated animals (P < 0.001).  It was found that 
administration of acetazolamide causes a rapid increase in hippocampal oxygen lasting for 
several hours.  
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Figure 8.18:  Effect of drug administrations on hippocampal glucose (Pt/PPD/GOx), showing the 
changes in area under the curve (AUC; nA.hour) for hippocampal glucose following DMSO and 
acetazolamide injections. 
 
Comparing the effects of saline, DMSO and acetazolamide treatment on hippocampal 
glucose, a 3 x 11 mixed factorial ANOVA on the normalised data showed that there was a 
significant effect for treatment (F = 3.75; df = 2, 15; P < 0.05), time (F = 6.05; df = 10, 150; 
P < 0.001) as well as an interaction effect (F = 3.00; df = 20, 150; P < 0.001).  
Compared to saline injections, a one-way ANOVA on the AUC-analysed data showed that 
there was a significant effect for drug treatment on hippocampal glucose (F = 6.679; df = 2; 
14; P < 0.01;Figure 8.18). Bonferroni post-hoc analysis revealed that while there was no 
significant difference between saline- and DMSO-treated animals (P >0.05), acetazolamide 
did have a significant effect on hippocampal glucose. Acetazolamide treatment 
significantly increases hippocampal glucose by 0.84 nA.hour compared to saline-treated 
animals (P < 0.001) but there was no significant difference between acetazolamide- and 
DMSO-treated animals (P > 0.05). 
Analysis on the normalised data suggests that DMSO treatment resulted in a significant 
increase in hippocampal glucose levels beginning approximately 3 hours after the injection 
and this result was also found following acetazolamide treatment. As acetazolamide 
treatment in the absence of DMSO is not associated with any changes in striatal glucose 
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(Dixon et al., 2002), this suggests that acetazolamide treatment itself has no effect on 
hippocampal glucose but the DMSO used as the vehicle does. There may be an interaction 
between the DMSO and acetazolamide as the AUC analysis showed that acetazolamide 
treatment significantly increased hippocampal glucose levels.  
8.3.3.5 Effect of Anesthesia 
Chloral hydrate has been previously used to increase brain tissue O2 (Lowry & Fillenz, 
2001; Bolger & Lowry, 2005).  This increase in O2 is thought to be due to an increase in 
rCBF.  The effect of chloral hydrate on the hippocampal oxygen and glucose (n=6, 6 
animals) is plotted below in Figure 8.19. 
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Figure 8.19:  Effect of i.p. Chloral Hydrate (350mg/kg) administrations on hippocampal oxygen (closed 
circles) and glucose (open squares). Injection is indicated by an arrow at time = 0 hours. All data 
expressed as a percentage of pre-injection baseline levels. 
 
A repeated-measures ANOVA on the normalised data revealed that chloral hydrate 
treatment had a significant effect on hippocampal oxygen when compared to baseline (F = 
12.98; df = 10; 70; P < 0.001) and on hippocampal glucose when compared to baseline (F = 
4.696; df = 10; 70; P < 0.001). 
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Figure 8.20:  Effect of control and anaesthetic administrations on hippocampal oxygen (CPE), showing 
the changes in area under the curve (AUC; nA.hour) for hippocampal oxygen following saline and 
chloral hydrate injections. 
 
Comparing the effects of saline and chloral hydrate treatment on hippocampal oxygen, a 2 
x 11 mixed factorial ANOVA with treatment (saline; chloral hydrate) as a between subject 
variable, and time (baseline and hours 1-10 post-injection) as a within subject variable on 
the normalised data showed that there was no overall significant effect for treatment when 
compared to the saline-treated group (F = 3.539; df = 1, 120; P > 0.05). However, there was 
a significant effect for time (F = 9.661; df = 10, 120; p < 0.001) and a significant interaction 
effect (F = 7.121; df = 10, 120; P < 0.001).  
Compared to saline injections at the same time points (0-3 hours post-injection), an 
unpaired t-test on the AUC-analysed data revealed that there was a significant increase in 
hippocampal oxygen of 65.36 ± 18.33 nA.min compared to baseline (t = 3.565; df = 13; P < 
0.01; Figure 8.20).  
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Figure 8.21:  Effect of control and anaesthetic administrations on hippocampal glucose (Pt/PPD/GOx), 
showing the changes in area under the curve (AUC; nA.hour) for hippocampal glucose following saline 
and chloral hydrate injections. 
 
Comparing the effects of saline and chloral hydrate treatment on hippocampal glucose, a 2 
x 11 mixed factorial ANOVA with treatment  (saline; chloral hydrate) as a between subject 
variable, and time (baseline and hours 1-10 post-injection) as a within subject variable on 
the normalised data showed that there was a significant effect for treatment (F = 4.894; df = 
1, 120; P< 0.05), a significant effect for time (F = 2.964; df = 10, 120; P < 0.01) and a 
significant interaction effect (F = 3.512; df = 10, 120; P < 0.001).  An unpaired t-test on the 
AUC-analysed data revealed that there was a non-significant increase of 1.12 ± 0.68 
nA/min in hippocampal glucose (0-10 hours post-injection) compared to baseline (t = 
1.801; df = 11; P > 0.05; Figure 8.21). 
8.3.3.6 Basal concentrations of oxygen and glucose in the hippocampus 
Caution needs to be applied when using in vitro electrode calibration data to estimate in 
vivo concentrations. This is primarily because of the differences between a free solution and 
a tissue matrix; factors such as capacitance current, diffusion, sensitivity, etc. need to be 
considered. However, it can be useful to estimate concentration data and with this in mind 
two time points were selected from each rat (n=10) on the second day of recording (one in 
the day, one in the night) in order to determine extracellular concentrations for comparisons 
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with previously reported work. The second day was chosen to allow time for sensors to 
settle and to allow for the expected post-implantation drop in sensitivity for biosensors (Hu 
et al., 1994) and so that baseline levels were determined prior to any experimental 
interventions. The baseline current values were matched to the post-implantation 
calibration data for the CPE (average sensitivity to oxygen = -1.072 nA/µM) and the pre-
implantation calibration data for Pt/PPD/GOx (average sensitivity to glucose = 1.560 
nA/mM) as post-implantation calibration data is not available for Pt/PPD/GOx as the GOx 
component is lost during the explant procedure (Lowry et al., 2002). It was determined that 
the basal oxygen concentration in the hippocampus is 100.26 ± 5.76 µM during the day and 
99.37 ± 5.51 µM during the night. It was determined that the basal glucose concentration in 
the hippocampus is 0.60 ± 0.06 mM during the day and 0.57 ± 0.07 mM during the night. 
Paired t-tests revealed no significant differences between day and night for hippocampal 
oxygen (t = 0.3361; df = 9; P > 0.05) or for glucose (t = 1.700; df = 9; P > 0.05). However, 
it must be noted that hippocampal oxygen levels fluctuate based on activity (McHugh et al., 
2011) so it is difficult to determine a true basal concentration.  
8.3.4 +-Maze experiments 
Glucose has been measured in the hippocampus utilising the microdialysis technique by 
research groups such as McNay as discussed in Section 8.1, however, data using biosensors 
during the +-maze task has not been obtained.  Hippocampal oxygen data has been 
presented during maze tasks (McHugh et al., 2011) yet the simultaneous measurement of 
glucose and oxygen using sensors and biosensors has not been explored.  This section 
examines the effect of glucose on performance in the +-maze task as well as the changes in 
glucose and oxygen levels for saline-treated and glucose-treated animals before, during and 
after the +-maze task (Section 3.7.7).  
8.3.4.1 Effect of glucose treatment on performance in the +-maze task 
It has been found that an i.p. injection of glucose has a cognitive enhancing effect (McNay 
et al., 2000).  A significant difference was found between the saline-treated control group 
and the glucose-treated group.  Glucose-treated animals were shown to perform superiorly 
during the +-maze task compared to the control group.  The cognitive enhancing effect for 
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glucose treatment was investigated.  30 min prior to being placed in the +-maze the control 
group was treated with saline (0.9 %; 1.0 ml/kg i.p.; n=5) and the other was treated with 
glucose (250 mg/kg; 1.0 ml/kg i.p.; n=6). 
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Figure 8.22:  Spontaneous alternation scores (% total possible alternations ± SEM) for animals in the 
+-maze following treatment with either saline (0.9 % i.p.; n = 5) or glucose (250 mg/kg i.p.; n = 6). 
 
From the results presented in Figure 8.22 it can be seen there was no significant difference 
between the percentage of spontaneous alternations performed by either group with a P 
value of 0.4620.  It can be concluded that there is no cognitive enhancing effect for 
glucose-treated animals. 
8.3.4.2 Effect of glucose treatment on hippocampal glucose, monitored using 
Pt/PPD/GOx electrodes 
McNay and colleagues (2000) demonstrated that in addition to a cognitive enhancing effect 
for glucose treatment, such animals showed no performance-related reduction in 
hippocampal glucose levels. The saline-treated group showed a decrease in hippocampal 
glucose during the 20 min +-maze exploration trial.  The administration of saline and 
glucose on hippocampal oxygen and glucose was measured using CPEs and Pt/PPD/GOx 
electrodes respectively.  A typical raw data trace for each of these treatments is presented 
below in Figure 8.23. 
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Figure 8.23:  Typical raw data traces for oxygen and glucose from (A) an animal treated with saline 
(0.9 % i.p.) and (B) an animal treated with glucose (250 mg/kg i.p.) performing a +-maze task, 
monitored in the hippocampus using CPEs and Pt/PPD/GOx electrodes. 
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Data was averaged over 5 min periods to allow for direct comparisons to microdialysis 
data. Data was also averaged over 1 min periods to show the information that is lost over 5 
min averaging, demonstrating the limitations of microdialysis. Data was normalised to the 
post-injection time period (the 20 min prior to the maze). 
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Figure 8.24:  Hippocampal glucose monitored using Pt/PPD/GOx electrodes showing the average 
changes in glucose before, during and after a +-maze task with saline (n=5) and glucose (n=6) treated 
animals.   Data averaged in 5 min time bins with all data normalised to baseline levels. 
 
For data averaged over 5 min periods (Figure 8.24), a 2 x 12 repeated measures ANOVA 
showed that there was a significant effect for time on hippocampal glucose (F = 2.47; df = 
11, 110; P < 0.01). There was no significant effect for drug treatment (F = 0.362; df = 1, 
110; P > 0.05) and there was no interaction effect (F = 0.898; df = 11, 110; P > 0.05). A 
one way repeated ANOVA failed to show any significant differences between time points 
in either the saline-treated (F = 1.19; df = 11, 55; P > 0.05) or glucose-treated groups (F = 
1.78; df = 11, 55; P > 0.05). 
Chapter 8: Hippocampal Glucose & Oxygen  
262 
0 20 40 60
90
95
100
105
110
115
120
+-mazePost-injection Post-maze
Saline
Glucose
Time (min)
%
 P
o
s
t-
in
je
c
ti
o
n
( 
 S
E
M
)
 
Figure 8.25:  Hippocampal glucose monitored using Pt/PPD/GOx electrodes showing the average 
changes in glucose before, during and after a +-maze task with saline (n=5) and glucose (n=6) treated 
animals.   Data averaged in 1 min time bins with all data normalised to baseline levels. 
 
Data averaged over 1 min periods (Figure 8.25) also showed a significant effect for time on 
hippocampal glucose following a 2 x 60 repeated measures ANOVA (F = 2.07; df = 59, 
590; P < 0.001). There was no significant effect for drug treatment (F = 0.338; df = 1, 590; 
P > 0.05) and there was no interaction effect (F = 0.796; df = 59, 590; P > 0.05). Unlike the 
data averaged over 5 min, a one way repeated ANOVA  revealed that there was a 
significant difference between time points in the saline-treated group (F = 1.50; df = 59, 
295; P < 0.05).  From results presented in this section it can be seen that there is an increase 
in hippocampal glucose during exploration of the +-maze followed by a further increase 
when animals were returned to their home bowl therefore it can be determined that there is 
no performance related reduction in hippocampal glucose during the +-maze task.  
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8.3.4.3 Effect of glucose treatment on hippocampal O2 
The administration of saline and glucose on hippocampal oxygen was measured using 
CPEs during a +-maze task. Data was averaged over 5 min periods and over 1 min periods 
to allow comparisons to hippocampal glucose data presented in Section 8.3.4.2.  Data was 
normalised to the post-injection time period (the 20 min prior to the maze). 
0 20 40 60
90
100
110
120
130
140
+-mazePost-injection Post-maze
Saline
Glucose
Time (min)
%
 P
o
s
t-
in
je
c
ti
o
n
( 
 S
E
M
)
 
Figure 8.26:  Hippocampal oxygen monitored using CPEs showing the average changes in oxygen 
before, during and after a +-maze task with saline (n=5) and glucose (n=6) treated animals.   Data 
averaged in 5 min time bins with all data normalised to baseline levels. 
 
For data averaged over 5 min periods (Figure 8.26), a 2 x 12 repeated measures ANOVA 
showed that there was a significant effect for time on hippocampal O2 (F = 4.30; df = 11, 
110; P < 0.001). There was no significant effect for drug treatment (F = 3.66; df = 1, 110; P 
> 0.05) and there was no interaction effect (F = 1.18; df = 11, 110; P > 0.05). One way 
repeated ANOVA showed significant differences between time points in the saline-treated 
group (F = 3.62; df = 11, 55; P < 0.001).  
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Figure 8.27:  Hippocampal oxygen monitored using CPEs showing the average changes in oxygen 
before, during and after a +-maze task with saline (n=5) and glucose (n=6) treated animals.   Data 
averaged in 1 min time bins with all data normalised to baseline levels. 
 
Data averaged over 1 min periods (Figure 8.27) showed a significant effect for time on 
hippocampal O2 following a 2 x 60 repeated measures ANOVA (F = 4.53; df = 59, 590; P 
< 0.001). There was no significant effect for drug treatment (F = 3.62; df = 1, 590; P > 
0.05) and there was no interaction effect (F = 1.20; df = 59, 590; P > 0.05). A one way 
repeated ANOVA revealed that there was a significant difference between time points in 
the saline-treated group (F = 3.88; df = 59, 295; P < 0.001).  
From results presented in this section it can be seen that there is a significant increase in 
hippocampal oxygen in the first minutes in the maze and the first minutes following the 
animal being returned to the home bowl following the +-maze task.  As with the 
hippocampal glucose data (Section 8.3.4.3), there is some loss of accuracy by averaging 
over 5 min and the greater accuracy gained from using a smaller time resolution allows for 
a more complete picture of the changes occurring in the brain at any given time. 
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8.4 Conclusions 
CPEs have been previously used to measure hippocampal oxygen during various 
behavioural tasks (McHugh et al., 2011). Results presented in this chapter demonstrate the 
characterisation of hippocampal metabolism using CPEs and Pt/PPD/GOx electrodes and 
demonstrate that the temporal relationships between hippocampal oxygen and glucose 
levels vary during a number of different conditions. 
As discussed previously there have been few studies in which sensors are used to measure 
hippocampal glucose as the popular choice is the microdialysis technique.  Reported values 
for the glucose concentration in freely-moving rats in the hippocampus are between 1-1.5 
mM: 1.00 ± 0.06 mM (McNay & Gold, 1999), 1.20 ± 0.03 mM  (McNay et al., 2000), 1.05 
± 0.02 mM (McNay & Sherwin, 2004), 1.49 ± 0.05 mM (Rex et al., 2009) and 1.36 ± 0.04 
mM (De Bundel et al., 2009) higher than our findings of 0.60 ± 0.06 mM.  These studies 
utilise a zero net flux (ZNF) model of measuring glucose and there has been criticism of the 
use of this method to determine basal concentrations of analytes in the brain due to the 
trauma caused by the implantation of the microdialysis probe (Chen, 2003, 2005b, a, 2006). 
These criticisms are reinforced by the discrepancies observed between sensor recordings 
and microdialysis analysis due to the trauma caused by the much larger microdialysis probe 
(Khan & Michael, 2003).  Our concentration may also be artificially lower than actual 
concentrations as it has been shown that enzyme-based sensors have a tendency to lose 20-
50 % sensitivity when implanted into the brain (Hu et al., 1994). From these results and 
previous findings it is thought that the basal glucose concentration in the hippocampus is 
somewhere between our estimate and those of the microdialysis studies referenced above. 
Reported values for oxygen levels in the hippocampus are 33.6 mm Hg (~52.8 µM) in the 
anaesthetised gerbil (Nair et al., 1987) and 20.3 mm Hg (~31.9 µM) in the anaesthetised rat 
(Cater et al., 1961) much lower than our basal findings of 100.26 ± 5.78 µM.  These 
findings are only an estimate since baseline levels are difficult to establish as it is hard to 
objectively determine what constitutes a baseline level of activity when considering the 
normal functions of a specific brain region, and overall changes in rCBF could impact on 
the oxygen levels. 
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Results presented in Section 8.3.3.2.1 show that neuronal activation in the form of a tail 
pinch cause an increase in hippocampal oxygen, similar to findings in the striatum (Bolger 
& Lowry, 2005).  There was also an increase in hippocampal glucose, not consistent with 
findings in the striatum (Lowry et al., 1998a) where a decrease in striatal glucose was 
reported during a tail pinch and post-tail pinch a increase in glucose higher than baseline 
levels. This effect of the tail pinch on striatal glucose has also been found using 
microdialysis (Fray et al., 1996).  Findings in this thesis show an overshoot in hippocampal 
oxygen following removal of the clip and glucose rapidly returning to baseline levels.  It 
appears there is an increase in supply of hippocampal oxygen with a simultaneous increase 
in utlisation during the tail pinch.  Evidence for this is derived from the increase in oxygen 
when the clip is removed, the utlisation of hippocampal oxygen decreases as neuronal 
activation decreases.  However the supply remains elevated for several minutes upon 
removal of the clip thought to reflect an increase in the rCBF due to the stress induced 
increase in activity of the animal.  This increase may be due to an increase in locomotor 
activity which has been shown to be closely associated to increases in the hippocampal 
oxygen signal (McHugh et al., 2011).  For hippocampal glucose an increase in its supply 
but not in utilisation is observed, as tissue levels increased during the tail pinch.  This 
would suggest an alternative use for glucose during the tail pinch compared to the striatum.  
Differences in the brain regions are not unexpected as neuronal activation in the form of a 
tail pinch has been shown to increase striatal dopamine and ascorbic acid compared with 
and increase in 5-hydroxytryptamine and 5-hydroxyindole acetic acid in the hippocampus 
(Boutelle et al., 1990), possibly indicating different mechanisms and roles for the two 
regions. 
An increase in hippocampal oxygen was observed following the administration of 
acetazolamide which is similar to findings in the striatum where the increase in striatal 
oxygen was correlated to rCBF (Bolger & Lowry, 2005).  In order to administer 
acetazolamide the solvent DMSO was used as a vehicle for drug administration.  From the 
data presented in Sections 8.3.3.3.2 and 8.3.3.4.1 it can be seen that DMSO treatment 
resulted in a significant increase in hippocampal glucose seen approximately 3 hours post-
injection and this was also observed following acetazolamide treatment.  Acetazolamide 
administration in the absence of DMSO is not associated with any changes in striatal 
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glucose (Dixon et al., 2002), suggesting that acetazolamide has no effect on hippocampal 
glucose but the vehicle (DMSO) does.  DMSO’s effect on brain metabolism has been 
previously suggested.  The application of DMSO to brain slices, increases glucose 
consumption and in vitro administration of DMSO has been shown to cause more varied 
dose-dependent in effects on glucose metabolism (Nasrallah et al., 2008)  Comparing our 
results to those of these other groups where with low concentrations of DMSO 
administered directly to brain tissue causes rapid changes in glucose metabolism in contrast 
to our findings where high concentrations of DMSO administered intraperitoneally caused 
a delayed but long-lasting increase in glucose concentration, perhaps reflecting a decrease 
in glucose consumption over longer time periods. 
Results for the administration of the anaesthetic chloral hydrate (Section 8.3.3.5) show an 
increase in hippocampal oxygen during anaesthesia and an increase following return to 
consciousness.  These results are similar to results found in the striatum (Bolger & Lowry, 
2005).  This increase in oxygen is associated with a decrease in neuronal activation and an 
increase in rCBF (Lowry et al., 1998a; Lowry & Fillenz, 2001).  The suppression of neural 
activity by anaesthesia and its effects on glucose in the brain has been previously 
demonstrated using a number of different anaesthetic agents, including chloral hydrate 
(Fellows et al., 1992; Fillenz & Lowry, 1998; Lowry et al., 1998a; Lowry & Fillenz, 2001; 
Uematsu et al., 2009; Horn & Klein, 2010).  The increase in hippocampal glucose during 
anaesthesia has been observed with hippocampal microdialysis data (Horn & Klein, 2010), 
the striatum (Fellows et al., 1992) and also from glucose biosensor data in the cortex 
(Netchiporouk et al., 2001).  Conflicting results have also been reported using 
electrochemical detection in the striatum where the administration of chloral hydrate has 
been associated with a decrease in tissue glucose (Fillenz & Lowry, 1998; Lowry & 
Fillenz, 2001).  It would be expected that a decrease in neuronal activity would result in an 
increase in tissue glucose due to decreased utilisation.  This is supported by evidence to 
suggest that the brain switches between glucose and lactate as energy substrates during 
different levels of activity (Dienel & Hertz, 2001). The utilisation of glucose by the brain 
has been suggested to be dependent on neuronal activity (Serres et al., 2005) and revealed 
that there is an increased utilisation of lactate during chloral hydrate anaesthesia, suggesting 
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that the brain switches to lactate as the energy source during this anaesthesia (Yamada et 
al., 2009) and other anaesthetic conditions (Serres et al., 2004; Horn & Klein, 2010). 
Results presented in Section 8.3.4 show the simultaneous measurement of glucose and 
oxygen using Pt/PPD/GOx electrodes and CPEs respectively during a +-maze task.  It has 
been shown that sensors and biosensors can be applied to maze experiments to allow for 
behavioural and electrochemical data to be simultaneously obtained in real-time.  The 
cognitive enhancing effect for glucose treatment reported by McNay et al. (2000) and the 
performance related reduction in hippocampal glucose levels was investigated using 
glucose and oxygen electrodes.  Our results show no cognitive enhancement for glucose-
treated animals and no performance related reduction in hippocampal glucose during the +-
maze task. 
Results presented in this chapter demonstrate that neuronal activation (increased during tail 
pinch, restraint test and decreased during anaesthesia) can alter levels of hippocampal 
oxygen and glucose, and changes in hippocampal oxygen following administration of 
acetazolamide can be monitored.  It has also been determined that hippocampal oxygen and 
glucose can be measured in freely-moving animals for behavioural experiments providing a 
valuable tool to enable real-time neurochemical data and behavioural data to be obtained 
simultaneously. 
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9.1 Introduction 
The field of neurochemical analysis using electrochemical techniques has advanced 
significantly over the last fifty years since the first design of an electrode for detection in 
brain tissue by Clarke et al. (Clark et al., 1958; Clark Jr & Lyons, 1965).  It was not until 
Adams and co-workers published their seminal paper in 1973, that voltammetric techniques 
were more widely incorporated as an analytical tool for monitoring electroactive species in 
the brain (Kissinger et al., 1973).  This work is the foundation for the research presented in 
this thesis which attempts to further understand brain energy metabolism via the 
development oxygen sensors for potential use in clinical environments, as well as in 
conjunction with pre-clinical fMRI imaging studies.  The monitoring of glucose and 
oxygen in the hippocampus to determine how basic behavioural and pharmacological 
Chapter 4 details the in vitro characterisation of carbon paste electrodes (CPEs) and a Pt-
based electrode modified with methyl-methacrylate (MMA) which is potentially suitable 
for use in the clinical environment as it is widely used in a wide variety of life science 
technologies i.e. hard contact lenses and dental fillings and can be easily sterilised.  The 
effect of changes in temperature, pH, ions, convection, and implantation on the sensitivity 
of CPEs to O2 was investigated.  Pt-MMA electrodes were fully characterised in vitro by 
determining the sensitivity of the sensor to O2 and the effects on the sensitivity following 
exposure to proteins, lipids and brain tissue.  The effects of temperatures, pH, ions, 
convection, interferents and implantation were also examined along with the stability of the 
sensors in relation to time.  It was concluded that Pt-MMA electrodes (-0.093 ± 0.003 
µAmm
-2
µM
-1
 (n=64)) have a higher sensitivity to O2 than CPEs (-0.033 ± 0.001 µAmm
-
2
µM
-1
 (n=24)).  The physiological temperature (37°C) affects the sensitivity of CPEs and 
Pt-MMA electrodes similarly and although convection experiments show that Pt-MMA 
electrodes are less affected by stirring than CPEs, these results only prove to be relevant for 
in vitro experiments.  The effect of implantation of the sensors into the living brain showed 
that implantation has less of an effect on CPEs than Pt-MMA electrodes, although there 
was a difference in the implantation period of approximately 2 weeks. Our published data 
shows that CPEs have a stable baseline over 12 weeks (Bolger et al., 2011b). These results 
indicate that Pt-MMA electrodes are an ideal choice for detection of brain tissue O2 in vivo 
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over short periods of time due to their high sensitivity and small probe size (125 µm), but 
CPEs, given their excellent long-term stability, would be the sensor of choice for long-term 
monitoring of brain tissue O2. 
Following on from the previous chapter, Chapter 5 investigates and characterises the use of 
Pt-MMA electrodes for the detection of brain tissue O2 in the striatum.  Pt-based electrodes 
have been shown to be a potential alternative to CPEs to monitor brain tissue O2 (Bolger et 
al., 2011a).  Comparisons between the Pt-MMA electrodes were made with striatal CPE 
data (Bolger & Lowry, 2005).  It has been demonstrate that Pt-MMA electrodes have the 
ability to monitor changes in striatal O2, evidenced by the response of the sensors to the 
administration of O2 and N2 gases to the animal’s snout.  The changes in tissue O2 
following neuronal activation in the form of a tail pinch, and the administrations of saline, 
DMSO, acetazolamide and chloral hydrate have also been demonstrated.  Pt-MMA 
electrodes exhibit a greater change in O2 current in terms of current density compared to 
CPEs when implanted in the striatum of freely-moving rats demonstrating that Pt-MMA 
electrodes provide a viable alternative to CPEs to monitor tissue O2 in the brain.  However, 
Pt-MMA electrodes are only suitable for short-term monitoring (established in Chapter 4) 
as there is a large reduction in sensitivity after 19 ± 3 days.  
 
The aim of Chapter 6 was to fabricate a stable and reproducible metal-free electrode for use 
in conjunction with fMRI studies that can be characterised in vitro and in vivo.  This 
follows on from work by (Lowry et al.) where BOLD fMRI and amperometric tissue O2 
data from  rat cerebral cortex was obtained verifying that real-time  metabolic information 
can be acquired during fMRI investigations and that the changes in the magnitude of the 
BOLD response can be directly correlated to changes in tissue O2 concentrations.  This 
technique provides an alternative to fMRI experiments as these O2 sensors can be used in 
freely-moving animals eliminating the disadvantages of anaesthesia. Carbon fibre 
electrodes (CFEs) were utilised in this study but were not standardised in terms of 
manufacture.  There were variations in both the amounts of carbon fibre strands that were 
used in each electrode and also the length of the carbon fibres. Due to the varying 
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dimensions of the carbon fibre bundle, reproducibility was difficult to obtain therefore 
hindering the characterisation of these sensors.  The chapter initially explored the 
standardisation of the CFEs which proved not to be successful so the examination of 
carbon-based composite electrode incorporating a CF transducer was investigated.  A 
carbon Rhoplex
®
 composite electrode (CRCE) was developed and subsequently 
characterised in vitro.  CRCEs were found to be biocompatible with no significant 
reduction in the sensitivity following exposure to proteins, lipids and brain tissue.  
However, the physiological temperature (37°C) affects the CRCEs causing a large increase 
in sensitivity.  Changes in pH did have an effect on the sensitivity, though changes in ions 
showed no significant effect.  The effect of implantation of the sensors into the living brain 
indicated that implantation has a detrimental effect on the sensitivity of the CRCEs which 
is thought to be due to fouling of the active surface of the electrodes.  During preliminary 
acute in vivo experiments (Chapter 7) using the CRCE it was found that the electrodes 
background current did not reach a steady state quickly enough for experiments to take 
place.  An fMRI compatible acute design was explored with an attempt at minimising the 
settling time which was unsuccessful.  The original CRCE design was found to be the 
superior design.  CRCEs can therefore be deemed suitable for use in chronic in vivo fMRI 
experiments for the detection of brain tissue O2 with further modifications such as 
elimination of the majority of the CF wire and pre-conditioning the sensors before the acute 
in vivo experiments by applying a potential to the electrodes overnight prior to the acute 
implantation. 
Chapter 7 investigated and characterised the use of CRCEs for the detection of brain tissue 
O2 in the striatum of freely-moving animals, following on from the in vitro characterisation 
in the previous chapter. It has been demonstrated that CRCEs (freely-moving design) have 
the ability to monitor changes in striatal O2, evidenced by the response of the sensors to the 
administration of O2 and N2 gases to the animal’s snout.  The changes in tissue O2 
following neuronal activation in the form of a restraint test, as well as the administrations 
of acetazolamide and chloral hydrate have also been demonstrated. These results compare 
well to CPE data (Bolger & Lowry, 2005). It can therefore be concluded that CRCEs 
provide a viable alternative to metal electrodes to monitor brain tissue O2 but do not offer 
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any advantage in comparison to CPEs in terms of stability or biocompatibility.  CRCEs are 
only suitable for short-term monitoring as there is a large reduction in sensitivity after 9 ± 2 
days.  The preliminary acute experiment using the CRCE full fMRI design performed in an 
anesthetised animal was not successful due to the background current not stabilising in 
time.  An alternative design was investigated in Chapter 6, however, the original CRCE 
proved to be the best design in terms of settling time. Therefore an elimination of the CF 
wire, pre-conditioning the electrodes and alterations to the acute experimental set-up are 
thought to be the remedy to this problem. 
Chapter 7 investigated and characterised the use of CRCEs for the detection of brain tissue 
O2 in the striatum of freely-moving animals, following on from the in vitro characterisation 
in the previous chapter. It has been demonstrated that CRCEs (freely-moving design) have 
the ability to monitor changes in striatal O2, evidenced by the response of the sensors to the 
administration of O2 and N2 gases to the animal’s snout.  The changes in tissue O2 
following neuronal activation in the form of a restraint test, as well as the administrations 
of acetazolamide and chloral hydrate have also been demonstrated. These results compare 
well to CPE data (Bolger & Lowry, 2005). It can therefore be concluded that CRCEs 
provide a viable alternative to metal electrodes to monitor brain tissue O2 but do not offer 
any advantage in comparison to CPEs in terms of stability or biocompatibility.  CRCEs are 
only suitable for short-term monitoring as there is a large reduction in sensitivity after 9 ± 2 
days.  The preliminary acute experiment using the CRCE full fMRI design performed in an 
anesthetised animal was not successful due to the background current not stabilising in 
time.  An alternative design was investigated in Chapter 6, however, the original CRCE 
proved to be the best design in terms of settling time. Therefore an elimination of the CF 
wire, pre-conditioning the electrodes and alterations to the acute experimental set-up are 
thought to be the remedy to this problem. 
Continuation of this body of work would involve the application and characterisation of the 
CRCEs in fMRI studies.  This would allow for real-time metabolic information to be 
acquired during fMRI and allow for tissue O2 concentrations to be monitored, and the 
relationship between BOLD and tissue O2 when variations in metabolic demand are 
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induced by local stimulation.  Although Long-term In Vivo Electrochemistry (LIVE) cannot 
substitute for imaging techniques such as fMRI in terms of providing whole brain 
information it might however be possible by implanting several electrodes at one time to 
measure the synchrony of activity between brain regions with a high temporal resolution.  
As LIVE can be applied to various neurochemicals the combination of these techniques 
may provide numerous possibilities for investigating the direct relationship between fMRI 
signal changes and the underlying neurochemistry across a range of different stimulation 
paradigms.  In the case of monitoring tissue O2 and glucose simultaneously in the 
hippocampus work is on-going in our group to compare hippocampal activity to different 
behaviours in a +-maze task.  Making it a possibility that LIVE during behavioural tasks 
can be coupled with drug interventions such as induced disease states and the changes 
observed can be compared directly to more traditional methods such as electrophysiological 
recordings and microdialysis sampling. 
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